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This study utilizes electronic health record data from the Medical University of
South Carolina’s intensive care units as the basis for this Monte Carlo simulation study—
which compares four methods for handling missing SOFA scores, both at the composite
and component levels. The four methods examined herein include: complete case
analysis, median imputation, zero imputation (the method recommended by the creators
of the SOFA score), and multiple imputation. This study found that zero imputation
introduced the most bias across all three outcomes studied, and therefore is not
recommended. Complete case analysis, or ignoring missing data, caused varying amounts
of bias—as did median imputation. Multiple imputation, on the other hand, performed
well for all three outcomes studied, both at the composite and component levels,
demonstrating this method’s superior value in the presence of missing SOFA scores.

iii

TABLE OF CONTENTS

Acknowledgements .......................................................................................................................... ii
List of Acronyms ........................................................................................................................... vii
List of Figures ............................................................................................................................... viii
List of Tables ................................................................................................................................ xvi
1

INTRODUCTION ................................................................................................................... 1

2

REVIEW OF THE LITERATURE.......................................................................................... 5
2.1

Problem Statement: Why Missing Data are Problematic ................................................. 5

2.2

Current State of Handling Missing Data in Health Services Research ............................ 7

2.3

Electronic Health Record Data for Research ................................................................. 10

2.4

Clinical Background – Respiratory Failure ................................................................... 13

2.4.1

Respiratory Failure: Population Statistics .............................................................. 13

2.4.2

Ventilator-Dependent Respiratory Failure ............................................................. 14

2.4.3

Respiratory Failure: Pathology .............................................................................. 15

2.5

Severity of Illness Scoring ............................................................................................. 15

2.5.1

SOFA Score ........................................................................................................... 16

2.5.2

Interpretation of SOFA Score ................................................................................ 21

2.5.3

Examples of SOFA Score in the Literature............................................................ 23

2.5.4

Missingness of SOFA Score Items ........................................................................ 23

2.6

Mechanisms of Missingness .......................................................................................... 24

2.6.1

Missing Completely at Random (MCAR) ............................................................. 25

2.6.2

Missing at Random (MAR).................................................................................... 25

2.6.3

Missing Not at Random (MNAR) .......................................................................... 26

2.6.4

Tests for Missing Data Mechanism ....................................................................... 27

2.7

Missing Data Patterns .................................................................................................... 28

2.8

Amount of Missing Data ................................................................................................ 29

2.9

Analytical Approaches to Missing Data ........................................................................ 29

2.9.1

Adjustment Methods .............................................................................................. 30

2.9.2

Imputation Methods ............................................................................................... 32

2.9.2.1

Deterministic Imputation ................................................................................... 32

2.9.2.2

Single Imputation ............................................................................................... 34

2.9.2.3

Multiple Imputation ........................................................................................... 35

2.9.3

Likelihood Methods ............................................................................................... 39
iv

2.9.3.1

Maximum Likelihood Estimation with EM Algorithm ..................................... 40

2.9.3.2

Full Information Maximum Likelihood ............................................................. 41

2.9.4
2.10
3

Recapitulation ................................................................................................................ 44

METHODS ............................................................................................................................ 45
3.1

Specific Aims and Hypotheses ...................................................................................... 45

3.2

Data Source .................................................................................................................... 46

3.3

Study Population ............................................................................................................ 47

3.4

Statistical Software and Data Management ................................................................... 48

3.5

Methods for Multiple Item Instruments ......................................................................... 48

3.6

Aim 1 – Univariate Missingness (SOFA Score, Composite Level) ............................... 50

3.7

Aim 2 – Multivariate Missingness (SOFA Score, Item Level) ...................................... 50

3.8

Simulation Process & Outcomes Analysis..................................................................... 51

3.8.1

Simulation Algorithm ............................................................................................ 51

3.8.2

Simulation Parameters ........................................................................................... 52

3.8.2.1

Missing Data Mechanism & Generation of Missing Data ................................. 53

3.8.2.2

Assignment of Missing Data Patterns ................................................................ 55

3.8.2.3

Simulation Runs & Percent Missingness ........................................................... 55

3.8.3

Missing Data Methods ........................................................................................... 56

3.8.3.1

Method 1: Complete Case Analysis ................................................................... 57

3.8.3.2

Method 2: Median Imputation ........................................................................... 58

3.8.3.3

Method 3: Imputation per SOFA Guidelines (Zero) .......................................... 58

3.8.3.4

Method 4: Multiple Imputation .......................................................................... 59

3.8.4

4

Methods Available in Common Statistical Software ............................................. 41

Analysis of Outcomes ............................................................................................ 61

3.8.4.1

Outcome 1: Death .............................................................................................. 62

3.8.4.2

Outcome 2: Total Charges ................................................................................. 63

3.8.4.3

Outcome 3: ICU Length of Stay ........................................................................ 65

3.8.5

Output of Results from Simulations....................................................................... 66

3.8.6

Assessment of Simulation ...................................................................................... 67

3.8.7

Monitoring of Simulation Process ......................................................................... 68

RESULTS .............................................................................................................................. 71
4.1

Data Used in Dissertation .............................................................................................. 71

4.1.1

Descriptive Characteristics .................................................................................... 73

4.1.2

Bivariate Analyses ................................................................................................. 75

4.1.3

SOFA Scores .......................................................................................................... 76

4.1.3.1

Missing Data Mechanism................................................................................... 76
v

4.2

Missing Data Patterns ........................................................................................ 79

4.1.3.3

Distribution of SOFA Scores ............................................................................. 82

Fully-Observed Dataset Outcomes ................................................................................ 83

4.2.1

Outcome 1: Death .................................................................................................. 84

4.2.2

Outcome 2: Total Charges ..................................................................................... 87

4.2.3

Outcome 3: ICU Length of Stay ............................................................................ 91

4.3

Aim 1 – Results .............................................................................................................. 94

4.3.1

Outcome 1: Death .................................................................................................. 95

4.3.2

Outcome 2: Total Charges ................................................................................... 102

4.3.3

Outcome 3: ICU Length of Stay .......................................................................... 109

4.4

Aim 2 – Results ............................................................................................................ 116

4.4.1

Outcome 1: Death ................................................................................................ 116

4.4.2

Outcome 2: Total Charges ................................................................................... 123

4.4.3

Outcome 3: ICU Length of Stay .......................................................................... 130

4.5
5

4.1.3.2

Summary and Comparison of Results .......................................................................... 137

DISCUSSION ...................................................................................................................... 139
5.1

Integration of Findings ................................................................................................. 139

5.2

Limitations ................................................................................................................... 142

5.3

Future Research ........................................................................................................... 143

APPENDICES ............................................................................................................................. 145
Appendix A. Analytical approaches to missing data, search terms ......................................... 146
Appendix B. Performance of missing data methods, tables..................................................... 147
Appendix C. Correlation table ................................................................................................. 153
Appendix D. Example SAS Code ............................................................................................ 155
REFERENCES ............................................................................................................................ 162

vi

List of Acronyms
ACA
APACHE
AUROC
BMI
CAM-ICU
CCA
CDW
EB
EM
EHR
FCS
GCS
GDP
FIML
HCUP
HSR
ICD-9-CM
ICD-10-CM
ICU
IPW
NIS
LOCF
MAP
MAR
MCAR
MCMC
MI
MICE
MIM
MLE
MNAR
MODS
MVNI
PICU
RASS
SBT
SIRS
SOFA
VDRF

Available case analysis
Acute physiology age and chronic health evaluation system
Area under the receiver operating characteristic curve
Body mass index
Confusion assessment method for the ICU
Complete case analysis
Clinical data warehouse
Entropy balance
Expectation maximization algorithm for maximum likelihood estimation
Electronic health record
Fully-conditional specification (another term for MICE)
Glasgow coma scale
Gross domestic product
Full information maximum likelihood
Healthcare cost and utilization project
Health services research
International Classification of Diseases, 9th revision, clinical modification
International Classification of Diseases, 10th revision, clinical modification
Intensive care unit
Inverse probability weighting
Nationwide Inpatient Sample
Last observation carried forward
Mean arterial pressure
Missing at random
Missing completely at random
Markov-chain Monte Carlo multiple imputation (an implementation of MVNI)
Multiple imputation
Multivariate imputation by chained equations
Missing indicator method
Maximum likelihood estimation
Missing not at random
Multiple organ dysfunction syndrome
Multivariate normal imputation
Pediatric intensive care unit
Richmond Agitation-Sedation Scale
Spontaneous breathing trial
Systemic inflammatory response syndrome criteria
Sequential organ failure assessment
Ventilator-dependent respiratory failure

vii

List of Figures
Figure 2.1 Maximum SOFA score vs. in-ICU mortality rate [84] ................................................. 22
Figure 2.2 Complete data matrix ................................................................................................... 24
Figure 2.3 Missing data patterns, monotonic vs. non-monotonic .................................................. 28
Figure 2.4 Taxonomy of analytical approaches to missing data .................................................... 30
Figure 2.5 Conceptual diagram of multiple imputation ................................................................. 37
Figure 3.1 Simulation algorithm .................................................................................................... 52
Figure 4.1 Data flow diagram ........................................................................................................ 72
Figure 4.2 Histogram of SOFA scores in the fully-observed dataset ............................................ 82
Figure 4.3 Forest plot of the odds ratios and 95% confidence intervals for predicting in-hospital
death in the fully-observed dataset ................................................................................................ 86
Figure 4.4 Comparison of percent coverage of the 95% confidence interval for the parameter
estimates of the SOFA score in the logistic regression model predicting Death (Aim 1 –
Composite Level) ........................................................................................................................... 97
Figure 4.5 Comparison of relative bias of parameter estimates of the SOFA score among the
methods for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MAR missing data mechanism (Aim 1 – Composite Level) ............... 98
Figure 4.6 Comparison of relative bias of parameter estimates of the SOFA score among the
methods for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MNAR Left missing data mechanism (Aim 1 – Composite Level) ..... 98
Figure 4.7 Comparison of relative bias of parameter estimates of the SOFA score among the
methods for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MNAR Middle missing data mechanism (Aim 1 – Composite Level) 99
Figure 4.8 Comparison of relative bias of parameter estimates of the SOFA score among the
methods for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MNAR Right missing data mechanism (Aim 1 – Composite Level) ... 99
viii

Figure 4.9 Comparison of the efficiency of parameter estimates of the SOFA score among the
methods for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MAR missing data mechanism (Aim 1 – Composite Level) ............. 100
Figure 4.10 Comparison of efficiency estimates for the SOFA score among the methods for
handling missingness at the composite-level in the logistic regression model predicting Death,
with the MNAR Left missing data mechanism (Aim 1 – Composite Level) ................................ 100
Figure 4.11 Comparison of efficiency estimates for the SOFA score among the methods for
handling missingness at the composite-level in the logistic regression model predicting Death,
with the MNAR Middle missing data mechanism (Aim 1 – Composite Level) ........................... 101
Figure 4.12 Comparison of efficiency estimates for the SOFA score among the methods for
handling missingness at the composite-level in the logistic regression model predicting Death,
with the MNAR Right missing data mechanism (Aim 1 – Composite Level) .............................. 101
Figure 4.13 Comparison of percent coverage of the 95% confidence interval for the parameter
estimates of the SOFA score in the gamma-transformed log linked generalized linear model
predicting Total Charges (Aim 1 – Composite Level) ................................................................ 104
Figure 4.14 Comparison of relative bias of parameter estimates of the SOFA score in the gammatransformed log linked generalized linear model predicting Total Charges, with the MAR missing
data mechanism (Aim 1 – Composite Level)............................................................................... 105
Figure 4.15 Comparison of relative bias of parameter estimates of the SOFA score in the gammatransformed log linked generalized linear model predicting Total Charges, with the MNAR Left
missing data mechanism (Aim 1 – Composite Level) ................................................................. 105
Figure 4.16 Comparison of relative bias of parameter estimates of the SOFA score in the gammatransformed log linked generalized linear model predicting Total Charges, with the MNAR
Middle missing data mechanism (Aim 1 – Composite Level) ..................................................... 106

ix

Figure 4.17 Comparison of relative bias of parameter estimates of the SOFA score in the gammatransformed log linked generalized linear model predicting Total Charges, with the MNAR Right
missing data mechanism (Aim 1 – Composite Level) ................................................................. 106
Figure 4.18 Comparison of the efficiency of parameter estimates of the SOFA score in the
gamma-transformed log linked generalized linear model predicting Total Charges, with the MAR
missing data mechanism (Aim 1 – Composite Level) ................................................................. 107
Figure 4.19 Comparison of the efficiency of parameter estimates of the SOFA score in the
gamma-transformed log linked generalized linear model predicting Total Charges, with the
MNAR Left missing data mechanism (Aim 1 – Composite Level) .............................................. 107
Figure 4.20 Comparison of the efficiency of parameter estimates of the SOFA score in the
gamma-transformed log linked generalized linear model predicting Total Charges, with the
MNAR Middle missing data mechanism (Aim 1 – Composite Level) ......................................... 108
Figure 4.21 Comparison of the efficiency of parameter estimates of the SOFA score in the
gamma-transformed log linked generalized linear model predicting Total Charges, with the
MNAR Right missing data mechanism (Aim 1 – Composite Level) ............................................ 108
Figure 4.22 Comparison of percent coverage of the 95% confidence interval for the parameter
estimates of the SOFA score in the negative binomial generalized linear model predicting ICU
Length of Stay (Aim 1 – Composite Level) ................................................................................. 111
Figure 4.23 Comparison of relative bias of parameter estimates of the SOFA score in the negative
binomial generalized linear model predicting ICU Length of Stay, with the MAR missing data
mechanism (Aim 1 – Composite Level) ...................................................................................... 112
Figure 4.24 Comparison of relative bias of parameter estimates of the SOFA score in the negative
binomial generalized linear model predicting ICU Length of Stay, with the MNAR Left missing
data mechanism (Aim 1 – Composite Level)............................................................................... 112

x

Figure 4.25 Comparison of relative bias of parameter estimates of the SOFA score in the negative
binomial generalized linear model predicting ICU Length of Stay, with the MNAR Middle missing
data mechanism (Aim 1 – Composite Level)............................................................................... 113
Figure 4.26 Comparison of relative bias of parameter estimates of the SOFA score in the negative
binomial generalized linear model predicting ICU Length of Stay, with the MNAR Right missing
data mechanism (Aim 1 – Composite Level)............................................................................... 113
Figure 4.27 Comparison of the efficiency of parameter estimates of the SOFA score in the
negative binomial generalized linear model predicting ICU Length of Stay, with the MAR missing
data mechanism (Aim 1 – Composite Level)............................................................................... 114
Figure 4.28 Comparison of the efficiency of parameter estimates of the SOFA score in the
negative binomial generalized linear model predicting ICU Length of Stay, with the MNAR Left
missing data mechanism (Aim 1 – Composite Level) ................................................................. 114
Figure 4.29 Comparison of the efficiency of parameter estimates of the SOFA score in the
negative binomial generalized linear model predicting ICU Length of Stay, with the MNAR
Middle missing data mechanism (Aim 1 – Composite Level) ..................................................... 115
Figure 4.30 Comparison of the efficiency of parameter estimates of the SOFA score in the
negative binomial generalized linear model predicting ICU Length of Stay, with the MNAR Right
missing data mechanism (Aim 1 – Composite Level) ................................................................. 115
Figure 4.31 Comparison of percent coverage of the 95% confidence interval for the parameter
estimates of the SOFA score in the logistic regression model predicting Death (Aim 2 –
Component Level) ....................................................................................................................... 118
Figure 4.32 Comparison of relative bias of parameter estimates of the SOFA score among the
methods for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MAR missing data mechanism (Aim 2 – Component Level) ............ 119

xi

Figure 4.33 Comparison of relative bias of parameter estimates of the SOFA score among the
methods for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MNAR Left missing data mechanism (Aim 2 – Component Level) .. 119
Figure 4.34 Comparison of relative bias of parameter estimates of the SOFA score among the
methods for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MNAR Middle missing data mechanism (Aim 2 – Component Level)
..................................................................................................................................................... 120
Figure 4.35 Comparison of relative bias of parameter estimates of the SOFA score among the
methods for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MNAR Right missing data mechanism (Aim 2 – Component Level) 120
Figure 4.36 Comparison of the efficiency of parameter estimates of the SOFA score among the
methods for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MAR missing data mechanism (Aim 2 – Component Level) ............ 121
Figure 4.37 Comparison of the efficiency of parameter estimates of the SOFA score among the
methods for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MNAR Left missing data mechanism (Aim 2 – Component Level) .. 121
Figure 4.38 Comparison of the efficiency of parameter estimates of the SOFA score among the
methods for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MNAR Middle missing data mechanism (Aim 2 – Component Level)
..................................................................................................................................................... 122
Figure 4.39 Comparison of the efficiency of parameter estimates of the SOFA score among the
methods for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MNAR Right missing data mechanism (Aim 2 – Component Level) 122
Figure 4.40 Comparison of percent coverage of the 95% confidence interval for the parameter
estimates of the SOFA score in the gamma-transformed log linked generalized linear model
predicting Total Charges (Aim 2 – Component Level) ............................................................... 125
xii

Figure 4.41 Comparison of relative bias of parameter estimates of the SOFA in the gammatransformed log linked generalized linear model predicting Total Charges, with the MAR missing
data mechanism (Aim 2 – Component Level) ............................................................................. 126
Figure 4.42 Comparison of relative bias of parameter estimates of the SOFA in the gammatransformed log linked generalized linear model predicting Total Charges, with the MNAR Left
missing data mechanism (Aim 2 – Component Level) ................................................................ 126
Figure 4.43 Comparison of relative bias of parameter estimates of the SOFA in the gammatransformed log linked generalized linear model predicting Total Charges, with the MNAR
Middle missing data mechanism (Aim 2 – Component Level).................................................... 127
Figure 4.44 Comparison of relative bias of parameter estimates of the SOFA in the gammatransformed log linked generalized linear model predicting Total Charges, with the MNAR Right
missing data mechanism (Aim 2 – Component Level) ................................................................ 127
Figure 4.45 Comparison of the efficiency of parameter estimates of the SOFA score in the
gamma-transformed log linked generalized linear model predicting Total Charges, with the MAR
missing data mechanism (Aim 2 – Component Level) ................................................................ 128
Figure 4.46 Comparison of the efficiency of parameter estimates of the SOFA score in the
gamma-transformed log linked generalized linear model predicting Total Charges, with the
MNAR Left missing data mechanism (Aim 2 – Component Level) ............................................. 128
Figure 4.47 Comparison of the efficiency of parameter estimates of the SOFA score in the
gamma-transformed log linked generalized linear model predicting Total Charges, with the
MNAR Middle missing data mechanism (Aim 2 – Component Level) ........................................ 129
Figure 4.48 Comparison of the efficiency of parameter estimates of the SOFA score in the
gamma-transformed log linked generalized linear model predicting Total Charges, with the
MNAR Right missing data mechanism (Aim 2 – Component Level) .......................................... 129

xiii

Figure 4.49 Comparison of percent coverage of the 95% confidence interval for the parameter
estimates of the SOFA score in the negative binomial generalized linear model predicting ICU
Length of Stay (Aim 2 – Component Level) ................................................................................ 132
Figure 4.50 Comparison of relative bias of parameter estimates of the SOFA score in the negative
binomial generalized linear model predicting ICU Length of Stay, with the MAR missing data
mechanism (Aim 2 – Component Level) ..................................................................................... 133
Figure 4.51 Comparison of relative bias of parameter estimates of the SOFA score in the negative
binomial generalized linear model predicting ICU Length of Stay, with the MNAR Left missing
data mechanism (Aim 2 – Component Level) ............................................................................. 133
Figure 4.52 Comparison of relative bias of parameter estimates of the SOFA score in the negative
binomial generalized linear model predicting ICU Length of Stay, with the MNAR Middle missing
data mechanism (Aim 2 – Component Level) ............................................................................. 134
Figure 4.53 Comparison of relative bias of parameter estimates of the SOFA score in the negative
binomial generalized linear model predicting ICU Length of Stay, with the MNAR Right missing
data mechanism (Aim 2 – Component Level) ............................................................................. 134
Figure 4.54 Comparison of the efficiency of parameter estimates of the SOFA score in the
negative binomial generalized linear model predicting ICU Length of Stay, with the MAR missing
data mechanism (Aim 2 – Component Level) ............................................................................. 135
Figure 4.55 Comparison of the efficiency of parameter estimates of the SOFA score in the
negative binomial generalized linear model predicting ICU Length of Stay, with the MNAR Left
missing data mechanism (Aim 2 – Component Level) ................................................................ 135
Figure 4.56 Comparison of the efficiency of parameter estimates of the SOFA score in the
negative binomial generalized linear model predicting ICU Length of Stay, with the MNAR
Middle missing data mechanism (Aim 2 – Component Level).................................................... 136

xiv

Figure 4.57 Comparison of the efficiency of parameter estimates of the SOFA score in the
negative binomial generalized linear model predicting ICU Length of Stay, with the MNAR Right
missing data mechanism (Aim 2 – Component Level) ................................................................ 136

xv

List of Tables
Table 1 SOFA score calculation .................................................................................................... 18
Table 2 Scoring of the Glasgow Coma Scale (GCS) ..................................................................... 20
Table 3 Missing data methods available in SAS, SPSS, and Stata ................................................ 43
Table 4 ICD-9 and ICD-10 procedure codes for study inclusion .................................................. 48
Table 5 Example calculations of the SOFA score ......................................................................... 49
Table 6 Simulation output table (example) .................................................................................... 67
Table 7 Demographics and characteristics of patients in the original dataset ............................... 74
Table 8 Interpretation of Spearman’s rank correlation coefficients............................................... 76
Table 9 Odds ratios and 95% confidence intervals for predicting a SOFA score being missing in
the original data ............................................................................................................................. 78
Table 10 Frequency of missing SOFA score components in original data .................................... 80
Table 11 Twenty-five most common missing data patterns .......................................................... 81
Table 12 Distribution of SOFA scores in the fully-observed dataset ............................................ 83
Table 13 Odds ratios and 95% confidence intervals for predicting in-hospital death in the fullyobserved dataset ............................................................................................................................. 85
Table 14 Differences (expressed as a ratio) between the point estimates and 95% confidence
intervals for Total Charges in comparison to reference groups in the fully-observed dataset ....... 89
Table 15 Least squares means exponentiated point estimates and 95% confidence intervals for
Total Charges, expressed in thousands of dollars, in the fully-observed dataset ........................... 90
Table 16 Differences (expressed as a ratio) between the point estimates and 95% confidence
intervals for ICU Length of Stay in comparison to reference groups in the fully-observed dataset
....................................................................................................................................................... 92
Table 17 Least squares means exponentiated point estimates and 95% confidence intervals for
ICU Length of Stay, expressed in days, in the fully-observed dataset .......................................... 93
Table 18 Coverage of the 95% confidence interval for various missing data methods (Aim 1) . 147
xvi

Table 19 Coverage of the 95% confidence interval for various missing data methods (Aim 2) . 148
Table 20 Relative bias for various missing data methods (Aim 1) .............................................. 149
Table 21 Relative bias for various missing data methods (Aim 2) .............................................. 150
Table 22 Efficiency for various missing data methods (Aim 1) .................................................. 151
Table 23 Efficiency for various missing data methods (Aim 2) .................................................. 152
Table 24 Intercorrelations for variables used in this study, measured by Spearman’s rank
correlation coefficient, ρs ............................................................................................................ 154

xvii

1

INTRODUCTION
The cost of caring for critically-ill patients has grown from $55.5 billion in 2000 [1] to $81.7

billion in 2005 [2]. The increase in expenditures on critical care medicine from 2000-2005
represents an 17.9% increase in percent of gross domestic product (GDP) over a five-year span,
from 0.56% to 0.66% of GDP, accounting for 4.1% of health expenditures nationwide—
demonstrating the costs are growing in comparison with overall national expenditures. This rapid
increase in expenditures on critical care could be partially attributed to the rise in incidence of
mechanical ventilation amongst adults in intensive care units (ICU), which increased from 284
per 100,000 adults in 1996 to 314 per 100,000 in 2002 [3]. While these figures are in need of
refreshing with more recent estimates, they illustrate the magnitude of money that is spent in one
area of medicine, critical care medicine, and how this area has a measurable impact on our
nation’s budget.
Admission to an ICU not only has large financial consequences, sequelae of stays in the ICU
also manifest. One such outcome is the development of acute post-traumatic stress disorder
(PTSD) related symptoms, possibly due to delirium during the patient’s ICU stay [4, 5].
Approximately 1 in every 5 ICU survivors have clinically-significant PTSD symptoms within 12
months of ICU discharge [6]. Several recommendations for decreasing the likelihood of PTSD
symptoms and other psychiatric morbidities exist. The first recommendation includes offering
lighter amounts of sedation to improve patient recall [7]. Another recommendation is to have ICU
diaries, written in the second person in patient-friendly language by clinicians caring for the
patient and family members [6]. Finally, another recommendation is to use the ABCDEF bundle
(Assess, prevent, and manage pain; Both spontaneous awakening trials and spontaneous breathing
trials; Choice of analgesia and sedation; Delirium: assess, prevent, and manage; Early mobility
and exercise; and Family engagement and empowerment [8]) to improve outcomes [5]. Other
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potential sequalae of ICU stays include anxiety, depression, cognitive impairments, family and
social network distress, sleep abnormalities, general distress, and diminished quality of life [9].
The problems of increasing costs of caring for the critically ill, as well as comorbidities
associated with that care, drive the need for research to improve patient outcomes and reduce
overall costs. This is accomplished through both interventional and retrospective studies.
Interventional studies within the intensive care unit are increasingly using designs such as the
pragmatic cluster-randomized stepped wedge design. This design specifies that all clusters—in
this case ICUs—will be randomly crossed over from the control group to the intervention group
[10]. In both interventional and retrospective outcomes studies, use of a patient severity score—
such as the Sequential Organ Failure Assessment (SOFA) score—is vital in multivariable models
to control for baseline patient severity. While caution has been given for using these patient
severity scores on the individual level for prognosis, they work well for severity adjustment and
case-mix adjustment [11]. Therefore, the use of severity score systems for ICU patients is
common, but not without imperfections in their execution.
Severity scores such as the SOFA score are component scores of multiple datapoints. In the
case of the SOFA score, there are 6 items that are physiological clues of organ failure, such as
platelet counts (indicative of coagulation dysfunction), bilirubin levels (indicative of liver
dysfunction), and the Glasgow Coma Scale (indicative of central nervous system dysfunction). It
is not uncommon that one value may be missing from the medical record, preventing the
calculation of the SOFA score.
When this baseline measurement of disease severity is missing in retrospective observational
studies, patients may be excluded from the analysis as either an a priori methodological decision
or inadvertently through complete case analysis. The result of this methodological choice has the
potential to bias the study’s results and will certainly decrease the statistical power to find a
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difference in groups, should a difference exist. As the utilization of EHR data is necessarily
retrospective—there is nothing that a researcher can do to improve the rates of data collection—
focus needs to be given to methods of dealing with these missing data, rather than preventing
missing data.
This study has been designed to examine the effects of missing SOFA score data in
retrospective observational studies that use electronic health record data capturing patient stays in
the intensive care unit for ventilator-dependent respiratory failure (VDRF) to accomplish the
following:
1) Ascertain the degree to which results may be biased at various percentages of
missing SOFA score data
2) Examine methods of dealing with missing data that are commonly available in
statistical software packages used by Health Services Researchers
AIM 1
To examine the impact of missing SOFA score data on ICU clinical outcomes studies
among patients with ventilator-dependent respiratory failure at various percentages of
missingness, along with various statistical techniques for handling missing data at the composite
score level.
AIM 2
To examine the impact of missing SOFA score data on ICU clinical outcomes studies
among patients with ventilator-dependent respiratory failure at various percentages of
missingness, along with various statistical techniques for handling missing data at the component
item level.

Rationale of Importance (AIMS 1 & 2)
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Examination of techniques for handling missing SOFA score data that are available in
statistical software that is most commonly used by applied researchers—SAS, SPSS, and Stata—
will provide valuable insight to researchers and clinicians. The insights this study will provide
include suggestions for the best methods of handling missing data; whether missing data should
be handled at the component level of the SOFA score or at the composite level of the SOFA
score; and how missingness of the SOFA score affects various outcomes. Finally, the findings of
these aims will provide researchers with guidelines for determining at what percentage of
missingness of the SOFA score should one be worried, as currently most recommendations for
missing data are ballpark figures and are not specific to the SOFA score in particular, nor ICU
severity scoring systems in general.

2
2.1

REVIEW OF THE LITERATURE
Problem Statement: Why Missing Data are Problematic
Missing data present a special problem in statistics in that it is impossible to use

numbers that are not present. While this may seem obvious, its implications are serious as data
which are missing have the potential to seriously bias results—possibly resulting in inaccurate
estimates of effect size and even direction. While the general advice is to avoid missing data at
all costs, this point is irrelevant in areas where research uses secondary data sources—such as
billing or electronic health records (EHR). For researchers who use secondary data sources, the
only option is to deal as effectively as one can with the available data to try to answer research
questions with as much accuracy and precision as possible.
In multivariable regression models, where multiple independent variables (or
covariates) are contributing toward explaining a single dependent variable (or outcome) the
problem with missing data may not even be realized by the researcher. If one covariate’s value
is missing in a regression analysis the default behavior in all major statistical software is to
simply exclude this entire observation from the analysis. This exclusion is indifferent to the
importance of the missing value—that covariate may offer little (or very much) explanatory
value to the model. The exclusion is also indifferent to the amount of other data available in
that observation; there may be scores of other covariates that provide rich information toward
explaining the outcome variable. Yet the entire observation is excluded from the analysis due
to a missing value in one covariate—something termed complete case analysis (CCA). While
missingness of less than 5% is considered trivial [12], the amount of missing data and the
implications of omitting these observations from analysis needs attention.
In other cases, the problem with missing data may be realized by the researcher—yet
ignored due to the large number of cases available for analysis. This is the case with research
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that uses electronic medical records of large health systems or research that uses billing
records. In these cases, sufficient numbers of cases with complete covariate data may exist for
analysis—resulting in a study that is well powered to find a difference if one exists, even with
excluding lots of records due to missing data. The researcher simply makes the decision to set a
study inclusion criterion that all cases must have complete data. Little consideration to the
amount and types of missing data is given in presentation of how the cohort was developed. It
is no wonder Paul Allison (2009) describes missing data as the, “dirty little secret of statistics”
(p. 72).
Reporting guidelines are available to aid HSR studies to improve the quality and aid
reproducibility of research. One guideline is the Strengthening The Reporting of Observational
Studies in Epidemiology (STROBE), whose purpose is offering full disclosure in the analysis
to allow for reproducibility and provide candor. STROBE underscores the importance of
handling missing data—requiring an explanation of how missing data were handled along with
an explanation of the number of subjects with missing data for each item of interest with the
methods section of a peer-reviewed paper [13]. Another guideline is the Reporting of studies
Conducted using Observational Routinely-collected health Data (RECORD), an extension of
STROBE, upholds all the requirements of STROBE but adds the requirement of discussing the
implications of missing data in the limitations section of the paper [14]. In fact, the
International Conference on Medical Journal Editors (ICMJE) highly encourages that journal
articles be submitted with completed guideline checklists, such as those discussed above [15].
Unfortunately, the International Society for Pharmacoeconomics and Outcomes Research’s
(ISPOR) guidelines for retrospective database studies merely mentions missing data as a
quality check of the data source, and not as a potential source of bias [16]. However, a recent
taskforce report from ISPOR and the International Society for Pharmacoepidemiology (ISPE)
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acknowledges that missing data are a threat to validity that should be addressed [17], and offers
suggestions for how describing how missing data were handled [18]. Finally, the PatientCentered Outcomes Research Institute (PCORI) published methodology standards for
scientifically valid patient-centered outcomes research [19]. There are 12 detailed standards,
with one entire standard devoted toward the prevention and handling of missing data.
While most of the guidelines provide a cautious set of recommendations for handling
missing data, all of them mention it as an item for methodological and statistical
consideration—demonstrating the importance of properly handling missing data in health
services research studies.
2.2

Current State of Handling Missing Data in Health Services Research
Unfortunately, methods for handling missing data are not widely used in health services

research. One review of the utilization of multiple imputation (MI) in two top-tier journals—The
Lancet and New England Journal of Medicine—over a 6-year period (2008 through 2013) found
only 103 articles that used MI, 45 in NEJM and 58 in The Lancet [20]. Of these 103 studies only
30 (29.1%) were observational with 11 (10.7%) being studies using routinely collected data. The
study also found nearly all the papers handled these data with insufficient rigor. The study does
not give the total number of studies in the two journals during that timeframe that were evaluated,
which would have informed readers about the incidence of MI during the time examined.
However, a manual search for this dissertation revealed 1,373 research articles in NEJM and
1,064 in The Lancet, totaling 2,437 articles. This shows that only 4.2% of articles in these two
top-tier journals used MI; 3.3% in NEJM, 5.5% in The Lancet. This suggests that missing data are
a somewhat rare phenomenon, perhaps being dealt with methodologically in the analysis (but not
reported), or are simply being ignored; the latter of these possibilities, rather than the former is
more likely.

8

Therefore, a more systematic approach to help understand how well health services
researchers are doing with handling missing data is warranted. In the next section, an examination
of missing data approaches will be conducted to determine the extent to which missing data
techniques are utilized, or if missing data are mentioned anywhere in the paper, for a one-month
period of all literature that used a popular commercial claims database.
Truven Health Analytics MarketScan® research databases are widely-used for health
services research. The most commonly used MarketScan databases are the Commercial and
Medicare supplemental databases. These databases provide de-identified health insurance claims
across the continuum of care (e.g. inpatient, outpatient, outpatient pharmacy, carve-out behavioral
healthcare) as well as enrollment data from roughly 350 large employers and health plans across
the United States who provide private healthcare coverage for more than 50 million employees,
their spouses, dependents, and Medicare-eligible retirees with supplemental plans [21]. This
administrative claims database includes a variety of fee-for-service, preferred provider
organizations, and capitated health plans. In total, there are more than 20 billion service records in
these databases spanning back to 1995. A review of research published using MarketScan
databases provides illustration of the breadth, depth, and quality of research being conducted in
health services research.
In August 2017, a review of all papers published in January of 2017 that used
MarketScan research databases was conducted to determine the extent to which missing data
techniques were utilized, or if missing data were mentioned anywhere in the paper. To locate
these papers a search of the Ovid MEDLINE database for the terms Truven or MarketScan in the
title or abstract was conducted, which yielded 18 papers. These papers were then searched for any
of the terms listed in Appendix A—which includes terms for all the major analytical approaches
to handling missing data, as well as indicators that missing data were considered (e.g. the term
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missing). These papers were also manually reviewed to ascertain if missing data were mentioned,
or if addressed using any analytical technique for handling missing data.
Of these 18 papers, 13 (72.2%) did not mention missing data or any analytical approaches
to handling missing data anywhere in the text [22-34]; only 5 papers (27.8%) mentioned missing
data at all [35-39]. Of these 5 papers, 4 collapsed categories in potential covariates to include
missing with another category (e.g. Other/Missing) [35, 36, 38, 39] and one used missingness as
an exclusion criterion without discussion of potential bias as a result of that decision [37]. In
summary, none of the papers investigated over this one-month sample of time utilized a
satisfactory method of handling missing data. This illustrates the common practice within health
services research when using large secondary data sources—such as billing data—of simply
excluding subjects with missing data, or when the data are categorical, of lumping together
missing with the smaller categorical groups.
In summary, the case has been made that missing data are problematic for research
studies as they can bias the findings. An examination into the state of handling missing data in
health services research has also been made, showing a large area for improvement in using
missing data methods. In sections that follow we will examine the clinical syndrome through
which we explore missing data, examining respiratory failure and a severity of illness scoring
system used for intensive care unit patients. We will then explore electronic health record data as
a data source for observational research. Finally, we will take a look at the statistical topic of
handling missing data, to include mechanisms for missingness, missing data patterns, amount of
missing data, analytical approaches available to deal with missing data, and finally existing
guidelines for working with missing data.
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2.3

Electronic Health Record Data for Research
Electronic health record (EHR) data as a source for research purposes was promised to be

the “golden egg” for research. A seemingly unlimited amount of data available to researchers for
asking clinical research questions held the promise of forever changing research. The thought was
that since the full record was available to researchers for retrospective studies, this would allow
any pertinent question to be asked as all the key information—diagnoses, medications
administered, radiological tests, and laboratory results—are available. This opened the door for a
variety of research, including comparative effectiveness research, rare disease research, and
evaluation of quality improvement initiatives.
Prior to the availability of EHR data for research, retrospective studies relied on previously
recorded data, such as billing records or clinical trials data that was being repurposed to pose new
research questions. These data sources have their limitations, as they were created for a specific
purpose and are subject to their inherent limitations. However, EHR data are different as the
entire clinical picture of care for populations of patients is seemingly captured; one would think
that everything that is pertinent is available within the EHR—just waiting to be queried.
Combining quasi-experimental techniques that minimize selection bias, such as propensity score
matching [40, 41], with this rich source of EHR data further underscored the possibility of
conducting causal analyses using these retrospective data. Further, having EHRs would transform
healthcare by, in part, allowing implementation of research findings for disease prevention and
chronic disease management [42]. The future looked bright for research, but reality had not yet
set in.
Unfortunately, electronic health record data are a bit more difficult to work with than
administrative data, due to the nature of these data. Administrative data are already coded with
diagnosis and procedure codes. However, EHR data—while also having this information—has
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much more information that is unstructured in free-text fields, such as provider notes, as well as
bedside and laboratory data that are harder to turn into discrete fields by which research questions
can be asked. For free-text fields, natural language processing is required for automated chart
review. This approach requires validation for each disease or condition being phenotyped, and is
subject to common problems—such as misspellings, abbreviations, and negation terms (e.g.,
“absence of hepatocellular nodules”) that might otherwise give a false-positive [43].
A systematic literature review of all health outcomes research studies conducted in the
United States from 2000-2007 that used EHR data was conducted in 2009 to examine how EHRs
were being used for outcomes research and to describe the methods used therein [44]. This review
found 98 EHR-based outcomes research studies, with 88% being published in specialty medical
journals. Of the outcomes studied, clinical and pharmacologic outcomes were the most common
(31% and 19% respectively), whereas economic outcomes were the least common (3%). The
study also examined 28 conference abstracts from ISPOR and Academy Health’s Annual
Research Meeting. Of these 124 studies, only 78 (63%) used multivariable regression methods to
control for confounding, and only 1 study used propensity score methods to control for selection
bias. Further, no consideration of handling of missing data in the studies evaluated was given.
Finally, this literature review perpetuates the misconception that, “[EHR] data can easily be
queried to identify patients based on diagnoses, procedures, and dispensed medications” and that
these data are “readily accessible in real time” (p. 618). Such assertions are typical in earlier EHR
research literature and are demonstrative of oversimplification of the challenges researchers face
when using EHRs for research. As we will see next, more modern papers acknowledge some of
these challenges.
In a study that used the biorepositories of five large institutions which are part of the
Electronic Medical Records and Genomics Network (eMERGE) [45] for genome-wide
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association studies, investigators sought to phenotype diseases [46]. In this study, all sites had
different EHRs—including both internally-made and commercially-procured—that were all
exceeding meaningful use requirements for EHRs, set forth by the Office of the National
Coordinator. However, race, ethnicity, exposure history, and family history of illness had varying
rates of capture within the EHR. Further, when captured, these items were often stored in a freetext (structured format), in inconsistent nomenclatures, meaning it had to be parsed out with
natural language processing [46]. It is worth re-emphasizing these sites that are part of the
eMERGE network, in spite of the challenges presented by EHRs have found 48 disease or
condition phenotypes to date [47]. While many of these phenotypes rely on natural language
processing, some do not.
In spite of the challenges inherent within the scope of using EHR data for research, the
field of EHR data research is still promising. It is just not the easy, golden egg researchers once
thought. Other problems still persist, such as censoring, missing data, and attrition. The United
States is still a long ways off from having a comprehensive, single medical record for each
patient—which some thought simply hinged on increased Internet bandwidth and financial
incentives [48]. Even once we have overcome challenges inherent within EHR records, more
challenges are systematic due to our system of healthcare delivery, which is highlighted by
fragmented care. Unless a patient is seen solely within one integrated health system, her records
are in many EHRs—including primary care, emergency care (if not in the same system), and
specialty care. Nonetheless, while there are many challenges that must be overcome, including
dealing with missing data, it is imperative we press forward to solve some of these challenges as
the data within the EHR—while not a golden egg—holds promise.
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2.4

Clinical Background – Respiratory Failure
Respiratory failure is a syndrome whereby the lungs fail in their primary function of gas

exchange; the lungs fail to adequately expel carbon dioxide or oxygenate the blood. Many
conditions can result in respiratory failure, such as chronic obstructive pulmonary disease
(COPD), cystic fibrosis, pneumonia, emphysema, chronic bronchitis, pulmonary embolism, and
stroke [49, 50]. Further, respiratory failure can be a sequela of surgery or trauma.
Respiratory failure is of large concern for medicine, as it is the leading cause of in-hospital
death, and the 3rd leading cause of death in the United States [51, 52]. For patients who
experience respiratory failure and require the assistance of a ventilator (VDRF), this typically
involves admission to the ICU.
In the following sections the epidemiology of respiratory failure will be reviewed,
including where it ranks for cause of death in the United States and its prevalence in the
community and among the aged in institutionalized settings. Then a brief examination of the
etiology of respiratory failure will be undertaken.
2.4.1

Respiratory Failure: Population Statistics
Chronic lower respiratory disease was the 3rd leading cause of death in the United States in

2014 according the the Centers for Disease Control and Prevention (CDC), claiming 147,101
lives and comprising 5.6% of all deaths [52]. Further, acute respiratory distress was the 8th
leading cause of death among newborns, claiming 460 lives and comprising 2.0% of all newborn
deaths [52]. In 2010, of the more than 700,000 people who died as an inpatient (2% of all
admissions), respiratory failure was the leading first-listed diagnosis (16.5% of deaths), followed
by septicemia (16.3%), and pneumonitis due to solids or liquids (13.6%) [51]. Further, the
mortality rate among adults has been shown to steadily increase with age, with nonagenarians—
those in their 90s—experiencing a nearly four-fold rate of mortality when compared with adults

14

aged 18-40 (83% vs. 21%) [53]. While the in-hospital death rate for adult patients with
respiratory failure has been on the decline—25.3% in 2000, 19.3% in 2005, and 16.5% in 2010—
it has been the leading first diagnosis among in-hospital deaths during this period, and the trend is
reflective of the overall trend in the decline of in-hospital deaths [51].
A 2010 national survey of assisted living and similar residential care facilities found 4.2%
had asthma, 2.0% chronic bronchitis, 10.8% COPD, and 1.2% emphysema—all conditions that
could lead to respiratory failure [54]. Of this same population, nearly one-quarter (23.8%) had
one or more overnight inpatient stays in a hospital in the 12 months prior.
An examination of the costs of patients who ventilator-dependent using Healthcare Cost
and Utilization Project (HCUP) National Inpatient Sample (NIS) data using 2009 data showed the
costs per ventilated patient varied widely [53]. The highest costs per patient were seen among
surviving pre-term infants, with those aged 24 weeks or younger having a median cost around
$200,000. The median costs per patient among adult patients was fairly steady, ranging from
$17,000 to $25,000 depending on the age group. In nearly all age groups, a similar amount of percapita money was spent on surviving and non-surviving ventilated patients.
2.4.2

Ventilator-Dependent Respiratory Failure
A prospective study was conducted in 2008 of 60 pediatric ICUs (PICUs) in 13 countries

of all children admitted to the PICU in a one-month period during the season when acute lowerrespiratory infections were more prevalent in each respective country [55]. This study found that
50.1% of admissions to the PICU required invasive mechanical ventilation, either intubation or
tracheotomy. Further, patients who required reintubation following planned extubation was 24%,
with the mortality rate being higher amongst patients who required reintubation (21% vs. 1%).
For ventilated patients overall in the ICU, the mortality rate estimates vary—ranging from 2031% in the adult population [56-58] and 13% in the pediatric population [55].
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2.4.3

Respiratory Failure: Pathology
Respiratory failure is a syndrome whereby the lungs fail in their primary function of gas

exchange; the lungs fail to adequately expel carbon dioxide or oxygenate the blood. Respiratory
failure is diagnosed through arterial blood gas measurements [49]. Respiratory failure is classified
as hypercapnic, meaning the level of CO2 in the arterial blood is excessive (PaCO2 > 45 mm Hg),
or hypoxemic, meaning the level of oxygen in the arterial blood is inadequate (PaO2 < 55 mm Hg
when the fraction of inspired oxygen [FiO2] ≥ 0.60 mm Hg) [49]. It is not uncommon for
respiratory failure to be both hypercapnic and hypoxemic.
2.5

Severity of Illness Scoring
There are a number of severity of illness scoring systems in use in the ICU, including the

Acute Physiology and Chronic Health Evaluation (APACHE), Logistic Organ Dysfunction
System (LODS), Mortality Prediction Model (MPM), Simplified Acute Physiology Score
(SAPS), and Sequential Organ Failure Assessment (SOFA). These ICU scoring systems are
widely used for outcome prediction (most commonly mortality), severity of illness
stratification—both in clinical trials and research that uses administrative data—and as a case-mix
adjustment for comparing quality of care [11].
Severity of illness scores are different, however, from comorbidity scores—such as the
Charlson and Elixhauser scores. The Charlson comorbidity score was created to estimate the 1year mortality risk from comorbidities in longitudinal studies using information manually
extracted from inpatient medical record review [59]. The Charlson comorbidity score was
modified by Deyo et al. to allow for use with administrative databases by mapping International
Classification of Diseases, 9th revision, clinical modification (ICD-9-CM) diagnosis codes to the
diseases described by Charlson et al., listing seventeen diagnostic categories, each containing
multiple ICD-9-CM diagnoses [60]. The Elixhauser comorbidity score was created specifically
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for use with administrative data, giving a set of 30 comorbidities for which a researcher can use
for statistical control in multivariable analyses to predict charges, length of stay, or in-hospital
mortality [61]. Severity of illness scores differ from comorbidity scores, however, in that they
measure physiological derangement—using clinical and laboratory data—rather than presence or
absence of comorbid conditions associated with death. As such, they are used in two different
manners for risk adjustment, with one adjusting for baseline health and the other adjusting for
severity of illness. To be certain, two patients in the ICU with the same comorbidities and
Charlson score could have markedly different severity of illness scores, and therefore prognosis.
Further, while both the Charlson and Elixhauser comorbidity scores have been shown to
have good predictive ability of mortality among ICU patients—Charlson had 65% area under the
Receiver Operating Characteristic Curve (AUROC) and Elixhauser 66% AUROC for 30-day
mortality among ICU patients [62]—their predictive ability is likely to be lower than that of
severity of illness based scores due to using patient comorbidities, rather than severity of illness
scores which measure actual physiological derangement and are more real-time. One study
examined the predictive ability of the Charlson score to that of one severity of illness score
(SAPS II), finding the severity of illness-based SAPS II score to be superior in prediction of 30day mortality than the Charlson score at α=0.05, 0.821 vs. 0.607 AUROC respectively [63].
Therefore, when available, the researcher is wise to use physiology-based severity of illness
scores in addition to comorbidity scores for baseline risk adjustment. For this dissertation, focus
will be given to one of the more commonly-used physiology-based severity of illness scoring
systems, the SOFA score.
2.5.1

SOFA Score
The Sequential Organ Failure Assessment (SOFA) score was created by the European

Society of Intensive Care Medicine (ESICM) in 1994 via a consensus meeting—essentially using
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the Delphi technique—to provide an objective scale to describe the degree of organ dysfunction
or failure [64]. The score uses information that is routinely-collected in the ICU, making it a
scoring system that is easily implemented. The SOFA score was envisioned to have two
applications [64]. The first application was to understand the course of organ dysfunction (and
failure), including the relationship of multiple organ failure. The second application was as an
instrument to be used for baseline severity assessment and measurement of the effects of
interventions. The authors of the SOFA score emphatically asserted that it was designed as a tool
for description, not prediction [64]. However, its usage has changed over time as it has
demonstrated to be a good prognostic tool among ICU patients. The SOFA score is recommended
for assessment of septic patients by the Third International Consensus Definitions for Sepsis and
Septic Shock (Sepsis-3) guidelines [65] and is even used as an element of consideration in
emergency triage in some states’ crisis standard of care plans [66].
The SOFA score ranges from 0 to 24, composed of 6 sub-scores. The sub-scores have a
range of 0 to 4 points being assigned to each of six organ systems: respiratory, hematologic,
hepatic, cardiac, neurologic, and renal. A higher score represents a higher level of dysfunction,
and thus greater severity. Calculation of the SOFA score is shown in Table 2.1, representing the 6
organ systems covered.
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Table 1 SOFA score calculation
Assigned Score
System

0

1

2

3

4

Respiration
PaO2/FiO2,
mmHg

≥ 400

< 400

< 300

< 200a

< 100a

Coagulation
Platelets
x 103/mm3

≥ 150

< 150

< 100

< 50

< 20

< 1.2
(< 20)

1.2 – 1.9
(20 – 32)

2.0 – 5.9
(33 – 101)

6.0 – 11.9
(102 – 204)

≥ 12.0
(> 204)

MAP ≥
70 mm
Hg

MAP <
70 mm
Hg

Dopamine ≤ 5
or
Dobutamine
(any dose)b

Dopamine > 5
or
Epinephrine ≤ 0.1
or
Norepinephrine ≤ 0.1
or
Phenylephrinec ≤ 0.22

Dopamine > 15
or
Epinephrine > 0.1
or
Norepinephrine > 0.1
or
Phenylephrinec > 0.22

15

13 – 14

10 – 12

6–9

<6

< 1.2
(< 110)

1.2 – 1.9
(110 – 170)

2.0 – 3.4
(171 – 299)

3.5 – 4.9
(300 – 440)

> 5.0
(> 440)

< 500

< 200

Hepatic
Bilirubin, mg/dl
(µmol/l)
Cardiovascular
Hypotension

Central Nervous
System
Glasgow Coma
Scale Score
Renal
Creatinine,
mg/dl (µmol/l)
Urine output,
ml/day
a

With respiratory support
Administered for at least 1 hour
c Phenylephrine added by Knox et al. to list of vasopressors according to standard equivalency [67]
b

The first organ system is respiratory dysfunction, which is calculated as the ratio of the
partial pressure of oxygen (PaO2) to the fraction of inspired oxygen (FiO2)—often referred to as
the Carrico index or P/F ratio [50]. The partial pressure of oxygen (PaO2) measures the level of
oxygenation within the arterial blood, with normal values ranging from 70-95 mm Hg [68]. The
fraction of inspired oxygen (FiO2) measures the percentage of oxygen in the air being inhaled.
This P/F ratio then measures the degree of hypoxemia, with the scores of 2, 3, and 4 matching the
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mild, moderate, and severe categories respectively of the Berlin definition of acute respiratory
distress syndrome [69].
The second organ system measured by the SOFA score is coagulation, measured as
platelet count, where decreasing levels of platelet counts confer a higher coagulation score in the
SOFA system. Platelet counts considered to thrombocytopenic—less than 150,000/mm3 [70]—
are assigned a score of at least one, with lower counts garnering a higher coagulation component
SOFA score.
The third organ system measured by the SOFA score is hepatic, measured as the
concentration of bilirubin in the blood. Elevation of serum bilirubin, known as
hyperbilirubinemia, occurs when the liver fails to adequately metabolize bilirubin—a byproduct
of the metabolism of heme, which is approximately 70-90% hemoglobin of erythrocytes (red
blood cells) [71]. Hyperbilirubinemia is typically caused by liver dysfunction or disease, bilirubin
metabolism disorders (such as Gilbert syndrome), or biliary tract obstructions [57]. Further,
elevated serum bilirubin levels have been shown to be predictive of short-term mortality [72-75].
Increasing amounts of bilirubin correspond to a higher hepatic component SOFA score.
The fourth organ system measured by the SOFA score is cardiovascular, measuring
hypotension and pharmaceuticals administered to return the patient to a normotensive state. A
patient is assigned a score of 1 when deemed hypotensive, defined as a mean arterial pressure
(MAP) < 70 mm Hg. Mean arterial pressure is calculated as follows,
𝑀𝐴𝑃

𝑑𝑖𝑎𝑠𝑡𝑜𝑙𝑖𝑐 𝑏𝑙𝑜𝑜𝑑 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒

𝑠𝑦𝑠𝑡𝑜𝑙𝑖𝑐

𝑑𝑖𝑎𝑠𝑡𝑜𝑙𝑖𝑐
3

and a hypotensive state means the body’s organs are being insufficiently perfused [76]. As the
patient exhibits greater hypotension, increased amounts of vasopressive drugs are administered—
such as dopamine, dobutamine, epinephrine, or norepinephrine—to constrict the blood vessels,
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with the goal of raising the MAP and returning the patient to a normotensive state [76].
Increasing doses of vasopressors correspond to a higher cardiovascular component SOFA score.
The fifth organ system measured by the SOFA score is the central nervous system, as
measured by the Glasgow Coma Scale. The Glasgow Coma Scale (GCS) was developed in 1974
by two physicians to quantify the level of consciousness of critically ill patients by measuring
three aspects of behavior: eye, verbal, and motor response to allow for longitudinal monitoring
[77]. The GCS is scored as shown below, from 3 to 15—with a lower composite score
representing a worse prognosis. Each category is rated as the best response for the category that
uses a standardized approach for evaluation.
Table 2 Scoring of the Glasgow Coma Scale (GCS)
Eye Response
Verbal Response
1. None
1. None
2. Incomprehensible speech
2. Open to pain
3. Inappropriate speech
3. Open to speech
4. Open spontaneously 4. Confused conversation
5. Orientated

Motor Response
1. None
2. Extension
3. Abnormal flexion
4. Normal flexion (withdrawal)
5. Localizing response
6. Obeys commands

The GCS has been integrated into intensive care medicine in over 80 countries, with the
three components being used to describe the impairment of consciousness on individual patients
[78]. Further, the GCS is used as a risk-adjustment or prognostic tool in outcomes research [78].
Finally, a demonstration of the clinical importance of the GCS is its incorporation into the
International Classification of Diseases, 10th revision, Clinical Modification (ICD-10-CM) which
allows for component and composite GCS scores to be coded (code R40.2xx), along with the time
of measurement [79].
The sixth, and final, organ system measured by the SOFA score is renal, measured as
creatinine clearance or daily urine output. An elevated serum creatinine or decreased urine output
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are signs of diminished kidney function, possibly acute kidney injury [80]. Worldwide the
incidence of acute kidney injury was estimated at 21.6% in hospitalized adults and 33.7% in
hospitalized children, with mortality rates of 23.9% and 13.8% respectively in a meta-analysis of
154 studies of 3.6 million people [81]. Further, two classification systems of acute kidney
injury—which involve change in serum creatinine levels and daily urine output—have been
shown to be predictive of outcomes in ICU patients, including mortality, renal failure, and length
of stay [82, 83].
2.5.2

Interpretation of SOFA Score
According to the Sepsis-3 consensus paper, the baseline SOFA score—which is

calculated upon admission to a critical care unit—should be assumed to be zero, unless the patient
has a known organ dysfunction [65]. A change in total SOFA score of at least two points
represents organ dysfunction, and a SOFA score that is 2 or greater is associated with a 10% inhospital mortality rate [65].
The SOFA score was validated in an ICU setting, which demonstrated the presence of
sepsis was associated with higher component organ SOFA scores [84]. Further, of the patients
whose ICU stay was for at least 7 days, an increase of SOFA scores from baseline was correlated
with greater odds of death (44% of non-survivors vs. 20% of survivors; p < .001); whereas a
decrease in SOFA score from baseline was correlated with greater odds of survival (21% of nonsurvivors vs. 33% of survivors; p < .001) [84]. When examined as the maximum SOFA score
throughout an ICU admission, there is a trend toward increasing in-ICU mortality as the
maximum SOFA score increased, as shown below in Figure 2.1 (below).

22

Figure 2.1 Maximum SOFA score vs. in-ICU mortality rate [84]

The SOFA score has been examined for other clinical populations as well. The SOFA
score has been modified and adapted for the pediatric population (pSOFA) in predicting inhospital mortality, showing excellent discrimination of 0.94 AUROC (95% CI: 0.92-0.95) using
age-adjusted SOFA parameters [85]. Additionally, the SOFA score on the day of admission to the
ICU has been compared to the APACHE II score in oncology patients admitted to the ICU and
found superior at predicting in-ICU mortality (0.925 AUROC, 95% CI: 0.859-0.991 vs. 0.710,
95% CI: 0.578-0.843 respectively), and similar in predicting in-hospital mortality (0.835
AUROC, 95% CI: 0.734-0.934 vs. 0.655, 95% CI: 0.491-0.819) [86]. The SOFA score on the
seventh day post-transplant has also been shown to be highly predictive of mortality for livingdonor liver transplant recipients in predicting 3-month post-operative mortality (0.952 AUROC,
95% CI: 0.874-1.00) [87]. Similarly, the SOFA score has been used to predict mortality among
trauma patients [88], those with hematological malignancies [89], patients in acute geriatric care
settings [90], and even ICU-treated refractory status epilepticus patients [91]. Finally, the
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admission SOFA score has also been shown to be associated with diminished quality of life one
year post-discharge among ICU survivors, as measured by the EuroQoL-5D [92].
2.5.3

Examples of SOFA Score in the Literature
The SOFA score is often used in outcomes studies of ICU-treated conditions as a predictor

or adjustment variable. The SOFA score serves as a measure of patient severity within the ICU,
which is a measure upon which one can statistically control to examine outcomes.
One prospective, multicenter study of adult ventilated ICU patients examined the risk of
developing adult respiratory distress syndrome (ARDS) [93]. In the final statistical model that
examined risk of ARDS, the baseline SOFA score—along with other covariates, such as BMI and
functional status—were used to predict risk of developing ARDS among ICU patients. However,
the study admitted that data were missing for elements of the SOFA score, with those cases
simply being omitted from the analysis. This is problematic, as the number of cases excluded was
not mentioned and the potential for biased findings due to the missingness was not discussed.
2.5.4

Missingness of SOFA Score Items
Missingness of SOFA score items, or the total score itself, varies across studies. In one

study the admission SOFA score had 0% missingness, but was a prospective one-year study [92].
In the validation study for the SOFA score, bilirubin values were the most commonly
missing item, whereas platelet counts were the most infrequently missing—however the percent
of time these items were missing was not mentioned [84]. For imputation of missing items, the
mean of the value prior to and after the missing value was imputed; in cases where multiple
observations were missing, the missing value was left untouched—resulting in available case
analysis being used for the analyses [84]. In a later study by some of the same authors as the
validation study, similar missingness was found, with bilirubin being the most commonly missing
item, and platelets and PaO2/FiO2 ratios being the most infrequently missing items [94].
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2.6

Mechanisms of Missingness
The mechanism of missingness is the process that governs whether data are missing. The

theory for missing data mechanisms was first proposed by Rubin—applying it to survey designs
[95], which was simplified by Little & Rubin [96] to remove the response parameter that is
inherent in survey methodology. Using the groundwork laid therein, the mechanisms of
missingness can be defined symbolically.
If a complete dataset is specified as 𝑌

𝑦

with i representing subjects (as rows) and j

representing variables (as columns), with a size of (n x K). Then 𝑦 is the vector of variables for
subject i, which can be expressed as 𝑦

𝑦 ,… 𝑦

. This complete dataset is shown below in

Figure 2.1, which shows a matrix Y with a size of (3 x 4), representing 3 observations—each
observation containing 4 variables. In this table you can see cell 𝑦

,

, which represents the 4th

variable for the 3rd subject.

Figure 2.2 Complete data matrix

To indicate whether data are missing, 𝑀
same size as Y, with 𝑚

𝑚

is a matrix of binary variables of the

1 indicating the datum at 𝑦 is missing and 𝑚

0 indicating the

datum at 𝑦 is observed. The mechanism of missingness is represented by a conditional
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distribution of 𝑀, where 𝑓 𝑀|𝑌, 𝜙 , where 𝜙 are latent parameters. And thus, the groundwork of
introducing the symbols for defining the missing data mechanisms has been laid.
2.6.1

Missing Completely at Random (MCAR)
The first missing data mechanism is known as Missing Completely At Random (MCAR),

meaning the probability of missingness does not depend values of Y, whether observed (Yobs) or
missing (Ymiss). Using the Little & Rubin equation, MCAR can be written as
𝑓 𝑀|𝑌, 𝜙

𝑓 𝑀|𝜙

for all values of Y and 𝜙. In the case of MCAR, when data are missing it is equivalent to a simple
random sample of the full dataset [97]. This is equivalent to asserting that the function of
missingness cannot be described by the data, but rather is a stochastic process modeled by the
latent parameters 𝜙. Further, the probability of missingness for one variable can be related to the
probability of missingness of another variable, such as is the case of unit non-response in a survey
[97]. The MCAR equation given above has been made more comprehensible by Allison [97]—
who adds X as a vector of fully-observed variables, writing MCAR as
Pr 𝑌

|𝑌, 𝑋

Pr 𝑌

The MCAR mechanism is akin to taking a completely random sample (𝑌

) from a

population (Y). Further, excluding Ymiss from any analysis should not bias the results of an
analysis at moderate percentages of missingness.
2.6.2

Missing at Random (MAR)
The second missing data mechanism is known as Missing At Random (MAR), which

means that the probability of missingness does not depend on the missing values of Y, (Ymiss), but
may depend on the observed values of Y, (Yobs). The MAR equation can be written as
𝑓 𝑀|𝑌, 𝜙

𝑓 𝑀|𝑌

,𝜙
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for all values of Ymiss and 𝜙. Once again Allison makes this equation more comprehensible,
representing it as
Pr 𝑌

|𝑌, 𝑋

Pr 𝑌

|𝑋

MAR means that the missing values do not depend on the values themselves, but can depend on
other observed values [98]. Some authors assert that it is possible to take data from NMAR to
MAR in survey and intervention designs through asking subjects how likely they are to drop out
of a study, or by using proxy measures that are highly correlated with the missing covariate [99],
thus adding a predictor of missingness to the Yobs vector.
2.6.3

Missing Not at Random (MNAR)
The third, and final, missing data mechanism is known as Missing Not At Random

(MNAR), which means that the probability of missingness depends on the missing values of Y,
(Ymiss) themselves. The MNAR equation can be written as
𝑓 𝑀|𝑌, 𝜙

𝑓 𝑀|𝑌

,𝜙

for all values of Y and 𝜙. An example of MNAR is found in job applications where a question
asking if a person has ever been arrested would depend on the answer itself. A person who has
never been arrested will readily answer no, however one who has been arrested would be
apprehensive to answer that question. Another example of MNAR from the literature is the issue
of non-response of income reporting to the U.S. Census Bureau, where those with higher incomes
were less likely to report their incomes [100].
The importance of understanding the missing data mechanism—whether MCAR, MAR, or
MNAR—has been covered well in the literature [19, 95, 98]. Several studies have suggested less
discrete definitions of these mechanisms. One study posits a more fluid definition of missingness,
asserting it is more like a continuum between MCAR and MNAR [101], although interesting, the
point is quixotically impractical. Another theory-building simulation study that examined missing
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data methods using all three missing data mechanisms asserted one single mechanism is unlikely
to be the cause of missingness [102]. The focus must remain on having a solid understanding of
the missing data process, as selecting an analytical approach to missing data is predicated on an
understanding of the missing data mechanism.
2.6.4

Tests for Missing Data Mechanism
Unfortunately, few tests exist to distinguish between the three missing data mechanisms

and the ones that do exist have their limitations. The most commonly-cited test is known as
Little’s test, which gives a single χ2 test statistic for testing the MCAR assumption on multivariate
continuous data [103]. It is useful for situations where the researcher is trying to ascertain if the
data are MCAR or MAR. Essentially, Little observed that one would need to split the data into
two groups, those with missing values for a given variable and those without missing values.
Then one would compare the distributions for each variable in the dataset between these two
groups using a two-sample Student’s t-test, with a significant difference indicating the data are
not MCAR. However, for p number of variables in a dataset this would yield p(p - 1) t-tests. To
get around the multiple comparisons, Little created his likelihood ratio test that is asymptotically
chi-squared. However, situations where missingness is due to the MCAR mechanism are rare [97,
104], and categorical data are common, limiting the utility of this test.
Other tests aimed at longitudinal data include ones developed by Park & Davis, which is an
extension of Little’s test but for repeated measures categorical data that tests for MCAR [105],
and a test by Park & Lee based on generalized estimating equations that uses a missing indicator
using a pattern-mixture model [106].
Heitjan & Basu examined the MCAR and MAR missing data mechanisms from both the
Bayesian and Frequentist statistical inference perspective showing different ignorability
requirements exist through statistical simulation [107]. For Bayesian inference—such as would be
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done through using maximum likelihood estimation (MLE) to deal with missing data—showing
the ignorability condition is met if the likelihood function is the same with or without accounting
for the missing data mechanism. However, for Frequentist inference—such as would be done
through multiple imputation—the ignorability condition is only met if the data are MCAR.
2.7

Missing Data Patterns
The pattern of missing data is important to understand, as various methods require a certain

data pattern. The pattern of missing data is essentially the unique patterns of values of the missing
data vectors, 𝑚 , in the missing data matrix 𝑀

𝑚

. Recall that i represents subjects (as rows)

and j represents variables (as columns). These patterns of missing data vectors are arranged from
most number of observed variables to least number of observed variables, as shown in Figure 2.3
below.

Figure 2.3 Missing data patterns, monotonic vs. non-monotonic

In Figure 2.3 one can see columns of three variables and the number of observations with
that pattern. In the cells below an X represents an observed value (𝑌
a missing value (𝑌

), whereas a dot represents

). A monotonic missing data pattern is one that will follow a stepwise

fashion as shown, where once a variable a missing in the list of patterns, that variable will always
be missing in subsequent patterns (c.f. Figure 2.3, V2). By definition, a dataset which has only
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one missing variable will be necessarily monotonic. Further, when only one variable is missing,
analytical methods to address the missing data are known as univariate methods—regardless of
whether the imputed variable is a dependent or independent variable in later analyses; when more
than one variable is missing, analytical methods to address the missing data are known as
multivariate methods.
2.8

Amount of Missing Data
The amount of missing data, represented symbolically by 𝛾, is of concern in all statistical

analyses due to risk of bias. The amount of missing data that is permissible prior to unacceptably
biasing results is not well-established. The general guideline in the missing data literature is 𝛾
5% is considered trivial [12]. However, for clinical trials data Yeatts and Martin caution the
range of 5-20% is of most concern because the rate is high enough to cause statistical bias, yet not
high enough for the findings to be rejected solely on the basis of missingness [108].
2.9

Analytical Approaches to Missing Data
How to handle missing data is a subject that has been explored deeply in statistical

literature; a taxonomy of analytical approaches to missing data is given below in Figure 2.4.
Moreover, strategies may vary depending on whether the missing data are outcomes or
covariates; the discussion henceforth centers on missing covariate data.
In addition to CCA—which relies on MCAR—there are other more sophisticated
techniques, all of which depend on the missing data mechanism. Alternatively, there exists
multiple imputation (MI) techniques which allow for multiple datasets to be created with various
values imputed for each missing value when the MAR mechanism for missing data is likely. Each
dataset is analyzed separately, then the parameter estimates and confidence intervals from each
separate analysis combined using Rubin’s rules [98]. MI techniques allow for the uncertainty
surrounding the values of the missing data to be accounted for in the analysis.
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Figure 2.4 Taxonomy of analytical approaches to missing data

2.9.1

Adjustment Methods
Missing data are a problem in research, as statistical software rely on complete data for

all variables in a regression model. If one value for a variable is missing the entire observation
is excluded from the analysis, which leads to problems of potential bias and reduced power due
to smaller sample size. There are four main adjustment methods for dealing with missing
values: complete case analysis, available case analysis, dummy variable adjustment, and
missing data stratification.
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The first adjustment method is known as complete case analysis (CCA), or listwise
deletion. With this method the researcher removes all observations that have a missing value
for any of the outcome or explanatory variables, for all intended analyses.
The second adjustment method is known as available case analysis (ACA), or pairwise
deletion—the default method of all statistical software. With this method any observation that
has a missing outcome or explanatory variable is excluded from the analysis. This leads to
problems of changing samples, as during model fitting as potential covariates are added and
removed the sample size will change. Further, secondary analyses will also have different
sample sizes—and essentially different samples—than the primary analysis. Clearly, such a
strategy is problematic as will be discussed next.
The first problem with CCA and ACA methods is that reduced statistical power is
achieved due to a smaller sample size. While the magnitude of this problem varies based on the
total sample size and the percent of missing data, it is still a problem. The second problem with
CCA and ACA is that unless the data that are missing are missing completely at random
(MCAR), the results will likely be biased [109]. If it is completely a chance occurrence the data
are missing— or MCAR—removing the case will not bias the results using CCA [109].
However, CCA and ACA will result in a loss of precision of the estimate, yielding a wider
confidence interval. Therefore, dealing with the missing data, rather than ignoring it, is
warranted.
The third adjustment method available is dummy variable adjustment. With this
method, a constant value is imputed for all missing values—often the mean of the observed
data—when a value is missing for a predictor in a regression model [110]. Then a missing data
indicator is added, such that 1 indicates the datum was missing and 0 indicates the datum was
observed. In the analysis both the predictor with the missing and imputed data along with the
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indicator are regressed on the outcome of interest. This model has the prima facie advantage of
using all available data. However, dummy variable adjustment has been shown to create
severely biased parameter estimates—both in magnitude and direction and often in an
unpredictable direction—even when data are MCAR or the percent of missing data is low (e.g.
2.5%) [109, 111].
The fourth method available to the researcher is missing data stratification. This
method is common in health services research when categorical data are missing, such as race
or marital status. In this method an additional missing stratum is created. As was the case with
the dummy variable adjustment method, missing data stratification has the prima facie
advantage of using all available data. However, despite the fact that this results in severely
biased parameter estimates [111], it is still of common use [112].
2.9.2

Imputation Methods
There are two classes of imputation techniques. The first class is deterministic

imputation, which fills-in—or imputes—one value for every missing value. The second class of
imputation techniques incorporates randomness into the imputed values, with two variants of this
class. The first variant imputes one value for every missing value, which is known as single
imputation. The second variant is known as multiple imputation (MI), which also imputes values,
but does so a number of times—creating multiple datasets. These datasets are then analyzed using
normal analysis techniques, whereby the point estimates and standard errors are combined using
standard combining rules known as Rubin’s rules [98].
2.9.2.1

Deterministic Imputation
There are at least three variants of deterministic imputation methods: last observation

carried forward (LOCF), mean imputation, and regression imputation. All of the deterministic
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imputation techniques create one complete dataset by filling in the missing values to allow all the
data to be used.
The first deterministic imputation method is known as last observation carried forward,
which is used in repeated measures data. The researcher simply imputes the last observation’s
value for all subsequent missing observations, until (and if) a subsequent observation is recorded.
Unfortunately, in longitudinal data one must be concerned about the mechanism of missingness,
as there is likely a systematic difference between those who complete a study and those who do
not, likely making these data MAR or MNAR.
The second deterministic imputation method is known as mean imputation. Here the
researcher simply imputes the mean value, or median in the case of skewed data, value for all
missing continuous data. This method has been rejected by Rubin as being unacceptable for
research [113], and has been repeatedly shown in studies to introduce unacceptable bias and overprecise confidence intervals [114] because it artificially reduces overall variance.
The third, and final, deterministic imputation method is known as regression imputation.
Here the researcher uses linear regression to predict missing values using the complete cases. For
instance, if there are three variables in our dataset (𝑋 , 𝑋 , 𝑋
one would regress 𝑋 on 𝑋 , 𝑋 . This would yield 𝐸 𝑋

with 𝑋 containing missing values,
𝛽

𝑋𝛽

𝑋 𝛽

𝜀, allowing the

researcher to impute the missing values of 𝑋 .
Deterministic imputation techniques allow for standard statistical techniques to be used,
as if no data were missing. However, these methods suffer from various drawbacks—including
biased estimates, and naively-small confidence intervals of those estimates, as the uncertainty
surrounding the missing data is not accounted for in the analysis [98, 113, 115].
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2.9.2.2

Single Imputation
Similar to the deterministic imputation methods, single imputation methods create a

complete dataset by filling in the missing values with plausible values to allow all the data to be
used—rather than discarded, as is the case with CCA. However, single imputation methods differ
from the deterministic methods in that they introduce random variation into the imputed values.
There are at least two main variants of single imputation: hot deck imputation, and regression
imputation with a random component.
The first single imputation method, known as hot deck imputation, was developed at the
U.S. Census Bureau in the 1960s to address survey item non-response to the question of
household income in the Current Population Survey [100]. Essentially, the hot deck method finds
all the observations in the dataset that are similar to the observation with a missing variable—the
hot deck—then randomly picks one of the observations from the group of similar fully-observed
observations and imputes that value into the observation with missing data.
To illustrate hot deck imputation, suppose income is missing for a Caucasian male, 33
years of age, who worked full-time in a professional occupation, in the state of Florida. Hot deck
imputation would find all males in the age group 25-34, who are full-time professionals in the
Southeastern United States. Then, a random pick of one person from this group of fully-observed
data would be made, and the income of this individual being imputed into the missing
observation.
Advantages of hot deck imputation include that is makes a logical assumption regarding
imputed values, as one would expect a missing value to be very similar to a nearly identical
person’s value. Another advantage is that hot deck imputation imputes realistic values for missing
observations, since the imputed values are drawn from the fully-observed dataset.
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A number of adaptations of hot deck imputation exist, including predictive mean
matching (PMM) which uses linear regression to estimate the values of missing continuous data,
then randomly picks one of the similar case’s values to use as the imputed value [116, 117].
Interestingly, the hot deck imputation method is still being used by the U.S. Census Bureau today
[118, 119].
Another single imputation method is known as regression imputation with a random
component, also referred to as stochastic regression imputation. Here the method is nearly
identical to the deterministic regression imputation technique, however a random component is
introduced. Using the previous example with three variables in our dataset (𝑋 , 𝑋 , 𝑋

where

𝑋 contains missing values, one would again regress 𝑋 on 𝑋 , 𝑋 . This would yield
𝐸 𝑋

𝛽

𝑋𝛽

𝑋 𝛽

𝜀. However, one would then introduce randomness by adding a

random component through multiplying the error term 𝜀 (which is the root mean squared error of
the regression equation) times a random draw from the standard normal distribution (~𝑁 0,1 ).
This regression equation with the random component added then allows the researcher to impute
the missing values of 𝑋 .
Single imputation methods suffer from the same drawbacks as deterministic imputation
techniques, such as biased estimates and small confidence intervals of those estimates, and the
uncertainty surrounding the missing data is not accounted for in the analysis [98].
2.9.2.3

Multiple Imputation
Multiple imputation (MI) techniques are similar to single imputation techniques, but they

create multiple datasets which Rubin (1987, p.2) described as “ representing a distribution of
possibilities” [98]. Multiple imputation is used when the MAR missing data mechanism is likely.
Multiple imputation techniques are also believed to be an option when the data are MNAR, so
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long as the missing data mechanism is correctly specified [97]. However, the probability of
correctly modeling the missing data mechanism is unlikely to occur.
The goal of MI is not to make up data, but rather to allow all the data that are present to
be used in analyses to achieve valid statistical inference, not perfect point prediction [113]. In
fact, even when the percentage of missing data is small and the data are MCAR—meaning the
point estimates generated in an analysis will be unbiased—MI has the advantage of increased
power, yielding tighter confidence intervals around those estimates. This was demonstrated in
Bounthavong et al. (2015) which compared CCA to MI to study the outcome of dyslipidemia in
the Veteran population using electronic medical record (EMR) data [120]. This study found that
with 22% missingness the point estimates changed very little, but the confidence intervals were
much narrower using MI (m = 5), demonstrating the utility of MI even when data are believed to
be MCAR.
There are techniques for univariate and multivariate missingness. The techniques for
univariate missingness are the same as the single imputation techniques described previously,
varying only by creating m number of multiply-imputed datasets. However, prior to explaining
specifics of various MI techniques, it is prudent to explain the general process of multiple
imputation process.
Essentially, MI fills in the values that are missing with plausible values, to allow all of
the existing data to be used—rather than discarded, as is the case with CCA. Multiple imputation
is composed of three phases [95, 98], see Figure 2.5 below. The first phase fills in the missing
values for each variable through one of several MI techniques, repeating this process a certain
number of times (m times). This first phase is where all MI techniques vary. The second phase is
where each of the m multiply-imputed datasets are analyzed separately using normal regression
analysis techniques, yielding m number of vectors of parameter estimates and standard errors.
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The third, and final, phase is where the m vectors of parameter estimates and standard errors are
pooled together using a technique commonly known as Rubin’s rules [98], which essentially
averages the repeated parameter estimates and standard errors from the m datasets to give one
vector of parameter estimates and another of standard errors.

Figure 2.5 Conceptual diagram of multiple imputation

There are two common methods of MI for multivariate missing data, multivariate
imputation through chained equations (MICE) and Markov-Chain Monte Carlo (MCMC)
multiple imputation. These two MI methods vary based on their statistical assumptions and
execution, which are discussed below.
The first MI method is Multivariate Imputation through Chained Equations (MICE),
which also is known as Fully-Conditional Specification (FCS) in the literature [121]. MICE is a
special type of MI whereby various regression-based techniques—typically generalized linear
models, such as linear or logistic regression—can be used for each type of missing variable in the
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data, using the observed variance and covariance matrices. In other words, a logistic regression
model can be used to help predict missing binary values; an ordinary least-squares (linear)
regression model can be used to help predict missing continuous variables. The MICE method
also has further flexibility through allowing discriminant function methods to predict missing
binary or nominal data [12], and predictive mean matching (PMM) for continuous data [122].
One model is created for each variable with missing data. Each of these models are used to to
impute the missing values, with MICE iterating through m times to create m multiply-imputed
datasets, which are then combined in the same manner as all other MI models, using Rubin’s
rules.
The amount of missing data, 𝛾, is of concern with any missing data model. The MICE
method has demonstrated good results across a range of missingness, from 𝛾 = 5 to 90%. One
study by Janssen et al. (2010) compared MICE to other simpler methods—namely CCA and
dropping of predictors with missing data [123]. The study examined a wide-range of missingness
(from 𝛾 = 10 to 90%) under the MAR missing data mechanism for three predictors of deep
venous thrombosis (DVT), using 500 simulated datasets. For the MICE method, m=10 multiplyimputed datasets were created. The MICE method worked well at all percentages of missingness,
yielding less bias in the regression coefficients for these predictors and better coverage of the
95% confidence interval of the full dataset regression coefficient.
Another theory-building simulation study by Knol et al. (2010) compared MICE to CCA
and the missing indicator method (MIM) for dealing with missing observations for one predictor
of major depressive disorder (income) using data from a prior clinical trial [109]. The study
examined five levels of missingness (𝛾 = 2.5%, 5%, 10%, 20%, and 30%) under the MCAR and
MAR missing data mechanisms, using 1,000 simulated datasets. For the MICE method, m=5
multiply-imputed datasets were created. This study found that both CCA and MIM resulted in
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biased results, with the amount of bias increasing with the amount of missing data. The authors
recommended that MIM and CCA never be used, even with small percentages of missing data.
Unfortunately, MICE does not always converge to the correct posterior distribution.
There is at least one example from the literature where MICE failed to converge in a study that
used EHR data, albeit there was 70% missingness [124]. Nonetheless, MICE has advantages in
CER studies due to the wide range in the types of variables for which one might control in a
regression analysis, allowing separate imputation models to be used for each variable with
missing data. Typically, continuous, ordinal, categorical, and binary variables will all be used in
the same analysis as covariates—demonstrating the appeal of using MICE.
The second MI method is Markov Chain Monte Carlo MI (MCMC), which is a method of
multivariate normal imputation (MVNI) that assumes multivariate normality of all continuous
variables [12]. In contrast to the MICE method, which specifies a conditional distribution to
predict missing values for each missing data type, the MCMC method specifies a single joint
distribution for all variables with continuous data. For continuous variables that are skewed,
transformation prior to using the MCMC method can yield good results [125].
2.9.3

Likelihood Methods
Likelihood methods rely on maximum likelihood estimation (MLE) to estimate

parameters for predictors that predict an outcome. Maximum likelihood estimation is similar to
MI in that a guess is made at the missing values, however it is done in a more implicit—rather
than explicit—manner [126]. The manner in which this is accomplished is through finding the
parameter estimates that would maximize the probability of observing what has been observed,
known as the maximum likelihood method [115]. Maximum likelihood is also the method by
which generalized linear models are solved, whereby the difference between the observed and
predicted data is minimized. For one familiar with calculus, this is akin to finding the maxima of
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a function by conducting a second derivative test; in this case, the likelihood function is
maximized to find the point of highest probability. Upon completion of MLE, parameter
estimates will have been made, along with standard error estimates, without the need of creating
multiple datasets.
Maximum likelihood estimation is used when the MAR missing data mechanism is
likely. However, MLE methods are also believed to be an option when the data are MNAR, so
long as the missing data mechanism is correctly specified [115]. Unfortunately, MLE methods
rely on the assumption of multivariate normality—meaning that all continuous variables are
normally distributed and can be defined as a linear function of all the other variables, with the
error terms having equal variance (homoscedastic) and a mean of zero—a very strong assumption
[104].
2.9.3.1

Maximum Likelihood Estimation with EM Algorithm
The first type of maximum likelihood method is maximum likelihood estimation using

the Estimation-Maximization (EM) algorithm [101, 127]. This method relies on the MAR or
MCAR assumption [127] and produces unbiased parameter estimates, but has a drawback in that
it does not provide estimates of the standard error for each parameter estimate [104, 115].
There are two steps involved with this method: expectation and maximization [127]. The
first step, Expectation, imputes values for each missing value in the dataset. Next a regression
equation is constructed using the other variables to predict the missing value. Values are then
imputed into the dataset for all variables with missing data (𝑌

, creating the initial full dataset.

The second step, Maximization, involves recalculating the means, variances, and
covariances using the dataset from the prior step. When calculating the variances and covariances
the residual, or error, term used in the regression equation would be incorporated into these
calculations. For example, if Var1 and Var2 were used to predict Var3, meaning 𝐸 𝑉𝑎𝑟
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𝑉𝑎𝑟 𝛽

𝑉𝑎𝑟 𝛽

𝜖, then 𝜖 would help inform the variance and covariance matrix for all Var3

[104].
2.9.3.2

Full Information Maximum Likelihood
The second type of maximum likelihood method is Full Information Maximum

Likelihood estimation (FIML), also known as Direct Maximum Likelihood. One downside to
FIML is that it converges more slowly than with MLE using the EM algorithm [127]. However, it
is often preferred over MLE using the EM algorithm because it gives accurate estimates of the
standard error estimates [104].
2.9.4

Methods Available in Common Statistical Software
Surveying the statistical software for analytical approaches available is predicated on

knowing which statistical software packages are used in health services research—unless one’s
goal is an exhaustive review of all statistical software. One comprehensive review of statistical
software conducted in 1997 identified 220 statistical programs—of which 39 were general
statistical (e.g. SAS, SPSS), 25 were for mathematical statistics (e.g. Matlab), 14 for
econometrics, and 142 were specialized statistical software for multivariate analyses, specialized
modeling, or power and sample size calculation [128]. Keeping to an approach which favors
brevity, the literature was consulted to answer this question. Those software with broad
representation in health services research journals seems to be SAS (SAS Institute, Inc.; Cary,
North Carolina), SPSS (IBM Corp.; Armonk, NY), Stata (StataCorp LLC; College Station, TX),
and infrequently RStudio (RStudio Inc.; Boston, MA).
One study in 2014 examined the statistical methods and software used by all studies that
used the Canadian community health survey data, published from 2002-2012 (n=663) [129]. This
study found the most common statistical software to be SAS (30.8%), followed by Stata (13.1%),
SPSS (12.8%), SUDAAN (6.5%), and all others (2.6%). Another study published in 2011
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examined statistical software used in health services research published in the United States from
2007-2009 (n=877) [130]. This study found the most common statistical software to be Stata
(46.0%), followed by SAS (42.6%), SUDAAN (6.2%), and SPSS (5.8%). However, only 61% of
these articles mentioned the statistical software used. Of note, many of the articles mentioned
more than one statistical application being used—explaining why the percentages exceed 100%.
As one can see, the three most common statistical packages appear to be SAS, SPSS, Stata, and
SUDAAN. However, SUDAAN is typically used for more complex research designs—such as
correlated, clustered, or stratified designs [131]. The next step is to clearly define the approaches
available in these software packages to handling missing data—as they will be the ones most
handily available to health services researchers.
A review of the documentation for the latest versions of SAS (v. 9.4; SAS/STAT 14.3;
released December 2017), SPSS (v. 25; released August 2017), and Stata (v. 15; released June
2017) was conducted. The results of this review are included below in Table 3.
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Table 3 Missing data methods available in SAS, SPSS, and Stata
SAS

SPSS

Stata

Adjustment Methods
Listwise Deletion (Complete Case Analysis)
Pairwise Deletion (Available Case Analysis)

Yes
Yes

Yes
Yes

Yes
Yes

Imputation Methods
Default # datasets

25

5

10

Monotonic Imputation
Regression - Linear, Logistic, Ordered Logistic
Predictive Mean Matching
Discriminant Function (Nominal data)
Propensity Score (Continuous data)
Pattern-Mixture Models

Yes
Yes
Yes
Yes
Yes

Yes
Yes
No
No
No

Yes
Yes
No
No
No

Non-Monotonic Imputation
Markov-Chain Monte Carlo - Full dataset
Markov-Chain Monte Carlo - Monotone
Multivariate Imputation through Chained
Equations(MICE)
Pattern-Mixture Models

Yes
Yes
Yes

No
No
Yes

Yes
No
Yes

Yes

No

No

Likelihood Methods
Expectation Maximization (EM) algorithm
Full Information Maximum Likelihood (FIML)

Yes
Yes

Yes
No

Yes
Yes

The default missing data method for a statistical analysis in all three of these programs is
listwise deletion (or complete case analysis). All three programs also offer maximum likelihood
estimation using the common expectation-maximization algorithm. All the programs also offer
multiple imputation (MI), with varying levels of features—which are discussed next.
SAS offers the most methods for addressing both monotonic and non-monotonic
missingness patterns, offering all the major MI methods. While Stata allows for MCMC MI, it
only does so as a full imputation of the dataset for every missing variable. SAS, however, allows
the researcher to use MCMC MI to move the dataset from a non-monotonic to monotonic missing
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data pattern—imputing data for variables until a monotonic missing data pattern is reached.
Neither SPSS nor Stata allow the researcher to use Discriminant Function nor Propensity Score
methods for MI for monotonic missingness. However, it is worth mentioning these two methods
are possible through some statistical programming as SPSS and Stata have built-in methods for
discriminant function analysis and propensity score methods. Finally, the default number of
datasets constructed with multiple imputation, m, varies greatly by software program—from 5 in
SPSS, to 10 in Stata, and 25 in SAS (which was changed from 5 with SAS/STAT 14.2).
This section has shown for non-monotonic missingness there are two major options for the
researcher who decides not to ignore the missing data: MICE or MLE. With monotonic
missingness, such as when only one predictor is missing, a few more options abound: monotonic
regression, predictive mean matching, or maximum likelihood estimation—however monotonic
missingness is not the usual scenario.
2.10 Recapitulation
In December 2015, PCORI convened a workgroup to discuss missing data and data
quality for research using electronic medical records and claims data—identifying problems,
highlighting current solutions to some of those problems, and suggesting areas for future research
[132]. One identified need was for research to understand the effects of various amounts of
missing data, whether the results would be significantly altered by the amount of missing data.
Another need was to understand which covariates experience missingness, what the mechanism
for missingness is (e.g. MAR), and whether simulations could be used to learn more about these
covariates and the impact of missing data. Finally, the PCORI workgroup asserted one of the next
steps would be to bring researchers who have experienced success in handling missing data in
EMR studies with researchers who are new to EMR studies to help disseminate this knowledge.

3
3.1

METHODS
Specific Aims and Hypotheses
This study has been designed to examine the effects of missing data in studies that use

electronic health record data capturing patient stays in the intensive care unit for ventilatordependent respiratory failure (VDRF) to accomplish the following:

1) Ascertain the degree to which results may be biased at various percentages of
missing data
2) Examine methods of dealing with missing data that are commonly available in
statistical software packages used by Health Services Researchers

Therefore, the aims of this study are as follows:

AIM 1
To examine the impact of missing SOFA score data on ICU clinical outcomes studies
among patients with ventilator-dependent respiratory failure at various percentages of
missingness, along with various statistical techniques for handling missing data at the composite
score level.

Hypothesis 1: All methods for handling missing data will result in more accurate
parameter estimates for all outcomes studied than simple pairwise deletion.
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Hypothesis 2: Multiple imputation (MI) methods will result in the most accurate
parameter estimates, when compared with the three other methods for dealing with
missing data.

AIM 2
To examine the impact of missing SOFA score data on ICU clinical outcomes studies
among patients with ventilator-dependent respiratory failure at various percentages of
missingness, along with various statistical techniques for handling missing data at the component
item level.

Hypothesis 1: All methods for handling missing data will result in more accurate
parameter estimates for all outcomes studied than simple pairwise deletion.

Hypothesis 2: Multiple imputation (MI) methods will result in the most accurate
parameter estimates, when compared with the three other methods for dealing with
missing data.

3.2

Data Source
The data used in this study were provided by the Medical University of South Carolina’s

Clinical Data Warehouse (CDW), which contains electronic medical record data. These data
include patient demographics, procedures, diagnoses, encounters, laboratory results, as well as
medications ordered or administered during an inpatient admission [133]. The Medical University
of South Carolina’s CDW provides access to MUSC investigators with Institutional Review
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Board approved studies for the purposes of retrospective research and patient recruitment [134].
The MUSC CDW has records collected since 1993 on 2.1 million patients, comprising 1.5
million inpatient admissions, 26.6 million outpatient encounters, 228 million laboratory results,
and 5.5 million procedures as of October 2017 [135, 136]. These data were made available
through funds from the South Carolina Clinical & Translational Research (SCTR) Institute, with
an academic home at the Medical University of South Carolina, and a Duke Endowment
Foundation Healthcare Division grant. These deidentified data were examined by the Institutional
Review Board at the Medical University of South Carolina and deemed as non-human research.
The data used for this study contains demographics (age, sex, race), height, weight,
primary payer, length of stay in the ICU, components of SOFA score upon admission to the ICU,
duration of mechanical ventilation, diagnosis codes, procedure codes, discharge disposition, and
total charges. Other pertinent clinical data were also retrieved, including Richmond AgitationSedation Scale (RASS) scores, Confusion Assessment Method for the ICU (CAM-ICU) scores,
and results of Spontaneous Breathing Trials (SBT).
3.3

Study Population
The study population is composed of adults, aged 18 years or older on the date of

admission, who were admitted to one of the ICUs at the Medical University of South Carolina
from January 1, 2015 through October 31, 2017 and placed on a ventilator due to respiratory
failure. Respiratory failure was defined as being indicated with an ICD-9 procedure code of
96.70, 96.71, 96.72; or an ICD-10 procedure code of 5A1935Z, 5A1945Z, 5A1955Z. The
descriptions of these ICD procedure codes are listed below in Table 4.
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Table 4 ICD-9 and ICD-10 procedure codes for study inclusion
ICD
Version

Procedure
Code

Description

9

96.70

Continuous mechanical ventilation of an unspecified duration

96.71

Continuous mechanical ventilation of ≥ 96 consecutive hours

96.72

Continuous mechanical ventilation of < 96 consecutive hours

5A1935Z

Respiratory ventilation, < 24 consecutive hours

5A1945Z

Respiratory ventilation, 24-96 consecutive hours

5A1955Z

Respiratory ventilation, > 96 consecutive hours

10

3.4

Statistical Software and Data Management
The data used for this dissertation was provided by the MUSC CDW team in comma

separated value (CSV) format. The data were then imported into SAS software format, using
SAS® software, version 9.4 for Windows (SAS Institute Inc., Cary, NC, USA). All simulations
and analyses were performed using SAS/STAT® version 14.3 for the Microsoft Windows
operating system.
3.5

Methods for Multiple Item Instruments
Instruments that have multiple component items present a decision point for the

researcher, as one can handle these at the item (or component) level or the composite level. For
instance, if a patient has values as shown below (Table 5), 4 out of 6 of the item level scores can
be calculated.

49

Table 5 Example calculations of the SOFA score
System

Value

Item Score

Respiration
PaO2/FiO2, mmHg

280

2

Coagulation
Platelets x 103/mm3

130

1

.

.

68

2

.

.

1.1

0

Hepatic
Bilirubin, mg/dl
Cardiovascular
MAP, mm Hg
Central Nervous System
Glasgow Coma Scale
Renal
Creatinine, mg/dl
SOFA Score

?

Unfortunately, the SOFA score itself—a summation of the 6 component scores—cannot
be calculated in the case of one or more missing component scores. In the case of one or more
missing component scores, the most one can say is that the SOFA score is at a minimum the sum
of the observed component scores (i.e. 2 + 1 + 2 + 0 = 5), and at most the observed component
scores plus the maximum scores available for the missing component items (i.e. 2 + 1 + 2 + 0 +
4 + 4 = 14). To further highlight the decisions available to the researcher, single imputation will
be used for illustration.
In the case of single imputation for the above hypothetical scenario, the researcher can do
single imputation for each component item missing, or for the composite SOFA score. However,
this is complicated in the approach for the component items, as two options present themselves.
The first option is to impute the missing values themselves (i.e. bilirubin level in mg/dl, and
Glasgow Coma Scale score), then calculate the component scores—allowing the composite
SOFA score to be calculated. The second option is to impute the component SOFA score—
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allowing the composite SOFA score to then be calculated. The importance of this decision has
been shown in the literature.
At least several studies have examined handling multiple item instruments at the composite
versus component level. One study examined the Pain Coping Inventory, a 12-item instrument,
using multiple imputation at both the composite and component levels [114]. This study found
that when the percentage of missing data exceeded 25%, multiple imputation at the component
level outperformed both mean imputation and multiple imputation at the composite level.

3.6

Aim 1 – Univariate Missingness (SOFA Score, Composite Level)
Aim 1 of this dissertation is to examine the impact of missing SOFA score data on ICU

clinical outcomes studies among patients with ventilator-dependent respiratory failure at various
percentages of missingness, along with various statistical techniques for handling missing data at
the composite score level. The effects of various methods for handling missing data, described in
subsequent sections, will be considered for their impact on the significance of three outcomes—
both magnitude and direction—for three common outcomes that use SOFA score data as a risk
adjuster. Essentially, using a dataset with complete SOFA scores, various percentages of
missingness will be imposed so that we can compare the parameter estimates from various
missing data techniques to those of the estimates from the full dataset.
3.7

Aim 2 – Multivariate Missingness (SOFA Score, Item Level)
Aim 2 of this dissertation is to examine the impact of missing SOFA score data on ICU

clinical outcomes studies among patients with ventilator-dependent respiratory failure at various
percentages of missingness, along with various statistical techniques for handling missing data at
the component item level. The effects of various methods for handling missing data, described in
subsequent sections, will be considered for their impact on the significance of three outcomes—
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both magnitude and direction—for three common outcomes that use SOFA score data as a risk
adjuster. Essentially, component SOFA score items will be deleted at various percentages of
missingness to compare the parameter estimates from various missing data techniques to those of
the estimates from the full dataset.
3.8

Simulation Process & Outcomes Analysis
This study is designed as a simulation study to compare four statistical missing data

methods to a known truth—the full dataset, to assess the performance of each. To aid in this
endeavor, the published guide on conducting simulation studies in medical statistics by Burton et
al. (2006) served as a guide for the simulation methods [137].
3.8.1

Simulation Algorithm
The simulation is represented in Figure 3.1 below. At the start of the simulation a

complete dataset is provided; all component values of the SOFA score, composite SOFA score,
potential covariates, and outcomes are fully-observed.
The two simulation parameters are specified. The first simulation parameter, S, denotes
the number of simulation runs. Typically, S will be 1,000 runs—each looping through the
simulation steps. The second simulation parameter, γ, denotes the percentage of observations
within the dataset that will contain one or more missing values.
Once the simulation parameters have been specified and the fully-observed dataset
chosen, the simulation loop proceeds as follows. From the complete dataset missing data will be
generated by choosing γ percent of the observations to have a missing SOFA score value, and
these values set to missing in the dataset. Then for each of the four missing data methods chosen,
the missing data method will be applied to the dataset. Then it will be analyzed for the three
outcomes chosen. For each analysis key results will be output to a table for later comparison. This
simulation loop will run from the beginning, until S simulation loops have been completed.
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Figure 3.1 Simulation algorithm

3.8.2

Simulation Parameters
There are two simulation parameters—S and γ. The first simulation parameter, S (not

shown in diagram), denotes the number of simulation runs. Typically, S will be 1,000 runs—each
looping through the simulation steps shown above in Figure 3.1. This creates S number of
independent datasets from which the simulation can proceed.
The second simulation parameter, γ, denotes the percentage of observations within the
dataset that will contain one or more missing values. For this study, a range of percent missing
data will be studied to help understand the behavior of these data at various percentages of
missingness. Studying a broad range of missing data percentages will further help Health Services
Researchers to better understand how bias varies in these data based on the percent of missing
data. Further, recommendations within the literature on the tolerable percentage of missing data
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varies. Two guidelines state that 5% missingness is where one needs to worry about bias [12,
138], whereas another states 10% [139]. These guidelines are sufficiently broad, and varying, so
further consideration in different types of data is warranted. To illustrate, while 5% missingness
of the SOFA score may be reasonable within a large ICU dataset studying mortality, 5%
missingness of race is likely excessive in disparities studies. Therefore, the tolerable percent
missing would vary based on the missing predictor’s strength of association with the outcome as
well as the research question being asked.
3.8.2.1

Missing Data Mechanism & Generation of Missing Data
Data can rarely be considered to be missing completely at random (MCAR) due to the

strict nature of these data—meaning it is akin to taking a random sample of the full data,
dependent only on a stochastic process. Whereas one can never be fully certain whether data are
missing at random (MAR) or missing not at random (MNAR). Even if one can model with good
accuracy the missing data mechanism under MAR, there exists the possibility that data may also
be missing due to a latent process—making those data MNAR. This was examined by Geert
Molenberghs et al. (2008), when they demonstrated that any MAR missing data mechanism
model has a corresponding MNAR model with equal fit, rendering empirical distinction between
the two missing data mechanisms impossible [140]. Therefore, generation of missing data shall
be conducted under the MAR and MNAR missing data mechanisms.
The MAR mechanism will be modeled using demographic missingness, similar to what
has been used in other studies [102]. Using the original ICU dataset, which includes both missing
and fully-observed data, we will model how demographic variables contribute toward
missingness. If the existing data’s missing data process were fully-MAR, then this would mimic
the MAR missing data process. The method of accomplishing this is as follows.
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If a subject’s ICU record contains a missing SOFA score element, the record will be
denoted as missing (SOFAmiss = 1), otherwise if all SOFA score elements are present then this
will be denoted as (SOFAmiss = 0). A multivariable logistic regression model will then be fit to
ascertain the estimated probability that a subject’s SOFA score is missing, given their observed
demographic and clinical factors—such as age, sex, race, and primary payor. Using the notation
of Hosmer, Lemeshow, and Sturdivant (2013) [141], if there are p independent predictor
variables, the vector of predictors is represented as 𝑥

𝑥 ,𝑥 ,…,𝑥

and the conditional

probability that the SOFA score is missing is denoted as follows:
1|𝑥′

Pr 𝑆𝑂𝐹𝐴

𝜋 𝑥′

From the multiple logistic regression model, we obtain parameter estimates for each of
the p predictors, yielding the logit transformation, 𝑔 𝑥 , shown below:
𝑔 𝑥

ln

𝜋 𝑥
1 𝜋 𝑥

𝛽

𝛽𝑥

𝛽𝑥

⋯

𝛽 𝑥

Finally, assigning the empirically-derived probability of having a missing SOFA score to
each record will be defined as follows:
Pr 𝑆𝑂𝐹𝐴

𝜋 𝑥

𝑒
1

𝑒

These values will not change across simulation iterations. However, for each run through
the simulation (depicted in Figure 3.1), random variation will be introduced to these probabilities.
To accomplish this, a random component R will be added to Pr 𝑆𝑂𝐹𝐴

. This random

component will consist of a random draw from the standard uniform distribution, where 𝑅 ∈
0,1 , by using the SAS function RAND(‘UNIFORM’,0,1). The fully-observed dataset will then
be sorted in descending order by its probability of missing, with the first γ% of observations
having their SOFA score (or 1 or more SOFA score components) set to missing.
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The MNAR mechanism will be modeled using three basic strategies. The first strategy
will be to impose missingness more commonly in the lower SOFA score categories, in the left
side of the observed SOFA distribution (hereinafter referred to as MNAR Left). This means that
SOFA scores closer to zero would have a higher likelihood of being deleted. This strategy aligns
well with the SOFA score creators’ guidelines to impute a zero when the score (or one of the subscores) is missing.
The second strategy will impose missingness more in the median SOFA score categories,
in the center of the observed SOFA distribution (hereinafter referred to as MNAR Mid). Finally,
the third strategy will be to impose missingness in the higher SOFA score categories, in the right
side of the observed SOFA distribution (hereinafter referred to as MNAR Right). These will be
accomplished using the methods outlined by Jaap Brand et al. (1993) using SAS/STAT software
[142], yielding γ% of the fully-observed dataset having missing SOFA score observations.
3.8.2.2

Assignment of Missing Data Patterns
The assignment of missingness patterns proceeded as follows. First for each observation

within the fully-observed dataset, a missing data pattern was assigned to each observation
according to the frequencies with which these patterns occurred within the dataset extracted from
electronic health record. Then, observations were chosen to be selected to have missing data
according to the respective missing data mechanism and percentage of missingness as prescribed
by the parameters within the simulation. If an observation was selected to be missing, the missing
data pattern that was previously assigned was then applied.
3.8.2.3

Simulation Runs & Percent Missingness
As mentioned previously, two simulation parameters are specified: the number of

simulation runs (S), and percentage of observations within the dataset that will contain one or
more missing values (γ). It is common within simulation studies that the number of simulation
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runs be set to a large number ranging from 200-1,000 [142]. Of the simulation studies examined
for this research, 1,000 simulation runs seemed to be the most common [102, 143-145], followed
by 500 simulation runs [114, 142]. Therefore, in this study the number of simulation runs, S, will
be set to 1,000—each looping through the simulation steps shown in Figure 3.1.
The second simulation parameter that will be specified, γ, denotes the percentage of
observations within the dataset that will contain one or more missing values. In this study, any
observation that has one or more items of the SOFA score missing contributes toward the number
of missing observations.
The most common guideline has asserted that >5% missingness is the level where a
researcher needs to worry about biasing the results of a study [12]. While this particular
percentage of missingness merits further investigation in these data, it would be wise to go much
higher than this amount. Further, sufficiently small steps to aid in decision making should be
taken between the percentage of missingness levels. Therefore, in this research project
percentages of missingness from 0% to 40% at 10% increments were investigated; we
investigated γ=0%, 10%, 20%, 30%, and 40% missingness. The baseline of 0% missingness—the
fully-observed dataset—was used as the referent group from which truth was derived, and all
comparisons in this study were be made.
3.8.3

Missing Data Methods
In this study we investigated four methods for handling missing data. These methods

include the most common method used in health services research, pairwise deletion (complete
case analysis), two deterministic imputation techniques (median imputation and imputation per
SOFA guidelines), and multiple imputation. Maximum likelihood estimation was not be
considered due to the assumption of multivariate normality, and the limitation of only being able
to model continuous outcomes using standard software—such as SAS, SPSS, and Stata; one
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would have to use specialized software such as Mplus for such applications of generalized linear
models [146]. As all three outcomes compared in this analysis required generalized linear models
(see Section 3.8.4), MLE was not considered for comparison in this study.
Therefore, the effects of these four methods for handling missing data were considered
for their impact on the significance of three outcomes—both magnitude and direction—that use
SOFA score data as a risk adjuster. These methods will be operationalized at the composite
SOFA score level (in support of Aim 1), and at the component SOFA score level (in support of
Aim 2). These missing data methods will be briefly explored below.
3.8.3.1

Method 1: Complete Case Analysis
The first method for handling missing data that that was explored in this study is

complete case analysis (CCA), whereby only those cases for which data exists on all outcomes
and potential explanatory variables are retained in the analysis. The second method is available
case analysis (ACA), also known as pairwise deletion, which is the default method of most
statistical software. With this method any observation that has a missing outcome or explanatory
variable is excluded from the analysis. This leads to problems of changing samples, as during
model fitting as potential covariates are added and removed the sample size will change. Further,
secondary analyses will also have different sample sizes—and essentially different samples—than
the primary analysis. Clearly, such a strategy is problematic as will be discussed next.
The first problem with CCA and ACA methods is that reduced statistical power is
achieved due to a smaller sample size. While the magnitude of this problem varies based on the
total sample size and the percent of missing data, it is still a problem. The second problem with
CCA and ACA is that unless the data that are missing are missing completely at random
(MCAR), the results will likely be biased [109]. If it is completely a chance occurrence the data
are missing— or MCAR—removing the case will not bias the results using CCA [109]. However,
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CCA and ACA will result in a loss of precision in the confidence interval. Therefore, dealing with
the missing data, rather than ignoring it, is warranted. However, in order show the magnitude of
bias at varying percentages of missing data, as well as mechanisms of missingness, it is
imperative that we explore this as a missing data method herein.
For this study any observation where the composite SOFA score is missing (in the case of
Aim 1), or any one component of the SOFA score is missing (in the case of Aim 2) will be
deleted. Then three outcomes will be analyzed, as described in Section 3.8.4.
3.8.3.2

Method 2: Median Imputation
The second method for handling missing data that was explored in this study is median

imputation. Median imputation is a deterministic imputation technique that creates one complete
dataset by filling in the missing values to allow all the data to be used. Essentially, the researcher
simply imputes the median value of the missing item and proceeds with analysis as if no data
were previously missing.
Granted, this method has been rejected by Rubin as being unacceptable for research
[113], and has been repeatedly shown in studies to introduce unacceptable bias and over-precise
confidence intervals [114]. However, it is important that this method be demonstrated within this
current research for the same reason that pairwise deletion will be used—this method is still being
used in scientific studies.
For this study the median composite SOFA score (in the case of Aim 1), or the median
component SOFA score (in the case of Aim 2) will be imputed in cases of missing values. Then
three outcomes will be analyzed, as described in Section 3.8.4.
3.8.3.3

Method 3: Imputation per SOFA Guidelines (Zero)
The third method for handling missing data that was explored in this study was to impute

a zero for each missing composite SOFA score (in the case of Aim 1), or a zero for each
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component item missing (in the case of Aim 2). This methodology of assuming the score is zero,
meaning there is no organ dysfunction, is in line with the SOFA score guidelines, outlined in the
2016 Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) consensus
paper. According to the Sepsis-3 consensus paper, the baseline SOFA score—which is calculated
upon admission to a critical care unit—should be assumed to be zero, unless the patient has a
known organ dysfunction [65]. In the quantitative study which informed the Sepsis-3 task force,
single imputation of a normal value (zero) was used [147], with the assertion made that this usage
“mirrors how clinicians would use the score at the bedside” (p. 764). While this observation has
merit, it is worth noting that a treating clinician would have access to information—the full
clinical picture—to which a later researcher would not have access.
Similar to median imputation, imputing a zero for data that are missing is a deterministic
imputation technique that creates one complete dataset by filling in the missing values with
zeroes to allow all the data to be used. For this missing data method, any observation where the
composite SOFA score is missing (in the case of Aim 1), a zero will be imputed. For cases where
any component of the SOFA score is missing (in the case of Aim 2), a zero will be imputed for
missing component scores. Then three outcomes will be analyzed, as described in Section 3.8.4.
3.8.3.4

Method 4: Multiple Imputation
The fourth method for handling missing data that was explored in this study is multiple

imputation. As discussed in-depth in Chapter 2, multiple imputation creates multiple datasets—
imputing values with a random component added, which represent the variation that we might
expect when sampling from a population. These datasets are then analyzed using normal analysis
techniques. Finally, the point estimates and standard errors are combined using standard combing
rules. Multiple imputation is used when the MCAR or MAR missing data mechanisms are likely,
but have been used with MNAR.
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The goal of MI is not to make up data, but rather to allow all the data that are present to
be used in analyses to achieve valid statistic inference, not perfect point prediction [113].
Essentially, MI fills in the values that are missing with plausible values, to allow all of the
existing data to be used—rather than discarded.
There are two common methods of MI for multivariate missing data that could be
considered for this study, multivariate imputation through chained equations (MICE) and
Markov-Chain Monte Carlo (MCMC) multiple imputation. Multivariate imputation through
chained equations is a type of MI whereby various regression-based techniques—typically
generalized linear models, such as linear or logistic regression—can be used for each type of
missing variable in the data. In other words, a logistic regression model can be used to help
predict missing binary values; an ordinary least-squares (linear) regression model can be used to
help predict missing continuous variables.
The second type of MI is Markov Chain Monte Carlo MI (MCMC), which assumes
multivariate normality of all continuous variables [12]. The MCMC method specifies a single
joint distribution for all variables with continuous data, which would be difficult to achieve.
Particularly in attempting to impute missing SOFA scores, as the components thereof are count
data rather than continuous, which would be required to specify a single joint distribution.
Multivariate imputation through chained equations has advantages in health services
research studies due to the wide range in the types of variables for which we might control in a
regression analysis, allowing separate imputation models to be used for each variable with
missing data. Typically, continuous, ordinal, categorical, and binary variables will all be used in
the same analysis as covariates—demonstrating the appeal of using MICE. For the foregoing
reasons, MICE will be the MI method explored herein.
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The number of imputations, denoted by m, is also of concern. The recommendation by
Rubin in 1987 was that between 2 and 10 imputations are sufficient [98], which he reemphasized
a decade later [113] asserting m = 3 or 5 is often sufficient.
The ground for Rubin’s assertion comes from his earlier work, which states that the
relative efficiency (in standard deviations) of m imputations and γ percent missingness, compared
to m=∞ is estimated as

[98]. As an example, with 30% missing data, and 25 imputations

performed (m=25), the relative efficiency is 99.4%. This is a small increase over simply
performing 10 imputations (m=10) at γ=30%, which has a relative efficiency of 98.5%.
Nonetheless, some of the more recent literature have demonstrated imputation variability with
smaller numbers of imputations, which coupled with the modest increase in processing time for
doing larger numbers of imputations make the case for doing more imputations than previously
recommended [148]. This thinking has been adopted by major statistical software packages, such
as SAS—which now defaults to m=25. For the MICE method, the default number of multiplyimputed datasets in SAS (m=25) will be used. Finally, the m number of datasets—specifically the
m number of parameter estimate vectors and standard error vectors—will be combined using
Rubin’s rules [98].
3.8.4

Analysis of Outcomes
There are three outcomes to be analyzed to compare the performance of the four methods

for handling missing data—death, total hospital charges, and the length of stay within the ICU.
Comparisons of the missing data methods were made using these three outcomes as indicators of
missing data method performance. The various missing data methods were compared to results
from the full dataset for these three outcomes. These three outcomes will be discussed in greater
depth in the sections that follow.
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For all of these analyses, the fully-observed model were fit first—prior to simulation
runs—to find parsimonious models that best predict each of the three outcomes. Then the chosen
model for each of the outcomes were used in the simulation runs without further model fitting.
Details of model fitting for each outcome, along with the importance of each outcome, will be
discussed next.
3.8.4.1

Outcome 1: Death
The outcome of in-hospital death is important, and often studied when using SOFA score

as an instrument for baseline severity assessment. While the authors of the SOFA score
emphatically asserted that it was designed as a tool for description, not prediction, [64] its usage
has changed over time as it has demonstrated to be a good prognostic tool among ICU patients.
As discussed in Section 2.5.3, the SOFA score is widely-used as a prognostic tool to predict inhospital (and in-ICU) death. As such, investigating the impact of missing SOFA score data on the
clinical outcome of in-hospital death among ICU patients with ventilator-dependent respiratory
failure at various percentages of missingness, along with various statistical techniques for
handling missing data is important.
This model will be fit with a multiple logistic regression model. This analysis will be
performed using PROC LOGISTIC with SAS/STAT. The first model will be fit on the fullobserved dataset, then the same model will be used in all of the simulations without subsequent
model fitting.
Multicollinearity between covariates will be evaluated using Spearman’s rank correlation
coefficients (𝜌 ), along with variance inflation factors (VIF) during modeling. Model fitting will
proceed as described by Hosmer, Lemeshow, and Sturdivant (2013), using manual backwards
selection, using the smallest Akaike Information Criterion (AIC) or Schwarz Criterion (SC), and
likelihood ratio tests, along with individual covariate significance (p-values) [141]. Clinically-
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relevant variables will be used to determine which covariates will initially be included in the
model to control for differences in comparison groups and potential confounding. Overall model
fit will be assessed using the Hosmer-Lemeshow goodness of fit test. Model assumptions of
linearity of the logit for continuous predictor variables will be assessed using graphical methods
(LOWESS scatterplot). Statistical significance for this outcome was determined a priori to be at
the α=0.05 level.
3.8.4.2

Outcome 2: Total Charges
Studies that examine total charges are useful in economic evaluations of treatment, such

as cost effectiveness analysis studies. However, without severity adjustment such evaluations will
have large confidence intervals in point estimates of cost savings. Herein shall be examined one
study that did not adjust for severity within the ICU, and another study that did.
The first study is one that did not adjust for patient severity within the ICU using a
validated severity of illness scoring system, such as the SOFA score. is a random-effects metaanalysis of 12 studies that examined early versus late tracheostomies among ventilated ICU
patients, showed the average ICU cost difference was $4,316 (95% CI: $403-8,229), favoring
early tracheostomies [149]. However, in this study severity adjustment was not made—which
might have shrunk those confidence intervals, to give better estimates of the cost difference
between early versus late tracheostomy among ventilated ICU patients.
The second study is one that did adjust for patient severity within the ICU using a
validated severity of illness scoring system. In this study the authors investigated, via simulation,
how to optimize telemedicine delivery to ICUs (Tele-ICU) based on patient severity of illness—
as measured by the Acute Physiology and Chronic Health Evaluation IV (APACHE-IV) score
[150]. The authors wanted to know at what severity of illness—typically associated with poorer
outcomes and higher costs of care—would tele-ICU prove to be cost effective. The study found

64

that using Tele-ICU among the 30-40% of highest risk patients demonstrated optimal cost
effectiveness, with an incremental cost effectiveness ratio (ICER) of $25,392 per quality-adjusted
life year (QALY). This study demonstrated the use of telemedicine among ICU patients with the
30-40% of highest severity could be cost effective, which could inform an intervention study.
In the first study mentioned, cost effectiveness of an intervention (early tracheostomy)
was studied—without adjusting for patient severity, which likely led to imprecision in cost
savings. The second study of cost effectiveness of tele-ICU was investigated, using patient
severity as a criterion for tele-monitoring; the optimal patient severity to demonstrate cost
effectiveness was found, which can aid decision-makers and clinicians.
Cost effectiveness studies will continue to be performed, as balancing the allocation of
resources among treatment alternatives, and patients, remains a priority in health services
research. In all such economic studies, severity of illness (along with other potential confounders)
should be adjusted for in analyses. As such, investigating the impact of missing SOFA score data
on the financial outcome of total hospital charges among ICU patients with ventilator-dependent
respiratory failure at various percentages of missingness, along with various statistical techniques
for handling missing data is important.
Total charges measure the acute episode of care, both professional and facility charges.
These charges do not include follow-up care, including post-acute, specialty referrals, nor any
therapy. To quantify the effect of SOFA scores (e.g. a patient’s severity of illness) on the total
charges—which is a measure of intensity of care—generalized linear modeling will be used.
This model will be fit with a gamma-distributed generalized linear model with a logtransformed link function. In a gamma distribution, the standard deviation of the outcome is
proportional to the mean (𝜎 ∝ 𝜇) [151]. Further, the generalized linear model has been shown to
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work well in healthcare cost studies, where costs are heavily right-skewed, as long as the logtransformed variable does not have excessive heteroscedasticity [152].
This analysis will be performed using PROC GENMOD with SAS/STAT. The first
model will be fit on the fully-observed dataset, then the same model will be used in all of the
simulations without subsequent model fitting. Multicollinearity between covariates will be
evaluated using Spearman’s rank correlation coefficients (𝜌 ), along with variance inflation
factors (VIF) during modeling. Initial modeling will proceed with manual backwards selection,
using the smallest Akaike Information Criterion (AIC) or Bayesian Information Criterion (BIC)
values, and individual covariate significance (p-values). Clinically-relevant variables will be used
to determine which covariates will initially be included in the model to control for differences in
comparison groups and potential confounding. Statistical significance for this outcome was
determined a priori to be at the α=0.05 level.
3.8.4.3

Outcome 3: ICU Length of Stay
The outcome of ICU length of stay is clinically-important. One large benchmark study of

all ICU admissions at 271 ICUs in the United States in 2008 found that for each day in the ICU, a
patient will spend 1.5 days in a non-ICU bed [153]. With the typical cost per day of an ICU stay
being $3,518 in 2005, and the typical non-ICU stay at $1,153 [2], reductions in ICU length of
stay can reap large reductions in healthcare expenditures. As such, investigating the impact of
missing SOFA score data on the clinical outcome of length of stay within the ICU among patients
with ventilator-dependent respiratory failure at various percentages of missingness, along with
various statistical techniques for handling missing data is important.
This model will be fit with either a negative binomial- or Poisson-distributed generalized
linear model, depending upon model fit. Typically, for count data a Poisson-distributed model
will be appropriate when the variance of the outcome equals the mean, whereas a negative
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binomial-distributed model will be appropriate when the variance of the outcome is a quadratic of
the mean [151]. Selection of appropriate model—negative binomial or Poisson—will be assessed
by comparing the model’s deviance per degree of freedom,

. .

, with the chosen model

exhibiting a value closest to unity (1.0). This analysis will be performed using PROC GENMOD
with SAS/STAT. The first model will be fit on the fully-observed dataset, then the same model
will be used in all of the simulations without subsequent model fitting.
Multicollinearity between covariates will be evaluated using Spearman’s rank correlation
coefficients (𝜌 ), along with variance inflation factors (VIF) during modeling. Initial modeling
will proceed with manual backwards selection, using the smallest Akaike Information Criterion
(AIC) or Bayesian Information Criterion (BIC) values, and individual covariate significance (pvalues). Clinically-relevant variables will be used to determine which covariates will be initially
added to the model to control for differences in comparison groups and potential confounding.
Statistical significance for this outcome was determined a priori to be at the α=0.05 level.
3.8.5

Output of Results from Simulations
For each analysis, parameter estimates (𝛽 ), standard errors (SE), sample size used in the

analysis, and the calculated variance of the parameter estimate (𝜎

𝑆𝐸

√𝑛

) will be output to

a table along with identifiers of the simulation run (i, γ, identifier for the outcome being modeled
[e.g. death], and the missing data method used) for later comparison. An example of the output
table is below, in Table 3.3.
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Table 6 Simulation output table (example)
Row
ID

i

γ

1
2
3
4
5

0
1
1
1
1

0
20
20
20
20

Missing Data
Method
Full Dataset
Complete Case
Multiple Imputation
Guidelines (Zero)
Median

Modeled
Outcome

β
Estimate

Standard
Error

n

Variance

Death
Death
Death
Death
Death

0.406
0.559
0.414
0.429
0.465

0.179
0.135
0.162
0.198
0.206

1000
800
1000
1000
1000

32.005
14.558
26.374
39.363
42.601

As one can see from the above Table, there are 5 rows, where column i represents the
number of the iteration through the simulation loop. Where i=0, these are the initial analyses on
the fully-observed dataset, against which comparisons will be made. Column γ denotes the
percent missing data generated in that run. Therefore, with 4 missing data methods chosen for
comparison in the simulation loop, each simulation loop iteration will yield 4 rows (as shown
above) for each outcome being modeled, which will be output to the results table for each
outcome being analyzed; for a simulation run where S=1,000 with 4 missing data methods and 3
outcomes being modeled, 12,000 rows (1,000 * 4 * 3) will be output to a table. These statistics
will be used to compute the test statistics described in the next section, allowing for comparison
of methods.
3.8.6

Assessment of Simulation

The simulation runs were compared using summary statistics of the three test statistics,
yielding the properties of the performance of each of the missing data methods examined. These
three statistics are described below.
1. Relative Bias is calculated as

.

Relative bias will be calculated for each simulation run and missing data method. With
this, 𝛽 represents the parameter estimate for the SOFA score for simulation run i for each
of the i = 1,…,S simulation runs in the generalized linear model, and 𝛽 represents the
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population parameter of the SOFA score from the fully-observed dataset. Ideally, this
number will be 0%—meaning no bias exists in the missing data technique incorporated.
Means and 95% confidence intervals of the relative bias for each missing data technique
at each percentage of missingness will be calculated, allowing the observation of the
magnitude and direction of bias that a missing data technique introduces.
2. Efficiency is calculated as

.

Efficiency will be calculated for each simulation run and missing data method. Efficiency
is a simple ratio of the variance of the parameter estimate of the SOFA score 𝛽 , denoted
as 𝜎 , compared to the variance of the parameter estimate for the SOFA score in the
fully-observed dataset 𝛽, denoted as 𝜎 . Means and 95% confidence intervals of the
efficiency for each missing data technique at each percentage of missingness will be
calculated.
3. Coverage Probability is the proportion of simulation runs for each missing data method
where the parameter estimate for the SOFA score in the fully-observed dataset 𝛽, is
contained within the confidence interval for the estimated coefficient 𝛽 . Since α=0.05
has already been set for this study, we desire a 1-α = 95% or greater coverage probability.
In general, for this alpha level 95% coverage is considered to be ideal, whereas coverage
of less than 95% is indicative of higher than expected Type-I error rate [137].

3.8.7

Monitoring of Simulation Process
For each simulation run one log was output to monitor the status of each simulation,

along with five tables. The simulation log contained all notes, warnings, and errors for each
simulation run, along with the times to accomplish each of the critical steps.
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The first table created was the fully-observed dataset’s parameter estimates for all three
outcomes. These parameter estimates were used as the truth against which each simulation
method’s parameter estimates would be compared.
The second table created contained the convergence status of each of the analyses was
conducted. This table was later analyzed to ensure all models converged.
The third table created contained all seeds used in the multiple imputation process. All
seeds for the multiple imputation processes were generated using a hybrid 1998/2002 32-bit
Mersenne twister pseudorandom number generation algorithm in SAS, exhibiting good statistical
qualities in mimicking a stochastic process [154]. This pseudorandom number generator has a
period of 219,937-1, which is the number of calls to the pseudorandom number generator one would
have to make in order to have a repeated sequence of values [155]. In spite of the infinitesimally
small probability of seed repetition across the simulation runs, the seeds generated in each
simulation loop were saved to a table for later evaluation of repetition. As expected, the 40,000
random number seeds generated were all unique integers, with no duplicates found across the
simulation runs—ensuring good statistical independence of each multiple imputation run.
The fourth table created contained the parameters from the multiple imputation process, along
with the variance of the parameter estimates used for multiple imputation.
Finally, and most critically, the fifth table created contained the parameter estimates from
each of the three analyses across the four missing data methods. The information within this table
was used to calculate the summary statistics used in this study—coverage, relative bias,
efficiency, and root mean square error in fulfillment of Aim 1 and Aim 2 of this study.
For each simulation run, approximately four minutes were required to build the 1,000 datasets
and impose missingness in accordance with the simulation parameters (i.e. missing data
mechanism, and percent missingness). Each of the first three methods for handling missing data
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took approximately 30 seconds to run for the 1,000 datasets—including both handling the missing
data and performing the analyses.
However, for the multiple imputation process, the multiple imputation of the 1,000 datasets
took approximately four hours to run. This is predominantly due to the scaling of the analyses; for
each dataset, the multiple imputation process is repeated 25 times. Therefore, for the 1,000
datasets in a single simulation, multiple imputation occurred 25,000 times. Following the multiple
imputation process, these 25,000 datasets were analyzed separately for each of the three
outcomes, with the results of each multiple imputation process being combined using Rubin’s
Rules—all of which occurs in one step in SAS using PROC MIANALYZE. Each analysis took
approximately five minutes to run. Therefore, the total time to run one full simulation was
approximately five hours. Given that this study examined two aims, each having 4 missing data
mechanisms (MAR, MNAR Left, MNAR Mid, MNAR Right) and 4 levels levels of missing data
(γ = 10%, 20%, 30%, 40%), a total of 32 simulations were ran, consuming approximately 160
hours of processing time.

4
4.1

RESULTS
Data Used in Dissertation
From the MUSC Enterprise Data Warehouse records for 4,384 patient admissions

to the various ICUs at MUSC from the period of January 1, 2015 through October 31,
2017 for ventilator-dependent respiratory failure among patients 18 or older were
extracted. Of these patients, 292 had multiple ICU admissions — therefore, only the first
admission to an ICU at MUSC were used. An additional 303 of these admissions were
missing either the start or end of ventilation dates resulting in exclusion from this study
due to the inability to calculate total time on a ventilator. This resulted in 3,789 patients
being eligible for the study. Of these patients, 1,930 (50.9%) had sufficient data to
calculate a full SOFA score; 1,859 of these patients (49.1%) were missing one or more
data elements required to calculate the SOFA score. The former of these two groups will
hereinafter be referred to as the fully-observed cohort, whereas the latter of these two
groups will be referred to as the partially-observed cohort. This process of building the
cohort from which this simulation study would pull—the fully-observed cohort—is
depicted below in Figure 4.1.
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Figure 4.1 Data flow diagram
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4.1.1

Descriptive Characteristics
A total of 3,789 unique patient admissions to the ICU were extracted from the

Medical University of South Carolina’s electronic health record during the time period
of January 1, 2015 through October 31, 2017 and placed on a ventilator due to
respiratory failure. Of these patient admissions, sufficient data elements were present
within the data extract to calculate SOFA scores for 1,930 patient admissions, whereas
insufficient data were present to calculate SOFA scores for 1,859 patient admissions—
representing 49.1% missingness within the original data extract. The demographics and
characteristics of these two groups of patients, grouped on whether or not the SOFA
score was able to be calculated, are represented below in Table 7.
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Table 7 Demographics and characteristics of patients in the original dataset
SOFA Score Present?
Yes
No
p-value†
(n = 1,930)
(n = 1,859)
Age, years
56.6 ±17.1
55.6 ±17.7
0.0844
Male
1,126 (58.3)
1,099 (59.1)
0.6277
Race
Black
White
Other/Unknown
Insurance
Commercial
Medicare/Medicaid
Other/Unknown
Charlson Score
Length of Staya
ICU
Overall
Total Charges
Died
SOFA Score
SOFA Components c
CNS
Cardiovascular
Coagulation
Hepatic
Renal
Respiratory

0.1631
794 (41.1)
1,042 (54.0)
94 (4.9)

735 (39.5)
1,051 (56.5)
73 (3.9)
0.9739

598 (31.0)
1,078 (55.9)
254 (13.1)
3.0 ±3.0

577 (31.0)
1,042 (56.1)
240 (12.9)
3.2 ±2.8

10.0 ±10.7
17.1 ±21.6
$198,539
±219,757

9.9 ±11.3
17.3 ±19.4
$200,896
±225,994

0.8137
0.7547
0.7449

704 (36.5)

507 (27.3)

<0.0001

0.0919

8.8 ±4.1
8 [6]b
2 [0-4]
1 [0-4]
0 [0-4]
0 [0-4]
1 [0-4]
3 [0-4]

Note. All values are expressed as mean ±S.D., n (%), or as otherwise indicated.
† P-values were calculated using the Wilcoxon Mann-Whitney U test for continuous measures, and the χ2
or Fisher’s Exact tests for categorical measures (as appropriate). Statistically-significant comparisons at
the α=0.05 level are given in bold.
a Expressed in days
b median [Interquartile range]
c median [Range]
Other/Unknown race is comprised of Asian, Hawaiian, Indian/Alaskan, and where this value was missing
from the original dataset.
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Comparison of the demographics and characteristics of these two groups of
patients reveals very little differences between the two groups. These two groups did not
differ significantly with respect to age, sex, race, insurance status, Charlson score, length
of stay, nor total charges. However, these groups did differ in the overall death rate. The
overall death rate was 36.5% among the patients for whom we were able to calculate a
SOFA score, whereas this rate was 27.3% among those for whom we could not calculate
a SOFA score (p<.0001).
As a higher SOFA score is indicative of greater patient acuity, this statisticallysignificant difference suggests that the SOFA scores among those patients who have a
missing SOFA score in this data extract would have been on the lower end of the scale,
meaning that these patients had less organ derangement and were therefore more healthy
and less likely to die. Furthermore, this suggests that the missing data mechanism in
these data may be dependent upon the SOFA score value, as those patients whose SOFA
scores are missing have a lower rate of death, which would be evidence toward
concluding the missing not at random (MNAR) missing data mechanism may be
present. However, as with any missing data process, other factors may be influential or
this statistically significant difference may be spurious.
4.1.2

Bivariate Analyses
Bivariate analyses examining the relationship between the SOFA score,

components of the SOFA score, and all potential predictors was undertaken. Spearman’s
rank correlation coefficients (𝜌 ) were calculated, along with p-values. These measures
are given in Table 24 of Appendix C. Correlation table, on page 154. Interpretation of
the coefficients is according to Shi (2008; p. 371; [156]), as shown below in Table 8.
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Table 8 Interpretation of Spearman’s rank correlation coefficients
|𝜌 |
0.00
0.20
0.40
0.60
0.80

to
to
to
to
to

Strength of correlation

0.19
0.39
0.59
0.79
1.00

Little to none
Slight
Substantial
Strong
Very Strong

|𝜌 | are given, with sign indicating direction of relationship, where 𝜌 ≥ 0.01 indicates a
positively-correlated relationship and 𝜌 ≤ -0.01 indicates a negatively-correlated relationship.
This table is adapted from Shi (2008), page 371.

4.1.3

SOFA Scores
In this section, an examination of the possible missing data mechanism of the

SOFA score, the missing data patterns observed for the components of the SOFA score,
as well as the distribution of the SOFA score within the fully-observed dataset will be
examined.
4.1.3.1

Missing Data Mechanism

A logistic regression model was fit to determine which covariates might predict
missingness of the SOFA score in the original data. A binary indicator variable
indicating whether or not the SOFA score was able to be calculated (SOFA_missing),
served as the primary outcome variable for the logistic regression model, with all
potential and relevant demographics and clinical outcomes measured in this study used
as potential predictors of missingness of the SOFA score. These potential predictors
tested were: discharge disposition, race, payor group, age group, sex, ICU length of stay,
Charlson score, and the natural logarithm of total charges. For records with total charges
equal to $0.00 (n=2; one from each SOFA_missing group), these charges were changed
to $1.00. The minimum RASS score and the maximum CAM-ICU score during the first
two days of ventilation were investigated for potential prediction ability. However, these
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variables were missing in 5.0% and 36.6% of the cases respectively, prohibiting
inclusion into the prediction model.
The final parsimonious model was selected using a backwards stepwise process,
retaining only those predictors that had a statistically significant ability to predict a
SOFA score to be missing (SOFA_missing = 1). The final model included only one
variable, discharge disposition. Discharge disposition was divided into three groups: (1)
died or sent to hospice, (2) sent home, and (3) sent to institutionalized care. The
Hosmer-Lemeshow goodness of fit test showed excellent model fit, with a p-value of
1.0.
The logistic regression model to predict a missing SOFA score showed
statistically-significant differences in missingness were found in the disposition groups.
Patients who died or were sent to hospice care had lower odds of having a missing
SOFA score when compared with patients who were discharged home (OR 0.571, 95%
CI: 0.491-0.665). Similarly, patients who were discharged to institutionalized care had
lower odds of having a missing SOFA score when compared with patients who were
discharged home (OR 0.764, 95% CI: 0.651-0.897). The results of the final logistic
regression model predicting a missing SOFA score are shown below in Table 9.
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Table 9 Odds ratios and 95% confidence intervals for predicting a SOFA score
being missing in the original data
95%
Confidence
Effect
Odds Ratio
Interval
p-value
Discharge Destination
Died/Hospice
0.571
0.491-0.665
<0.0001
Institutionalized
0.764
0.651-0.897
0.0008
Home
†
Note. Odds ratio estimates and Wald 95% confidence intervals given. Statistically-significant
comparisons at the α=0.05 level are given in bold.
† indicates the reference group.

Patients in the ICU who died, were sent to hospice, or were institutionalized are
patients who, in general, would be expected to have poorer outcomes in comparison
with those ICU patients who were sent home. This former group of patients who have
poorer outcomes would, in general, have higher SOFA scores; the latter group of
patients who are sent home would generally have better health outcomes and lower
SOFA scores. Certainly, the group who experienced death as their discharged
destination had a poor outcome, and likely higher rates of organ derangement, as
indicated by a higher SOFA score. However, for those who were also sent to hospice or
who were institutionalized following their ICU stay, their discharge destination would
be demonstrative of a poorer outcome than a patient who was deemed well enough to go
home by the Intensivist. Moreover, as a higher SOFA score positively correlates with
greater patient acuity within the intensive care setting as well as poor outcomes
following the ICU stay, it is probable that the SOFA scores for the patients whose scores
we were unable to calculate as a result of one or more missing components would have,
on average, lower SOFA scores than those whose SOFA scores we were able to
calculate. Therefore, if this is the case, a missing not at random (MNAR) mechanism is

79

present within the data—where lower SOFA scores have a greater likelihood of being
missing. Thus, special attention should be paid to results of the MNAR simulations at
the low end of the SOFA score range (MNAR Left). However, this finding is given with
caution as other studies have shown a single mechanism is unlikely to be the sole cause
of missingness [102]. Moreover, any MAR missing data mechanism model has a
corresponding MNAR model with equal fit, rendering empirical distinction between the
two missing data mechanisms impossible [140].

4.1.3.2

Missing Data Patterns

An examination of the missing data patterns that were present within the data was
conducted using PROC MI in SAS. This examination revealed 1,859 of the 3,789 ICU
admissions (49.1%) had one or more items from the SOFA score that were missing (c.f.
Table 10). The hepatic component of the SOFA score (measured by bilirubin) was the
item most commonly missing; this finding matches that of another study [94]. The
central nervous system component (measured by the Glasgow Coma Scale) was the
second most common missing item. The cardiovascular component (measured by mean
arterial pressure [MAP] and vasopressors) was the most infrequently missing; this
differs from another study, which found platelets (coagulation SOFA component) and
PaO2/FiO2 ratios (respiration SOFA component) to be the most infrequently missing
items [94].
In total, there were 45 distinct missing data patterns across the six component
items of the SOFA score, out of the 26 = 720 possible patterns. The top 25 most common
missing data patterns—which accounts for 92.8% of all observations with missing
SOFA score data—are shown below in Table 11. Of the 45 missing data patterns, only
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10 patterns exceeded more than 1% of the total missingness of the data. Therefore, these
10 missing data patterns along with their observed frequencies within the original
dataset are used as the missing data patterns for this simulation study.

Table 10 Frequency of missing SOFA score components in
original data
SOFA Component
Central Nervous System
Cardiovascular
Coagulation
Hepatic
Renal
Respiratory
Overall, any item missing

#
Missing
753
113
215
1,040
186
222
1,859

%
Missing
19.9
3.0
5.7
27.5
4.9
5.9
49.5
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Table 11 Twenty-five most common missing data patterns
SOFA Score Component
CNS
Card
Coag
Hep
Ren
Resp
Freq
%
1
1
1
0
1
1
718
38.6
0
1
1
1
1
1
495
26.6
0
1
1
0
1
1
133
7.2
1
1
1
1
1
0
93
5.0
1
1
1
0
1
0
41
2.2
1
1
0
1
1
1
38
2.0
1
0
1
1
1
1
34
1.8
1
1
0
0
0
1
33
1.8
1
1
0
1
0
1
31
1.7
0
1
1
1
1
0
30
1.6
1
1
1
0
0
1
17
0.5
1
1
0
0
1
1
16
0.4
1
1
1
1
0
1
15
0.4
0
1
1
0
1
0
15
0.4
1
0
0
1
0
1
12
0.3
0
1
0
1
0
1
12
0.3
1
1
0
0
0
0
11
0.3
0
0
1
1
1
1
10
0.3
1
0
1
0
1
1
9
0.2
1
0
0
0
0
1
8
0.2
0
1
1
1
0
1
8
0.2
0
1
0
1
1
1
8
0.2
0
1
0
0
0
1
8
0.2
0
0
0
1
0
1
7
0.2
1
0
0
1
1
1
6
0.2
Note: The 1/0 elements here represent items within a response vector, where 1 equals a
response (the SOFA score element is observed) and 0 represents a non-response (the SOFA
score element is missing). The component names are shortened as follows: CNS (central
nervous system), Card (cardiovascular system), Coag (coagulation system), Hep (hepatic
system), Ren (renal system), and Resp (respiratory system).
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4.1.3.3

Distribution of SOFA Scores
The histogram shown below in Figure 4.2 shows the distribution of SOFA

scores within the fully-observed dataset. An overlay of the normal and kernel densities
is also given, which shows the distribution is right-skewed, with a maximum observed
SOFA score of 22 out of 24.

Figure 4.2 Histogram of SOFA scores in the fully-observed dataset

Another method of examining the distribution of the SOFA scores is shown in
Table 12 below. Here the scores are binned into four categories. The first category is 0
to 3, which represents a range from no organ derangement (a SOFA score of zero) to at
most moderate organ derangement in only one organ system measured by the SOFA
score (a SOFA score of 3) or minor organ derangements in more than one organ system.
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The second category is 4 to 8, which represents fairly severe organ derangement in up to
two organ systems. This group represents most of the patients found within our fullyobserved dataset, representing 45.0% of all ICU admissions. The third category is 9 to
11, which represents fairly severe organ derangement and up to three organ systems.
The fourth, and final, category is 12 to 22 — which represents patients who could have
organ derangement in up to five SOFA score-measured organ systems, and are expected
to have, on average, poorer outcomes than patients with lower SOFA scores.

Table 12 Distribution of SOFA scores in the fully-observed dataset
SOFA Score
0-3
4-8
9-11
12-22
4.2

Freq
137
868
428
497

%
7.1
45.0
22.2
25.7

Fully-Observed Dataset Outcomes
All three outcomes that were analyzed in this simulation study were first

analyzed using the fully-observed dataset, which contained 1,930 records. These
outcomes were analyzed using the same covariates across all three outcomes. The main
predictor, SOFA score, was used in all regression models, as were the categorical
covariates age and race, and the binary covariate sex.
The age variable was grouped as follows: 18-29, 30-39, 40-49, 50-59, 60-69,
70-79, and 80 or older; the reference group was 18-29. The race variable was comprised
of White, Black, and Other/Unknown; the reference group was White. The Other
category was comprised of Asian, Hawaiian, and Indian/Alaskan. The sex variable was a
dichotomous variable indicating male or female; the reference group was male. The

84

SOFA score variable, while used as a continuous variable in the simulations and in most
research studies as a risk adjuster, is shown below in four groups for better illustration of
effect size and magnitude on the three outcomes. The SOFA score is grouped as
previously shown in Table 12: 0-3, 4-8, 9-11, and 12-24.
4.2.1

Outcome 1: Death
A logistic regression model was fit to examine the first outcome of this study,

death (a binary indicator variable with 1 representing an in-hospital death, and 0
representing the patient survived the admission). The Hosmer-Lemeshow goodness of fit
test showed that the model was a good fit, with a p-value of 0.4490, and a c-statistic of
0.712. The odds ratios and 95% confidence intervals for these predictors are given in
Table 13, and graphically in Figure 4.3.
As one can see from Figure 4.3, as the SOFA score increases, the odds of inhospital death increase in a stepwise fashion when compared with a low SOFA score
range of 0-3. The relatively wide confidence interval for the SOFA score group of 12-22
is attributable to the fewer number of patients within this dataset that contain this high
score. Likewise, as age of the patient in the ICU increases, so too does the odds of death.
Females exhibited 39.8% higher odds of death in comparison to males (OR 1.398, 95%
CI 1.142-1.711). Finally—regarding race—Blacks had 25.4% lower odds of death in
comparison to Whites (OR 0.746, 95% CI 0.605-0.919), whereas the Other/Unknown
group’s odds of death were not statistically different from patients who were White.
For this outcome using SOFA score as a continuous variable, how it was used in
the simulations, the univariate results showed SOFA score to be statistically-significant
predictor of death (OR 1.192, 95% CI 1.162-1.222, p<0.0001). In the adjusted model—
adjusting also for age, race, and sex—SOFA score was similarly predictive of death (OR
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1.205, 95% CI 1.174-1.237, p<0.0001). The odds ratios for the other predictors were
very similar to those shown below in Table 13, where SOFA score was categorized.
Table 13 Odds ratios and 95% confidence intervals for predicting in-hospital death
in the fully-observed dataset
Odds
95% Confidence Interval
Effect
Ratio
p-value
SOFA score
0-3
†
4-8
2.463
1.455 – 4.170
0.0008
9-11
4.445
2.584 – 7.648
<0.0001
12-24
10.472
6.111 – 17.942
<0.0001
Age group
18-29
30-39
40-49
50-59
60-69
70-79
80+
Female
Race
Black
Other/Unknown
White

†
1.413
1.077
1.702
2.088
3.050
3.320

0.851 – 2.347
0.667 – 1.739
1.114 – 2.602
1.377 – 3.167
1.972 – 4.717
2.015 – 5.469

0.1811
0.7608
0.0140
0.0005
<0.0001
<0.0001

1.398

1.142 – 1.711

0.0012

0.746
1.109
†

0.605 – 0.919
0.693 – 1.773

0.0060
0.6672

Note. Odds ratio estimates and Wald 95% confidence intervals given. Statistically-significant
comparisons at the α=0.05 level are given in bold.
† indicates the reference group.
Other/Unknown race is comprised of Asian, Hawaiian, Indian/Alaskan, and where this value was
missing from the original dataset.
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Figure 4.3 Forest plot of the odds ratios and 95% confidence intervals for predicting inhospital death in the fully-observed dataset
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4.2.2

Outcome 2: Total Charges

A gamma–distributed log–linked generalized linear model was fit to examine the second
outcome of this study, total charges. This model exhibited good fit, with a deviance of
0.8934 per degree of freedom. In
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Table 14 below, the exponentiated least square means estimates and 95%
confidence intervals differences of a group compared with a referent group (expressed
as a ratio of the reference group) are shown. The exponentiated least squares means
estimates of total charges, expressed in 1,000s of dollars, are shown below in Table 15.
Interestingly, these tables show no difference in total charges between SOFA
score group 4-8 when compared with the reference group, scores 0-3. However, the total
charges for those patients with SOFA scores in the range of 9-11 were 31.64% higher
than those in the reference group (ratio 1.316, 95% CI 1.045-1.658), and those with
SOFA scores in the range of 12-24 were 36.0% higher than those in the reference group
(ratio 1.360, 95% CI 1.148-1.707). This demonstrates the expected behavior that as the
SOFA score increases, so do total charges.
For this outcome using SOFA score as a continuous variable, how it was used in
the simulations, the univariate results showed SOFA score to be statistically-significant
predictor of total charges (β 0.0291, SE 0.0051, p<0.0001). In the adjusted model—
adjusting also for age, race, and sex—SOFA score was similarly predictive of total
charges (β 0.0255, SE 0.0051, p<0.0001).
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Table 14 Differences (expressed as a ratio) between the point estimates and 95%
confidence intervals for Total Charges in comparison to reference groups in the fullyobserved dataset
Effect
SOFA score
0-3
4-8
9-11
12-24

Difference Ratio

95% CI

p-value

†
1.146
1.316
1.360

0.975 – 1.346
1.108 – 1.563
1.148 – 1.611

0.0977
0.0017
0.0004

Age group
18-29
30-39
40-49
50-59
60-69
70-79
80+

†
0.893
0.938
0.820
0.781
0.663
0.553

0.741 – 1.075
0.789 – 1.115
0.703 – 0.957
0.670 – 0.910
0.563 – 0.780
0.456 – 0.671

0.2303
0.4674
0.0119
0.0015
<0.0001
<0.0001

Female
Race
Black
Other/Unknown
White

0.979
1.027
†

0.901 – 1.065
0.850 – 1.241

0.6203
0.7820

Note. Differences in total charges, expressed as a ratio from the reference group, are reported along with
Wald 95% confidence intervals. Statistically-significant comparisons at the α=0.05 level are given in bold.
† indicates the reference group.
Other/Unknown race is comprised of Asian, Hawaiian, Indian/Alaskan, and where this value was missing
from the original dataset.
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Table 15 Least squares means exponentiated point estimates and 95% confidence
intervals for Total Charges, expressed in thousands of dollars, in the fully-observed
dataset
Total Charges
Effect
* $1,000
95% CI
SOFA score
184
169 – 200
0-3
211
191 – 233
4-8
218
198 – 240
9-11
12-24
160
137 – 188
Age group
18-29
30-39
40-49
50-59
60-69
70-79
80+

242
216
227
199
189
160
133

210 – 279
186 – 250
200 – 258
179 – 220
171 – 209
143 – 180
115 – 157

197
187

182 – 213
171 – 204

187
197
191

175 – 201
164 – 236
179 – 204

Sex
Male
Female
Race
Black
Other/Unknown
White

Note. Total charges, expressed in 1000s of US dollars ($), are reported along with Wald 95% confidence
intervals. Charges have been rounded to the nearest $1,000.
Other/Unknown race is comprised of Asian, Hawaiian, Indian/Alaskan, and where this value was missing
from the original dataset.
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4.2.3

Outcome 3: ICU Length of Stay
A negative binomial-distributed log-linked generalized linear model was fit to

examine the third outcome of this study, ICU length of stay. This model exhibited good
fit, with a deviance of 1.0625 per degree of freedom. In Table 16 below, the
exponentiated least square means estimates and 95% confidence intervals differences of
a group compared with a referent group (expressed as a ratio of the reference group) are
shown. The exponentiated least squares means estimates of ICU length of stay,
expressed in days, are shown below in Table 17.
As expected, patients with higher SOFA scores did exhibit higher ICU lengths
of stay on average, as shown in Table 4.9 and 4.10. Interestingly, there were no
differences in ICU length of stay amongst the various race categories nor between male
and female. However, patients aged 80 or older had lengths of stay in the ICU that were
18.2% shorter in duration than those patients in the reference group, below the age of 30
(difference ratio 0.818, 95% CI 0.673-0.994, p=0.0432). Given that this group’s odds of
in-hospital death were greater than the reference group, the shorter length of stay in the
ICU should not be attributable to better outcomes.
For this outcome using SOFA score as a continuous variable, how it was used in
the simulations, the univariate results showed SOFA score to not be a statisticallysignificant predictor of ICU length of stay (β 0.0097, SE 0.0052, p=0.0642). In the
adjusted model—adjusting also for age, race, and sex—SOFA score was similarly not
predictive of total charges (β 0.0081, SE 0.0053, p=0.1210).
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Table 16 Differences (expressed as a ratio) between the point estimates and 95%
confidence intervals for ICU Length of Stay in comparison to reference groups in the
fully-observed dataset
Difference
Effect
Ratio
95% CI
p-value
SOFA score
0-3
†
4-8
1.192
1.011 – 1.404
0.0361
9-11
1.306
1.097 – 1.555
0.0027
12-24
1.201
1.011 – 1.426
0.0373
Age group
18-29
30-39
40-49
50-59
60-69
70-79
80+
Female
Race
Black
Other/Unknown
White

†
0.891
1.131
0.987
1.014
0.892
0.818

0.739 – 1.074
0.951 – 1.344
0.845 – 1.152
0.870 – 1.181
0.757 – 1.050
0.673 – 0.994

0.2258
0.1648
0.8650
0.8609
0.1688
0.0432

0.965

0.890 – 1.048

0.3974

1.065
1.063
†

0.979 – 1.158
0.879 – 1.285

0.1418
0.5302

Note. ICU length of stay, expressed in days, is reported along with Wald 95% confidence intervals.
Statistically-significant comparisons at the α=0.05 level are given in bold.
† indicates the reference group.
Other/Unknown race is comprised of Asian, Hawaiian, Indian/Alaskan, and where this value was
missing from the original dataset.
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Table 17 Least squares means exponentiated point estimates and 95% confidence
intervals for ICU Length of Stay, expressed in days, in the fully-observed dataset
Estimate,
95% CI
Effect
in days
SOFA score
0-3
8.2
7.0 – 9.6
4-8
9.8
9.0 – 10.6
9-11
10.7
9.7 – 11.8
12-24
9.9
8.9 – 10.9
Age group
18-29
30-39
40-49
50-59
60-69
70-79
80+

10.0
8.9
11.3
9.9
10.2
8.9
8.2

8.7 – 11.6
7.7 – 10.4
10.0 – 12.9
8.9 – 11.0
9.2 – 11.2
7.9 – 10.1
7.0 – 9.6

9.4
9.8

8.6 – 10.3
9.0 – 10.6

9.8
9.8
9.2

9.1 – 10.5
8.1 – 11.8
8.6 – 9.8

Sex
Female
Male
Race
Black
Other/Unknown
White

Note. ICU length of stay, expressed in days, is reported along with Wald 95% confidence intervals.
† indicates the reference group.
Other/Unknown race is comprised of Asian, Hawaiian, Indian/Alaskan, and where this value was
missing from the original dataset.
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4.3

Aim 1 – Results
The simulation runs were compared using three summary test statistics, yielding

the properties of the performance of each of the missing data methods examined. As
previously mentioned in Section 3.8.6–Assessment of Simulation, these three statistics
are (1) relative bias, (2) efficiency, and (3) coverage probability.
The first statistic, relative bias, gives the magnitude and direction of bias that a
missing data introduces. This statistic is calculated as

, where 𝛽 represents the

population parameter of the SOFA score from the fully-observed dataset and 𝛽
represents the parameter estimate for the SOFA score for each simulation run. Ideally,
this number will be 0%—meaning no bias exists in the missing data technique
incorporated.
The second statistic, efficiency, is a simple ratio of the variance of the parameter
estimate of the SOFA score. This statistic is calculated as

, where the variance of the

parameter estimate of the SOFA score 𝛽 , denoted as 𝜎 , is compared to the variance of
the parameter estimate for the SOFA score in the fully-observed dataset 𝛽, denoted as
𝜎 .
The third statistic, coverage probability, is the proportion of simulation runs for
each missing data method where the parameter estimate for the SOFA score in the fullyobserved dataset 𝛽, is contained within the confidence interval for the estimated
coefficient 𝛽 . Since α=0.05 has already been set for this study, we desire a 1-α = 95%
or greater coverage probability. In general, for this alpha level 95% coverage is
considered to be ideal.
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A discussion of the three outcomes examined in this simulation study follows,
using the three aforementioned statistics.
4.3.1

Outcome 1: Death
As mentioned in Section 4.2.1, in the full dataset, the SOFA score was

predictive of death in the adjusted model (OR 1.205, 95% CI 1.174-1.237, p<0.0001).
The four methods for handling missing data at the composite level for the outcome of
death vary in their performance. The coverage probability statistic for these methods at
the various percentages of missingness are given in Figure 4.4. Complete case analysis
as well as multiple imputation produce results at all percentages of missingness that
exceed 95%. However, median imputation quickly has low coverage at 20% or greater
missingness for MAR and MNAR right. Zero imputation, the recommended method by
the creators of the SOFA score, exhibits poor coverage regardless of missing data
mechanism and percent missingness.
The relative bias statistic for these methods at the various percentages of
missingness are given in Figure 4.5 (MAR missing data mechanism), Figure 4.6 (MNAR
Left missing data mechanism), Figure 4.7 (MNAR Middle missing data mechanism), and
Figure 4.8 (MNAR Right missing data mechanism). For the MAR missing data
mechanism, both median imputation and zero imputation show increasing amounts of
bias of the SOFA parameter estimates in the negative direction. Both complete case
analysis and multiple imputation show relatively unbiased estimates of the SOFA
parameter estimate, however the variance of these estimates increases as the percent of
missing data increases. This pattern of increasing variance with increasing percent of
missing data is the same for all missing data mechanisms (c.f. Figures 4.5 through 4.8).
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The efficiency statistic for these methods at increasing percentages of
missingness are given in Figure 4.9 (MAR missing data mechanism), Figure 4.10
(MNAR Left missing data mechanism), Figure 4.11 (MNAR Middle missing data
mechanism), and Figure 4.12 (MNAR Right missing data mechanism). Figure 4.9 shows
that with the MAR missing data mechanism, efficiency rapidly increases—as does the
spread of efficiency, showing much larger variance in the SOFA parameter estimates in
comparison to the true parameter estimates, and large change in variance across
simulation runs (as demonstrated by the spread of these estimates). This pattern is
repeated for all missing data mechanisms for the complete case analysis method (c.f.
Figures 4.9 through 4.12). Across all of the missing data mechanisms and increasing
percentages of missing data, MI shows good efficiency—near 1.0—for most of the
simulation scenarios.

97

Figure 4.4 Comparison of percent coverage of the 95% confidence interval for the
parameter estimates of the SOFA score in the logistic regression model predicting Death
(Aim 1 – Composite Level)
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Figure 4.5 Comparison of relative bias of parameter estimates of the SOFA score
among the methods for handling missingness at the composite-level in the logistic
regression model predicting Death, with the MAR missing data mechanism (Aim 1 –
Composite Level)

Figure 4.6 Comparison of relative bias of parameter estimates of the SOFA score
among the methods for handling missingness at the composite-level in the logistic
regression model predicting Death, with the MNAR Left missing data mechanism (Aim 1
– Composite Level)
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Figure 4.7 Comparison of relative bias of parameter estimates of the SOFA score
among the methods for handling missingness at the composite-level in the logistic
regression model predicting Death, with the MNAR Middle missing data mechanism
(Aim 1 – Composite Level)

Figure 4.8 Comparison of relative bias of parameter estimates of the SOFA score
among the methods for handling missingness at the composite-level in the logistic
regression model predicting Death, with the MNAR Right missing data mechanism (Aim
1 – Composite Level)
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Figure 4.9 Comparison of the efficiency of parameter estimates of the SOFA score
among the methods for handling missingness at the composite-level in the logistic
regression model predicting Death, with the MAR missing data mechanism (Aim 1 –
Composite Level)

Figure 4.10 Comparison of efficiency estimates for the SOFA score among the methods
for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MNAR Left missing data mechanism (Aim 1 – Composite
Level)
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Figure 4.11 Comparison of efficiency estimates for the SOFA score among the methods
for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MNAR Middle missing data mechanism (Aim 1 – Composite
Level)

Figure 4.12 Comparison of efficiency estimates for the SOFA score among the methods
for handling missingness at the composite-level in the logistic regression model
predicting Death, with the MNAR Right missing data mechanism (Aim 1 – Composite
Level)
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4.3.2

Outcome 2: Total Charges
As mentioned in Section 4.2.2, in the full dataset, the SOFA score was

predictive of total charges in the adjusted model (β 0.0255, SE 0.0051, p<0.0001). The
four methods for handling missing data at the composite level for the outcome of death
vary in their performance. The four methods for handling missing data at the composite
level for the outcome of total charges vary in their performance as well. The coverage
probability statistic for these methods at the various percentages of missingness are
given in Figure 4.13. Multiple imputation produces results at all percentages of
missingness that exceed 95%. Complete case analysis and median imputation produced
similar results for MNAR middle, but the performance of these methods dropped below
95% for MAR, MNAR left, and MNAR right. Zero imputation, the recommended
method by the creators of the SOFA score, exhibited poor coverage regardless of
missing data mechanism and percent missingness, with the only exception being the
MNAR left mechanism at 10% missingness.
The relative bias statistic for these methods at the various percentages of
missingness are given in Figure 4.14 (MAR missing data mechanism), Figure 4.15
(MNAR Left missing data mechanism), Figure 4.16 (MNAR Middle missing data
mechanism), and Figure 4.17 (MNAR Right missing data mechanism). For the MAR
missing data mechanism, both median imputation and zero imputation show increasing
amounts of bias of the SOFA parameter estimates in the negative direction. Both
complete case analysis and multiple imputation show relatively unbiased estimates of
the SOFA parameter estimate, however the variance of these estimates increases as the
percent of missing data increases, with complete case having consistently equal or
greater variability across simulation runs than multiple imputation. This pattern of
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increasing variance with increasing percent of missing data is the same for all missing
data mechanisms (c.f. Figures 4.14 through 4.17).
The efficiency statistic for these methods at increasing percentages of
missingness are given in Figure 4.18 (MAR missing data mechanism), Figure 4.19
(MNAR Left missing data mechanism), Figure 4.20 (MNAR Middle missing data
mechanism), and Figure 4.21 (MNAR Right missing data mechanism). Figure 4.18
shows that with the MAR missing data mechanism, efficiency rapidly increases—as
does the spread of efficiency for all methods besides zero imputation, showing much
larger variance in the SOFA parameter estimates in comparison to the true parameter
estimates, and large change in variance across simulation runs (as demonstrated by the
spread of these estimates). This pattern is repeated for all missing data mechanisms
except for the MNAR middle mechanism (c.f. Figures 4.18 through 4.21).
In contrast to the other methods, the efficiency rapidly decreases for the zero
imputation method, with little variance in these estimates, across all missing data
mechanisms (c.f. Figures 4.18 through 4.21). Across all of the missing data mechanisms
and increasing percentages of missing data, MI shows good efficiency—near 1.0—for
most of the simulation scenarios, albeit with increasing variance as the percentage of
missing data increases.
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Figure 4.13 Comparison of percent coverage of the 95% confidence interval for the
parameter estimates of the SOFA score in the gamma-transformed log linked
generalized linear model predicting Total Charges (Aim 1 – Composite Level)
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Figure 4.14 Comparison of relative bias of parameter estimates of the SOFA score in
the gamma-transformed log linked generalized linear model predicting Total Charges,
with the MAR missing data mechanism (Aim 1 – Composite Level)

Figure 4.15 Comparison of relative bias of parameter estimates of the SOFA score in
the gamma-transformed log linked generalized linear model predicting Total Charges,
with the MNAR Left missing data mechanism (Aim 1 – Composite Level)
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Figure 4.16 Comparison of relative bias of parameter estimates of the SOFA score in
the gamma-transformed log linked generalized linear model predicting Total Charges,
with the MNAR Middle missing data mechanism (Aim 1 – Composite Level)

Figure 4.17 Comparison of relative bias of parameter estimates of the SOFA score in
the gamma-transformed log linked generalized linear model predicting Total Charges,
with the MNAR Right missing data mechanism (Aim 1 – Composite Level)
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Figure 4.18 Comparison of the efficiency of parameter estimates of the SOFA score in
the gamma-transformed log linked generalized linear model predicting Total Charges,
with the MAR missing data mechanism (Aim 1 – Composite Level)

Figure 4.19 Comparison of the efficiency of parameter estimates of the SOFA score in
the gamma-transformed log linked generalized linear model predicting Total Charges,
with the MNAR Left missing data mechanism (Aim 1 – Composite Level)
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Figure 4.20 Comparison of the efficiency of parameter estimates of the SOFA score in
the gamma-transformed log linked generalized linear model predicting Total Charges,
with the MNAR Middle missing data mechanism (Aim 1 – Composite Level)

Figure 4.21 Comparison of the efficiency of parameter estimates of the SOFA score in
the gamma-transformed log linked generalized linear model predicting Total Charges,
with the MNAR Right missing data mechanism (Aim 1 – Composite Level)
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4.3.3

Outcome 3: ICU Length of Stay
As mentioned in Section 4.2.3, in the full dataset, the SOFA score was not

predictive of ICU length of stay in the adjusted model (β 0.0081, SE 0.0053, p=0.1210).
The four methods for handling missing data at the composite level for the outcome of
ICU length of stay vary in their performance as well, as they did for the previous
outcomes. The coverage probability statistic for these methods at the various
percentages of missingness are given in Figure 4.22. Multiple imputation produced
results at all percentages of missingness that exceed 95%. Complete case analysis and
median imputation produced similar results for MNAR middle, but the performance of
these methods dropped below 95% for MAR, MNAR left, and MNAR right. Zero
imputation, the recommended method by the creators of the SOFA score, exhibited poor
coverage for all missing data mechanisms and percent missingness, with the only
exception being the MNAR left mechanism.
The relative bias statistic for these methods at the various percentages of
missingness are given in Figure 4.23 (MAR missing data mechanism), Figure 4.24
(MNAR Left missing data mechanism), Figure 4.25 (MNAR Middle missing data
mechanism), and Figure 4.26 (MNAR Right missing data mechanism). For the MAR
missing data mechanism, both median imputation and zero imputation show increasing
amounts of bias of the SOFA parameter estimates in the negative direction. Both
complete case analysis and multiple imputation show relatively unbiased estimates of
the SOFA parameter estimate, however the variance of these estimates increases as the
percent of missing data increases; moreover, the variance of the relative bias on the
multiple imputation estimates is smaller than those of the complete case analysis
missing data method. This pattern of increasing variance with increasing percent of
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missing data is the same for all missing data mechanisms (c.f. Figures 4.23 through
4.26).
The efficiency statistic for these methods at increasing percentages of
missingness are given in Figure 4.27 (MAR missing data mechanism), Figure 4.28
(MNAR Left missing data mechanism), Figure 4.29 (MNAR Middle missing data
mechanism), and Figure 4.30 (MNAR Right missing data mechanism). Figure 4.27
shows that with the MAR missing data mechanism, efficiency rapidly increases—as
does the spread of efficiency for all methods besides zero imputation and multiple
imputation, showing much larger variance in the SOFA parameter estimates in
comparison to the true parameter estimates, and large change in variance across
simulation runs (as demonstrated by the spread of these estimates). This pattern is
repeated for all missing data mechanisms except for the MNAR middle mechanism (c.f.
Figures 4.27 through 4.30).
In contrast to the other methods, the efficiency rapidly decreases for the zero
imputation method, with little variance in these estimates, across all missing data
mechanisms except for MNAR Right (c.f. Figures 4.27 through 4.30). Across all of the
missing data mechanisms and increasing percentages of missing data, MI shows good
efficiency—near 1.0—for most of the simulation scenarios, albeit with increasing
variance as the percentage of missing data increases.
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Figure 4.22 Comparison of percent coverage of the 95% confidence interval for the
parameter estimates of the SOFA score in the negative binomial generalized linear
model predicting ICU Length of Stay (Aim 1 – Composite Level)
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Figure 4.23 Comparison of relative bias of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MAR missing data mechanism (Aim 1 – Composite Level)

Figure 4.24 Comparison of relative bias of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MNAR Left missing data mechanism (Aim 1 – Composite Level)
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Figure 4.25 Comparison of relative bias of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MNAR Middle missing data mechanism (Aim 1 – Composite Level)

Figure 4.26 Comparison of relative bias of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MNAR Right missing data mechanism (Aim 1 – Composite Level)
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Figure 4.27 Comparison of the efficiency of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MAR missing data mechanism (Aim 1 – Composite Level)

Figure 4.28 Comparison of the efficiency of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MNAR Left missing data mechanism (Aim 1 – Composite Level)
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Figure 4.29 Comparison of the efficiency of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MNAR Middle missing data mechanism (Aim 1 – Composite Level)

Figure 4.30 Comparison of the efficiency of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MNAR Right missing data mechanism (Aim 1 – Composite Level)
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4.4

Aim 2 – Results
As with Aim 1, these simulation runs were compared using three summary test

statistics, yielding the properties of the performance of each of the missing data methods
examined. As previously mentioned in Section 3.8.6–Assessment of Simulation, these
three statistics are (1) relative bias, (2) efficiency, and (3) coverage probability.
4.4.1

Outcome 1: Death
As mentioned in Section 4.2.1, in the full dataset, the SOFA score was

predictive of death in the adjusted model (OR 1.205, 95% CI 1.174-1.237, p<0.0001).
The four methods for handling missing data at the composite level for the outcome of
death vary in their performance. The four methods for handling missing data at the
component level for the outcome of death vary in their performance, as they did at the
composite level (Aim 1). The coverage probability statistic for these methods at the
various percentages of missingness are given in Figure 4.31. Complete case analysis as
well as multiple imputation produce results at all percentages of missingness that exceed
95%. Median imputation falls below 95% coverage only for the MAR missing data
mechanism at 40% missingness. Zero imputation, the recommended method by the
creators of the SOFA score, exhibits poor coverage at 20% or greater missingness with
the MAR missing data mechanism, and at 40% missingness with the MNAR left and
MNAR right missing data mechanisms.
The relative bias statistic for these methods at the various percentages of
missingness are given in Figure 4.32 (MAR missing data mechanism), Figure 4.33
(MNAR Left missing data mechanism), Figure 4.34 (MNAR Middle missing data
mechanism), and Figure 4.35 (MNAR Right missing data mechanism). For the MAR
missing data mechanism, both median imputation and zero imputation show increasing

117

amounts of bias of the SOFA parameter estimates in the negative direction, with zero
imputation exhibiting larger amounts of bias. Both complete case analysis and multiple
imputation show relatively unbiased estimates of the SOFA parameter estimate,
however the variance of these estimates increases as the percentage of missing data
increases. This pattern of increasing variance with increasing percent of missing data is
the same for all missing data mechanisms (c.f. Figures 4.32 through 4.35).
The efficiency statistic for these methods at increasing percentages of
missingness are given in Figure 4.36 (MAR missing data mechanism), Figure 4.37
(MNAR Left missing data mechanism), Figure 4.38 (MNAR Middle missing data
mechanism), and Figure 4.39 (MNAR Right missing data mechanism). With all of the
missing data mechanisms and at increasing percentages of missingness, the efficiency of
the complete case method’s parameter estimates rapidly increases, far outpacing the
efficiency growth of the other missing data methods (c.f. Figures 4.36 through 4.39). For
the other three missing data methods at increasing percentages of missingness, the
efficiency stays closer to zero—although the effect is somewhat distorted in these
figures, due to scaling.
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Figure 4.31 Comparison of percent coverage of the 95% confidence interval for the
parameter estimates of the SOFA score in the logistic regression model predicting Death
(Aim 2 – Component Level)
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Figure 4.32 Comparison of relative bias of parameter estimates of the SOFA score
among the methods for handling missingness at the composite-level in the logistic
regression model predicting Death, with the MAR missing data mechanism (Aim 2 –
Component Level)

Figure 4.33 Comparison of relative bias of parameter estimates of the SOFA score
among the methods for handling missingness at the composite-level in the logistic
regression model predicting Death, with the MNAR Left missing data mechanism (Aim 2
– Component Level)
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Figure 4.34 Comparison of relative bias of parameter estimates of the SOFA score
among the methods for handling missingness at the composite-level in the logistic
regression model predicting Death, with the MNAR Middle missing data mechanism
(Aim 2 – Component Level)

Figure 4.35 Comparison of relative bias of parameter estimates of the SOFA score
among the methods for handling missingness at the composite-level in the logistic
regression model predicting Death, with the MNAR Right missing data mechanism (Aim
2 – Component Level)
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Figure 4.36 Comparison of the efficiency of parameter estimates of the SOFA score
among the methods for handling missingness at the composite-level in the logistic
regression model predicting Death, with the MAR missing data mechanism (Aim 2 –
Component Level)

Figure 4.37 Comparison of the efficiency of parameter estimates of the SOFA score
among the methods for handling missingness at the composite-level in the logistic
regression model predicting Death, with the MNAR Left missing data mechanism (Aim 2
– Component Level)
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Figure 4.38 Comparison of the efficiency of parameter estimates of the SOFA score
among the methods for handling missingness at the composite-level in the logistic
regression model predicting Death, with the MNAR Middle missing data mechanism
(Aim 2 – Component Level)

Figure 4.39 Comparison of the efficiency of parameter estimates of the SOFA score
among the methods for handling missingness at the composite-level in the logistic
regression model predicting Death, with the MNAR Right missing data mechanism (Aim
2 – Component Level)
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4.4.2

Outcome 2: Total Charges
As mentioned in Section 4.2.2, in the full dataset, the SOFA score was

predictive of total charges in the adjusted model (β 0.0255, SE 0.0051, p<0.0001). The
four methods for handling missing data at the component level for the outcome of total
charges vary in their performance as well, as they did at the composite level (Aim 1).
However, the performance for this outcome of handling missing data at the component
level (Aim 2) is overall improved over handling missing data at the composite level
(Aim 1). The coverage probability statistic for these methods at the various percentages
of missingness are given in Figure 4.40. Multiple imputation produced results at all
percentages of missingness that exceed 95%. Complete case analysis and median
imputation produced similar results for MNAR middle, but the performance of these
methods dropped below 95% for MAR, MNAR left, and MNAR right. Zero imputation,
the recommended method by the creators of the SOFA score, exhibited poor coverage
only for the MAR mechanism at 20% or greater missingness.
The relative bias statistic for these methods at the various percentages of
missingness are given in Figure 4.41 (MAR missing data mechanism), Figure 4.42
(MNAR Left missing data mechanism), Figure 4.43 (MNAR Middle missing data
mechanism), and Figure 4.44 (MNAR Right missing data mechanism). For the MAR
missing data mechanism, both median imputation and zero imputation show increasing
amounts of bias of the SOFA parameter estimates in the negative direction. Both
complete case analysis and multiple imputation show relatively unbiased estimates of
the SOFA parameter estimate, however the variance of these estimates increases as the
percent of missing data increases, with complete cases being consistently more variable
than multiple imputation. However, while the pattern of increasing variance with
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increasing percent of missing data is the same for all MNAR missing data
mechanisms—MNAR left, MNAR middle, and MNAR right (c.f. Figure 4.42, Figure
4.43, and Figure 4.44, respectively)—most of the methods yielded results that had little
or moderate bias.
The efficiency statistic for these methods at increasing percentages of
missingness are given in Figure 4.45 (MAR missing data mechanism), Figure 4.46
(MNAR Left missing data mechanism), Figure 4.47 (MNAR Middle missing data
mechanism), and Figure 4.48 (MNAR Right missing data mechanism). These figures
show that with all missing data mechanisms, efficiency rapidly increases—as does the
spread of efficiency for the complete case method, showing much larger variance in the
SOFA parameter estimates in comparison to the true parameter estimates, and large
change in variance across simulation runs (as demonstrated by the spread of these
estimates). Similarly, efficiency for the zero imputation method moved away from 1.0
(fully-efficient) as function of increasing percentages of missingness in the negative
direction for MNAR left (c.f. Figure 4.46) and MNAR middle (c.f. Figure 4.47), but in
the positive direction for MNAR right (c.f. Figure 4.48). Across all of the missing data
mechanisms and increasing percentages of missing data, median imputation and MI
shows good efficiency—near 1.0—for most of the simulation scenarios, albeit with
increasing variance as the percentage of missing data increases.
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Figure 4.40 Comparison of percent coverage of the 95% confidence interval for the
parameter estimates of the SOFA score in the gamma-transformed log linked
generalized linear model predicting Total Charges (Aim 2 – Component Level)
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Figure 4.41 Comparison of relative bias of parameter estimates of the SOFA in the
gamma-transformed log linked generalized linear model predicting Total Charges, with
the MAR missing data mechanism (Aim 2 – Component Level)

Figure 4.42 Comparison of relative bias of parameter estimates of the SOFA in the
gamma-transformed log linked generalized linear model predicting Total Charges, with
the MNAR Left missing data mechanism (Aim 2 – Component Level)
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Figure 4.43 Comparison of relative bias of parameter estimates of the SOFA in the
gamma-transformed log linked generalized linear model predicting Total Charges, with
the MNAR Middle missing data mechanism (Aim 2 – Component Level)

Figure 4.44 Comparison of relative bias of parameter estimates of the SOFA in the
gamma-transformed log linked generalized linear model predicting Total Charges, with
the MNAR Right missing data mechanism (Aim 2 – Component Level)
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Figure 4.45 Comparison of the efficiency of parameter estimates of the SOFA score in
the gamma-transformed log linked generalized linear model predicting Total Charges,
with the MAR missing data mechanism (Aim 2 – Component Level)

Figure 4.46 Comparison of the efficiency of parameter estimates of the SOFA score in
the gamma-transformed log linked generalized linear model predicting Total Charges,
with the MNAR Left missing data mechanism (Aim 2 – Component Level)
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Figure 4.47 Comparison of the efficiency of parameter estimates of the SOFA score in
the gamma-transformed log linked generalized linear model predicting Total Charges,
with the MNAR Middle missing data mechanism (Aim 2 – Component Level)

Figure 4.48 Comparison of the efficiency of parameter estimates of the SOFA score in
the gamma-transformed log linked generalized linear model predicting Total Charges,
with the MNAR Right missing data mechanism (Aim 2 – Component Level)
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4.4.3

Outcome 3: ICU Length of Stay
As mentioned in Section 4.2.3, in the full dataset, the SOFA score was not

predictive of ICU length of stay in the adjusted model (β 0.0081, SE 0.0053, p=0.1210).
The four methods for handling missing data at the component level for the outcome of
ICU length of stay vary in their performance as well, as they did at the composite level
(Aim 1). The coverage probability statistic for these methods at the various percentages
of missingness are given in Figure 4.49. Multiple imputation produced results at all
percentages of missingness that exceed 95%. Coverage using the complete case analysis
method dropped below 95% at 40% missingness for all missing data mechanisms except
MNAR middle. Median imputation had coverage for all methods except for MAR at
40% missingness. Zero imputation, the recommended method by the creators of the
SOFA score, exhibited poor coverage at 20% and greater missingness for the MAR
mechanism.
The relative bias statistic for these methods at the various percentages of
missingness are given in Figure 4.50 (MAR missing data mechanism), Figure 4.51
(MNAR Left missing data mechanism), Figure 4.52 (MNAR Middle missing data
mechanism), and Figure 4.53 (MNAR Right missing data mechanism). For the MAR
missing data mechanism, both median imputation and zero imputation show increasing
amounts of bias of the SOFA parameter estimates in the negative direction, however the
bias was not enough to affect coverage rates (c.f. Figure 4.49). Both complete case
analysis and multiple imputation show relatively unbiased estimates of the SOFA
parameter estimate, however the variance of these estimates increases as the percent of
missing data increases; moreover, the variance of the relative bias on the multiple
imputation estimates is smaller than those of the complete case analysis missing data
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method. This pattern of increasing variance with increasing percent of missing data is
the same for all missing data mechanisms (c.f. Figures 4.50 through 4.53).
The efficiency statistic for these methods at increasing percentages of
missingness are given in Figure 4.54 (MAR missing data mechanism), Figure 4.55
(MNAR Left missing data mechanism), Figure 4.56 (MNAR Middle missing data
mechanism), and Figure 4.57 (MNAR Right missing data mechanism).
These figures show that with all missing data mechanisms, efficiency rapidly
increases—as does the spread of efficiency for the complete case method, showing
much larger variance in the SOFA parameter estimates in comparison to the true
parameter estimates, and large change in variance across simulation runs (as
demonstrated by the spread of these estimates). Similarly, efficiency for the zero
imputation method moved away from 1.0 (fully-efficient) as function of increasing
percentages of missingness in the negative direction for MNAR left (c.f. Figure 4.55)
and MNAR middle (c.f. Figure 4.56), but in the positive direction for MNAR right (c.f.
Figure 4.57). Across all of the missing data mechanisms and increasing percentages of
missing data, median imputation and MI shows good efficiency—near 1.0—for most of
the simulation scenarios, albeit with increasing variance as the percentage of missing
data increases.
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Figure 4.49 Comparison of percent coverage of the 95% confidence interval for the
parameter estimates of the SOFA score in the negative binomial generalized linear
model predicting ICU Length of Stay (Aim 2 – Component Level)
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Figure 4.50 Comparison of relative bias of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MAR missing data mechanism (Aim 2 – Component Level)

Figure 4.51 Comparison of relative bias of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MNAR Left missing data mechanism (Aim 2 – Component Level)
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Figure 4.52 Comparison of relative bias of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MNAR Middle missing data mechanism (Aim 2 – Component Level)

Figure 4.53 Comparison of relative bias of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MNAR Right missing data mechanism (Aim 2 – Component Level)
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Figure 4.54 Comparison of the efficiency of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MAR missing data mechanism (Aim 2 – Component Level)

Figure 4.55 Comparison of the efficiency of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MNAR Left missing data mechanism (Aim 2 – Component Level)

136

Figure 4.56 Comparison of the efficiency of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MNAR Middle missing data mechanism (Aim 2 – Component Level)

Figure 4.57 Comparison of the efficiency of parameter estimates of the SOFA score in
the negative binomial generalized linear model predicting ICU Length of Stay, with the
MNAR Right missing data mechanism (Aim 2 – Component Level)
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4.5

Summary and Comparison of Results
This chapter examined the effects of missing SOFA scores at increasing

percentages of missingness (γ = 10%, 20%, 30%, 40%), under four different missing
data mechanism scenarios (MAR, MNAR Left, MNAR Middle, MNAR Right) for three
different outcomes (Death, Total charges, ICU LOS), to help researchers understand the
effects of methodological choice of method for handling missing data. From the
complete dataset (n=1,930) simple random sampling from the dataset, with replacement,
were made (n=1,000). From this dataset parameter estimates were calculated, then
missingness was imposed at the given percent of missing data and under the assigned
missing data mechanism. The four missing data methods were then applied to this
dataset; handling of the missing data was accomplished at the composite level (Aim 1)
and the component level (Aim 2). Finally, analyses for the three outcomes were
conducted. Results from these analyses of the sampled datasets were compared to those
from the complete data.
Overall, for most of the methods studied herein, bias for the SOFA score
parameter estimates tended to increase with increasing levels of missingness, as
measured by the relative bias statistic. Similarly, the variance of these estimates also
tended to increase with increasing levels of missingness, as measured by the efficiency
statistic. Finally, coverage probability for the SOFA score tended to decrease with
increasing levels of missingness—indicating a higher than expected Type-I error rate.
However, ceteris paribus, handling missing data at the component level (Aim 2)
generally yielded better results than handing missing data at the composite level (Aim
1). Therefore, it is prudent to examine how each of the strategies—composite versus
component level—fared by outcome studied.
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Regarding the outcome of death in the full dataset, mentioned in Section 4.2.1,
the SOFA score was predictive in the adjusted model (OR 1.205, 95% CI 1.174-1.237,
p<0.0001). Handling missingness at both the composite and component levels at all
percentages of missingness was good for both complete case analysis and multiple
imputation methods. Using zero imputation at the composite level (at all percentages of
missingness) and the component level (above γ = 20% under MAR; above γ = 30%
under MNAR Left and MNAR Middle) results in poor coverage and increasing amounts
of bias in the parameter estimates.
Regarding the outcome of total charges in the full dataset, mentioned in Section
4.2.2, the SOFA score was predictive in the adjusted model (β 0.0255, SE 0.0051,
p<0.0001). Handling missingness at both the composite and component levels was good
for complete case analysis (at or below γ = 30%) and multiple imputation (at all
percentages of missingness). Using zero imputation at the composite level (above γ =
10% under MNAR Left; at all missingness levels under other missing data mechanisms)
and the component level (above γ = 10% under MAR) results in poor coverage and
increasing amounts of bias in the parameter estimates.
Regarding the outcome of ICU length of stay in the full dataset, mentioned in
Section 4.2.3, the SOFA score was not predictive in the adjusted model (β 0.0081, SE
0.0053, p=0.1210). With that in mind, handling missingness at both the composite and
component levels was good for complete case analysis (at or below γ = 30%) and
multiple imputation (at all percentages of missingness). Using zero imputation at the
composite level was poor under all missing data mechanisms, except for MNAR Left.
Using zero imputation at the component level worked well under all the MNAR missing
data mechanisms studied, and at MAR with γ = 10%.

5

DISCUSSION
In December 2015, PCORI convened a workgroup to discuss missing data and data quality

for research using electronic medical records and claims data—identifying problems, highlighting
current solutions to some of those problems, and suggesting areas for future research [132]. One
identified need was for more research to understand the effects of various amounts of missing
data, whether the results would be significantly altered by the amount of missing data. Another
need was to understand which covariates experience missingness, what the mechanism for
missingness is (e.g. MAR), and whether simulations could be used to learn more about these
covariates and the impact of missing data. Finally, the PCORI workgroup asserted one of the next
steps would be to bring researchers who have experienced success in handling missing data in
EMR studies with researchers who are new to EMR studies to help disseminate this knowledge.
This study has sought to provide evidence in regards to missingness in the SOFA score within
electronic medical records.
5.1

Integration of Findings
The SOFA score is a physiology-based severity of illness score that measures organ

derangement in six systems, and is often used in outcomes studies of ICU-treated conditions as a
predictor or severity adjustment variable. Severity of illness scores (e.g. SOFA score) differ from
comorbidity scores (e.g. Charlson or Elixhauser indices) in that they measure physiological
derangement—using clinical and laboratory data—rather than presence or absence of comorbid
conditions. As such, severity of illness and comorbidity scores are used in two different manners
for risk adjustment, with one adjusting for baseline health (i.e. chronic health) and the other
adjusting for severity of illness (i.e. acute health). Therefore, when available, the prudent
researcher ought to use physiology-based severity of illness scores in addition to comorbidity
scores for baseline risk adjustment. However, when a researcher is unable to calculate a
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physiology-based severity of illness score, such as the SOFA score, methodological choices for
handling (or ignoring) these missing scores must be made.
This dissertation has examined four techniques for handling missing data for SOFA
scores: (1) complete case analysis, (2) median imputation, (3) zero imputation, and (4) Multiple
Imputation through Chained Equations (MICE)—a technique that is readily available in the three
most common statistical software packages used by applied researchers (SAS, SPSS, and Stata).
These techniques have been applied using two approaches, both at the composite level (in support
of Aim 1) and at the component level (in support of Aim 2). These techniques were examined
using increasing percentages of missingness (γ = 10%, 20%, 30%, 40%), under four different
missing data mechanism scenarios (MAR, MNAR Left, MNAR Middle, MNAR Right) for three
different outcomes (death, total charges, and ICU length of stay), to help researchers understand
the effects of methodological choice for handling missing data.
Overall, methods for handling missing data at the component level resulted in superior
parameter estimates than handling at the composite level for all methods other than MICE.
Multivariate Imputation through Chained Equations, however, had equally good results handling
at both the composite and component levels; MICE was demonstrated to be an excellent method
for modeling all of the data within the dataset, yielding parameter estimates with excellent
coverage, little to no bias, and good efficiency. The value of using an MI approach, of which
MICE is but one choice among many, over other approaches tested herein should be discussed.
While in many of the simulations complete case analysis (CCA) resulted in unbiased
estimates of the SOFA parameter for many of the outcomes tested, one could see that the
precision of the estimate decreased across simulations. Further, the sample size is decreased with
this method—yielding lower powered estimates of effect size, and possibly biased estimates of
treatment effect and invalid statistical inference due to increased variation. The ramification of a
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lower powered study, even when using big data such as in EHR studies, is that the likelihood of
committing a Type II error increases—especially when studying a rare outcome.
Median imputation occasionally performed well, however it often resulted in biased
estimates and confidence intervals that belied the true certainty around the estimate given the
percent of missing data. It is no wonder this method has been rejected by Rubin as being
unacceptable for research [113], and has been repeatedly shown in studies to introduce
unacceptable bias and over-precise confidence intervals [114], as has been shown again in this
study.
The multiple imputation technique of MICE was investigated for its performance.
Multiple imputation by chained equations (MICE) demonstrated excellent statistical qualities. In
comparison, two of the alternatives tested herein—median and zero imputation, both
deterministic imputation techniques—yielded tighter confidence intervals than they should due to
lack of accounting for the missing data. Conversely, multiple imputation techniques create
multiple datasets which Rubin (1987, p. 2) described as “representing a distribution of
possibilities” [98]. As previously stated, the goal of multiple imputation is not to make up data,
but rather to allow all the data that are present to be used in analyses to achieve valid statistical
inference, not perfect point prediction [113].
Finally, and perhaps most importantly, the research conducted herein directly examined
the SOFA score creators’ recommendations on handling missing SOFA score data. According to
the Sepsis-3 consensus paper, the baseline SOFA score—which is calculated upon admission to a
critical care unit—should be assumed to be zero, unless the patient has a known organ
dysfunction [65]. While this may work within the clinical setting, later down the road when
research is being conducted such an assertion deserves investigation, as an important
methodological choice is being made. In this study, we have demonstrated that zero imputation
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results in biased estimates in nearly all of the scenarios examined, yielding estimates that were
biased in the negative direction. Because of this, it is the recommendation of this study that zero
imputation not be used as a methodological approach for handling missing SOFA scores.
As an alternative, a multiple imputation approach should be considered because of its
demonstrated performance; MICE resulted in strong coverage, almost always containing the true
parameter estimate, and little bias in most of the scenarios tested in this Monte Carlo simulation
study. After proper investigation into potential missing data mechanisms—which will ultimately
inform any missing data method—the researcher should opt to use a multiple imputation
technique, such as MICE, at either the component or composite level. Consideration should be
given to using MI at the composite level, as this can save complexity in statistical programming.
Regarding MI methods, MICE in particular should be given special consideration when handling
missingness at the component level, as this method does not require the specification of a joint
model for all missing variables, but rather as many conditional distributions as there are missing
variables. Moreover, when imputing at the component level for a multiple-item instrument, MICE
has appealing qualities—such as not requiring the researcher to specify the scale structure, nor the
numbers of factors, and does not assume conditional independence of scale items [157].
5.2

Limitations
This research used data from one academic medical center in the Southeastern United

States in Charleston, South Carolina. Further, by nature of the study design of requiring a starting
point of a complete dataset, the present study was only able to use those observations for which
complete SOFA scores could be calculated. Resultantly, at least three limitation arise.
The first limitation is that the overall percentage of missingness in this dataset was 49.1%,
with a missing data mechanism believed to be MNAR Left, where lower SOFA scores (those who
have lower amounts of organ derangement, and are therefore expected to have a better prognosis,
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shorter length of stay, and lower charges) were more likely to be missing. This could have an
effect on the interpretation of these results, as patient admissions to the ICU who had little to no
organ derangement are under-represented in this study—which leads to another limitation.
The second limitation is in the distribution of the observed SOFA scores within our data.
Notwithstanding the aforementioned likely mechanism of higher probability of missing SOFA
scores in what is likely the lower end of the SOFA score range, the SOFA scores within our
dataset did not span the full range of SOFA scores. The range of SOFA scores in our fullyobserved dataset ranged from 0 to 22, whereas the full range of SOFA scores is 0 to 24. This
limits generalizability to the very highest SOFA scores, as they were not available in our data.
However, it is not known from the literature the approximate percentage of patients within an
ICU setting who would be expected to have the two highest SOFA scores (scores of 23 or 24)
among patients with ventilator-dependent respiratory failure. If these highest scores are rare, then
this limitation would be of less concern.
The third, and final, limitation regards generalizability. This study was performed using
data from one academic medical center in the Southeastern United States. Because of this, the
performance of the missing data methods may vary based on patient characteristics, although this
concern is minimal. This limitation shall be addressed in the following section.
5.3

Future Research
It is the goal of this author to replicate this study using a larger dataset, with ideally a

smaller percent of missing data from which to sample for the Monte Carlo simulations.
Additionally, is important to test the generalizability of this study’s findings, specifically
geographic and historical transportability [158], to determine if these findings remain consistent
in a different population of patients. The MIMIC-III (Medical Information Mart for Intensive
Care) database seems like a viable choice for a replication study, as this database contains over
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40,000 patient ICU stays at the Beth Israel Deaconess Medical Center (the academic affiliate of
Harvard Medical School) in Boston, Massachusetts between 2001 and 2012 [159]. This source
may be an excellent source for a replication study, as it contains rich, longitudinal EHR data
including both in- and out-of-hospital mortality on a diverse and large population of ICU patients.
Moreover, the data are provided free of charge to researchers worldwide.
Results from this future study, if similar to the results found in the present study, could
bolster the argument for the power of multiple imputation methods at the component level for
handling large percentages of non-random missing SOFA score data in studies that use electronic
health record data—for a variety of research, including quality improvement, comparative
effectiveness research, and healthcare cost studies. Importantly, as the setting is in a markedly
different geographical region (Northeast United States vs. Southern United States) on a more
racially-diverse population, the generalizability of the findings from the current study could be
tested.
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Appendix A. Analytical approaches to missing data, search terms

available case analysis
complete case analysis
dummy variable adjustment
entropy balance
expectation maximization
expectation-maximization
FCS
Fully Conditional Specification
Fully-Conditional Specification
Heckman
hot deck
hot-deck
imputation
incomplete data
incomplete observations
informative missingness
inverse probability weighting
IPW
last observation carried forward
LOCF
Markov Chain Monte Carlo
Markov-Chain Monte Carlo
MCAR
MCMC
mean imputation
median imputation

missing
missing at random
missing completely at random
missing data
missing not at random
missing value
missing-at-random
missing-completely-at-random
missingness
missing-not-at-random
MNAR
monotonic
multiple imputation
NMAR
non informative missingness
noninformative missingness
non-informative missingness
nonresponse
non-response
pattern mixture
pattern mixture model
pattern-mixture
pattern-mixture model
predictive mean matching
selection model
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Appendix B. Performance of missing data methods, tables
Table 18 Coverage of the 95% confidence interval for various missing data methods (Aim 1)
Outcome
Death

Mechanism
MAR

MNAR Left

MNAR Middle

MNAR Right

ICU Length of Stay

MAR

MNAR Left

MNAR Middle

MNAR Right

Total Charges

MAR

MNAR Left

MNAR Middle

MNAR Right

Gamma
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40

Complete
Case Analysis
100
99.9
98.8
95.4
100
99.9
100
98.4
100
100
100
100
100
100
99.7
98.9
100
99.2
95.7
88.0
100
99.9
96.9
85.1
100
100
100
100
100
99.9
96.2
87.4
100
98.4
96.9
90.4
100
99.9
99.0
95.4
100
100
100
100
100
99.7
98.1
94.4

Missing Data Method
Median
Zero
Imputation
Imputation
99.4
0
57.6
0
6.6
0
0
0
100
33.4
99.9
0
99.2
0
93.2
0
100
1.0
100
0
100
0
100
0
100
0
90.9
0
91.8
0
68.6
0
100
0
89.1
0
48.4
0
9.9
0
100
99.9
99.6
98.8
97.5
96.0
85.6
96.0
100
91.4
100
74.0
100
59.4
100
42.2
100
87.9
99.7
74.9
96.9
68.6
90.7
68.1
99.5
0
92.3
0
65.7
0
26.4
0
100
97.2
99.8
74.3
99.6
49.4
96.2
31.2
100
68.3
100
23.3
100
11.3
100
4.6
100
49.7
98.6
21.0
97.7
13.1
95.0
6.0

Multiple
Imputation
100
100
100
99.5
100
100
100
99.9
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
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Table 19 Coverage of the 95% confidence interval for various missing data methods (Aim 2)
Missing Data Method
Outcome
Death

Mechanism
MAR

MNAR Left

MNAR Middle

MNAR Right

ICU Length of Stay

MAR

MNAR Left

MNAR Middle

MNAR Right

Total Charges

MAR

MNAR Left

MNAR Middle

MNAR Right

Gamma
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40

Complete
Case Analysis
100
100
98.0
95.4
100
100
100
99.3
100
100
100
100
100
100
99.8
99.0
99.9
99.1
96.9
89.1
100
99.6
97.5
83.6
100
100
100
100
100
99.6
95.9
85.8
99.9
99.6
96.0
90.8
100
99.8
99.3
95.6
100
100
100
100
100
99.7
97.6
92.5

Median
Imputation
100
100
99.9
93.5
100
100
100
100
100
100
100
100
100
100
100
100
100
100
99.7
89.1
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
99.1
100
100
100
100
100
100
100
100
100
100
100
100

Zero
Imputation
100
2.4
0
0
100
100
99.3
86.4
100
100
99.2
93.8
100
100
100
100
98.9
14.7
0
0
100
100
100
100
100
100
100
100
100
100
100
99.9
99.6
38.6
0.3
0
100
100
100
100
100
100
100
99.9
100
100
99.9
100

Multiple
Imputation
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
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Table 20 Relative bias for various missing data methods (Aim 1)
Missing Data Method
Outcome
Death

Mechanism
MAR

MNAR Left

MNAR Middle

MNAR Right

ICU Length
of Stay

MAR

MNAR Left

MNAR Middle

MNAR Right

Total Charges

MAR

MNAR Left

MNAR Middle

MNAR Right

Gamma
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40

Complete
Case Analysis
0.011 (0.265)
0.027 (0.427)
0.053 (0.657)
0.084 (1.106)
-0.035 (0.187)
-0.082 (0.298)
-0.144 (0.407)
-0.221 (0.564)
0.004 (0.212)
0.014 (0.306)
0.027 (0.404)
0.043 (0.507)
0.034 (0.232)
0.092 (0.366)
0.171 (0.528)
0.300 (0.773)
0.013 (0.802)
-0.022 (1.375)
-0.119 (1.943)
-0.384 (2.586)
0.010 (0.687)
-0.012 (1.156)
0.020 (1.549)
0.027 (2.104)
-0.003 (0.570)
0.005 (0.872)
0.017 (1.145)
0.024 (1.433)
-0.019 (0.654)
-0.072 (1.086)
-0.080 (1.527)
-0.156 (2.079)
-0.006 (0.437)
-0.029 (0.717)
-0.079 (0.948)
-0.195 (1.215)
0.058 (0.365)
0.155 (0.591)
0.273 (0.841)
0.454 (1.138)
-0.023 (0.342)
-0.053 (0.527)
-0.121 (0.695)
-0.174 (0.866)
-0.052 (0.365)
-0.158 (0.597)
-0.252 (0.817)
-0.429 (1.088)

Median
Imputation
-0.029 (0.108)
-0.050 (0.178)
-0.071 (0.242)
-0.079 (0.447)
0.002 (0.070)
0.002 (0.127)
0.014 (0.170)
0.021 (0.251)
-0.002 (0.031)
-0.004 (0.042)
-0.005 (0.049)
-0.009 (0.055)
-0.013 (0.105)
-0.030 (0.186)
-0.030 (0.221)
-0.052 (0.314)
0.002 (0.060)
0.002 (0.107)
0.003 (0.163)
-0.001 (0.244)
0.001 (0.038)
0.001 (0.066)
0.003 (0.079)
0.003 (0.110)
0.000 (0.016)
0.001 (0.025)
0.002 (0.027)
0.002 (0.033)
0.000 (0.047)
0.001 (0.073)
0.000 (0.091)
0.004 (0.120)
0.009 (0.076)
0.017 (0.120)
0.024 (0.158)
0.027 (0.187)
0.006 (0.046)
0.013 (0.076)
0.019 (0.089)
0.026 (0.113)
0.002 (0.027)
0.005 (0.039)
0.008 (0.046)
0.011 (0.053)
0.002 (0.072)
0.007 (0.116)
0.008 (0.133)
0.018 (0.165)

Zero
Imputation
-0.061 (0.372)
-0.086 (0.521)
-0.141 (0.585)
-0.248 (0.586)
-0.016 (0.093)
-0.025 (0.119)
-0.029 (0.136)
-0.028 (0.134)
-0.030 (0.167)
-0.041 (0.229)
-0.046 (0.265)
-0.050 (0.289)
-0.051 (0.297)
-0.061 (0.408)
-0.072 (0.456)
-0.079 (0.462)
0.004 (0.372)
-0.038 (0.686)
-0.087 (1.010)
-0.220 (1.305)
-0.000 (0.042)
-0.000 (0.053)
-0.000 (0.052)
-0.000 (0.051)
0.000 (0.070)
0.001 (0.091)
0.002 (0.099)
-0.000 (0.128)
0.001 (0.097)
0.001 (0.114)
0.000 (0.119)
0.002 (0.117)
0.033 (0.243)
0.039 (0.425)
0.030 (0.621)
-0.017 (0.801)
0.005 (0.074)
0.009 (0.088)
0.012 (0.095)
0.014 (0.093)
0.013 (0.108)
0.022 (0.137)
0.027 (0.137)
0.030 (0.139)
0.012 (0.164)
0.018 (0.188)
0.024 (0.195)
0.029 (0.183)

Multiple
Imputation
-0.001 (0.045)
-0.002 (0.030)
0.006 (0.042)
0.007 (0.050)
-2.753 (0.027)
0.000 (0.016)
-0.000 (0.017)
-0.000 (0.022)
0.001 (0.041)
0.003 (0.024)
-0.002 (0.029)
-0.002 (0.034)
-0.005 (0.067)
-0.006 (0.050)
0.014 (0.064)
0.016 (0.075)
-0.000 (0.041)
0.001 (0.026)
-0.000 (0.025)
-0.001 (0.032)
0.002 (0.061)
0.006 (0.038)
-0.005 (0.044)
-0.003 (0.054)
-0.008 (0.090)
-0.011 (0.070)
0.025 (0.086)
0.030 (0.094)
-0.000 (0.053)
0.002 (0.035)
-0.002 (0.034)
-0.002 (0.043)
0.005 (0.076)
0.011 (0.049)
-0.010 (0.057)
-0.006 (0.068)
-0.013 (0.113)
-0.018 (0.103)
0.041 (0.112)
0.051 (0.116)
-0.000 (0.062)
0.003 (0.045)
-0.003 (0.045)
-0.003 (0.053)
0.007 (0.090)
0.017 (0.063)
-0.017 (0.069)
-0.011 (0.093)
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Table 21 Relative bias for various missing data methods (Aim 2)
Missing Data Method
Outcome
Death

Mechanism
MAR

MNAR Left

MNAR Middle

MNAR Right

ICU Length
of Stay

MAR

MNAR Left

MNAR Middle

MNAR Right

Total Charges

MAR

MNAR Left

MNAR Middle

MNAR Right

Gamma
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40

Complete
Case Analysis
0.009 (0.258)
0.028 (0.420)
0.050 (0.658)
0.060 (1.085)
-0.034 (0.183)
-0.085 (0.291)
-0.133 (0.406)
-0.219 (0.552)
0.004 (0.213)
0.013 (0.312)
0.022 (0.410)
0.040 (0.490)
0.032 (0.229)
0.097 (0.372)
0.163 (0.548)
0.319 (0.757)
-0.000 (0.812)
-0.018 (1.418)
-0.139 (1.949)
-0.373 (2.621)
0.006 (0.664)
0.016 (1.125)
-0.001 (1.558)
0.033 (2.073)
-0.002 (0.552)
-0.006 (0.870)
0.020 (1.122)
0.001 (1.412)
-0.019 (0.651)
-0.064 (1.042)
-0.094 (1.536)
-0.139 (2.137)
-0.006 (0.452)
-0.039 (0.702)
-0.075 (0.962)
-0.191 (1.218)
0.058 (0.356)
0.158 (0.593)
0.290 (0.851)
0.456 (1.129)
-0.021 (0.335)
-0.065 (0.539)
-0.099 (0.702)
-0.187 (0.883)
-0.060 (0.379)
-0.153 (0.601)
-0.274 (0.850)
-0.419 (1.106)

Median
Imputation
-0.008 (0.040)
-0.015 (0.066)
-0.022 (0.085)
-0.027 (0.109)
-0.002 (0.016)
-0.004 (0.025)
-0.006 (0.032)
-0.008 (0.037)
-0.004 (0.024)
-0.008 (0.035)
-0.011 (0.044)
-0.014 (0.051)
-0.001 (0.035)
-0.004 (0.050)
-0.007 (0.061)
-0.008 (0.072)
0.001 (0.031)
0.003 (0.060)
0.003 (0.092)
0.004 (0.123)
0.000 (0.009)
0.000 (0.013)
0.000 (0.017)
0.000 (0.019)
0.000 (0.011)
0.000 (0.017)
0.000 (0.020)
0.001 (0.024)
0.000 (0.015)
0.000 (0.022)
0.000 (0.027)
0.000 (0.029)
0.003 (0.035)
0.007 (0.053)
0.010 (0.071)
0.013 (0.091)
0.000 (0.013)
0.001 (0.019)
0.001 (0.024)
0.002 (0.030)
0.000 (0.018)
0.001 (0.027)
0.001 (0.032)
0.002 (0.038)
0.001 (0.025)
0.002 (0.037)
0.004 (0.043)
0.006 (0.049)

Zero
Imputation
-0.012 (0.084)
-0.023 (0.141)
-0.032 (0.199)
-0.038 (0.254)
-0.005 (0.033)
-0.009 (0.046)
-0.012 (0.056)
-0.015 (0.061)
-0.007 (0.045)
-0.014 (0.067)
-0.018 (0.082)
-0.024 (0.094)
-0.002 (0.055)
-0.005 (0.077)
-0.006 (0.091)
-0.004 (0.109)
0.004 (0.087)
0.008 (0.181)
0.005 (0.270)
0.002 (0.350)
-0.000 (0.015)
-0.000 (0.021)
-0.000 (0.026)
-0.000 (0.027)
0.000 (0.021)
0.000 (0.033)
0.001 (0.037)
0.001 (0.048)
0.000 (0.025)
0.000 (0.036)
0.001 (0.044)
0.001 (0.049)
0.009 (0.070)
0.019 (0.114)
0.025 (0.163)
0.032 (0.211)
-0.000 (0.024)
0.000 (0.035)
0.000 (0.041)
0.001 (0.045)
0.000 (0.034)
0.004 (0.049)
0.005 (0.056)
0.008 (0.063)
0.001 (0.041)
0.003 (0.060)
0.006 (0.069)
0.008 (0.078)

Multiple
Imputation
-0.001 (0.025)
-0.002 (0.037)
-0.004 (0.049)
-0.004 (0.060)
0.001 (0.018)
0.003 (0.027)
0.005 (0.035)
0.007 (0.042)
-0.001 (0.023)
-0.002 (0.034)
-0.002 (0.043)
-0.003 (0.051)
-0.001 (0.026)
-0.002 (0.039)
-0.005 (0.048)
-0.007 (0.057)
-0.000 (0.015)
-0.000 (0.023)
-0.001 (0.031)
-0.001 (0.038)
0.000 (0.010)
9.358 (0.014)
-6.661 (0.019)
-0.000 (0.021)
3.916 (0.010)
-8.288 (0.016)
0.000 (0.018)
-0.000 (0.022)
6.951 (0.011)
-0.000 (0.018)
-0.000 (0.023)
-5.602 (0.028)
0.000 (0.023)
0.001 (0.034)
0.001 (0.042)
0.000 (0.052)
0.000 (0.015)
0.000 (0.022)
0.001 (0.028)
0.001 (0.035)
-0.000 (0.017)
-0.001 (0.026)
-0.002 (0.032)
-0.003 (0.037)
0.000 (0.019)
0.001 (0.029)
0.002 (0.037)
0.003 (0.045)
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Table 22 Efficiency for various missing data methods (Aim 1)
Missing Data Method
Outcome
Death

Mechanism
MAR

MNAR Left

MNAR Middle

MNAR Right

ICU Length of Stay

MAR

MNAR Left

MNAR Middle

MNAR Right

Total Charges

MAR

MNAR Left

MNAR Middle

MNAR Right

Gamma
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40

Complete
Case Analysis
1.315 (0.070)
1.856 (0.178)
3.006 (0.516)
6.860 (2.641)
1.212 (0.043)
1.505 (0.085)
1.923 (0.144)
2.557 (0.242)
1.242 (0.059)
1.590 (0.110)
2.115 (0.184)
2.945 (0.288)
1.264 (0.057)
1.660 (0.133)
2.299 (0.326)
3.470 (0.982)
1.271 (0.045)
1.641 (0.095)
2.112 (0.172)
2.531 (0.318)
1.243 (0.038)
1.595 (0.076)
2.124 (0.159)
2.947 (0.321)
1.242 (0.046)
1.590 (0.088)
2.111 (0.141)
2.925 (0.232)
1.225 (0.042)
1.531 (0.087)
1.970 (0.150)
2.617 (0.253)
1.251 (0.045)
1.593 (0.087)
2.031 (0.153)
2.485 (0.259)
1.242 (0.041)
1.592 (0.080)
2.121 (0.162)
2.940 (0.340)
1.241 (0.044)
1.587 (0.084)
2.104 (0.134)
2.916 (0.224)
1.226 (0.042)
1.535 (0.086)
1.978 (0.145)
2.637 (0.257)

Median
Imputation
0.971 (0.014)
0.946 (0.019)
0.923 (0.023)
0.890 (0.028)
0.991 (0.011)
0.975 (0.017)
0.969 (0.019)
0.950 (0.023)
0.998 (0.005)
0.997 (0.006)
0.996 (0.008)
0.994 (0.008)
0.981 (0.016)
0.955 (0.023)
0.941 (0.026)
0.913 (0.027)
1.000 (0.002)
1.001 (0.004)
1.000 (0.005)
0.997 (0.007)
1.000 (0.001)
1.001 (0.002)
1.001 (0.003)
1.001 (0.004)
1.000 (0.000)
1.000 (0.001)
1.000 (0.001)
1.000 (0.001)
1.000 (0.002)
1.000 (0.003)
0.999 (0.004)
1.000 (0.005)
1.004 (0.005)
1.007 (0.007)
1.009 (0.008)
1.010 (0.009)
1.001 (0.003)
1.003 (0.005)
1.005 (0.006)
1.007 (0.008)
1.000 (0.002)
1.001 (0.002)
1.001 (0.003)
1.002 (0.003)
1.001 (0.005)
1.003 (0.008)
1.004 (0.009)
1.007 (0.010)

Zero
Imputation
0.894 (0.023)
0.889 (0.031)
0.935 (0.037)
1.082 (0.083)
0.980 (0.014)
0.972 (0.016)
0.970 (0.016)
0.971 (0.016)
0.963 (0.019)
0.950 (0.022)
0.943 (0.021)
0.942 (0.021)
0.922 (0.024)
0.896 (0.028)
0.885 (0.028)
0.890 (0.027)
0.989 (0.012)
0.954 (0.021)
0.888 (0.037)
0.769 (0.052)
0.999 (0.002)
1.000 (0.002)
1.000 (0.002)
1.000 (0.002)
1.000 (0.003)
1.000 (0.003)
1.000 (0.004)
1.000 (0.004)
0.999 (0.004)
1.000 (0.005)
1.000 (0.005)
1.000 (0.005)
1.008 (0.012)
0.991 (0.019)
0.951 (0.032)
0.879 (0.041)
1.000 (0.004)
1.001 (0.005)
1.001 (0.005)
1.001 (0.004)
1.003 (0.007)
1.005 (0.007)
1.006 (0.008)
1.007 (0.008)
1.005 (0.010)
1.007 (0.010)
1.008 (0.011)
1.008 (0.010)

Multiple
Imputation
1.004 (0.010)
1.009 (0.016)
1.016 (0.024)
1.025 (0.039)
1.003 (0.006)
1.008 (0.010)
1.013 (0.014)
1.021 (0.021)
1.004 (0.007)
1.010 (0.011)
1.016 (0.015)
1.023 (0.019)
1.004 (0.010)
1.009 (0.015)
1.014 (0.020)
1.017 (0.024)
1.000 (0.001)
1.000 (0.002)
1.001 (0.003)
1.002 (0.004)
1.000 (0.000)
1.000 (0.001)
1.000 (0.002)
1.001 (0.003)
1.000 (0.000)
1.000 (0.001)
1.000 (0.001)
1.000 (0.002)
1.000 (0.001)
1.000 (0.001)
1.000 (0.002)
1.000 (0.002)
1.001 (0.003)
1.003 (0.005)
1.005 (0.006)
1.008 (0.008)
1.000 (0.002)
1.001 (0.003)
1.003 (0.004)
1.005 (0.006)
1.000 (0.002)
1.001 (0.003)
1.002 (0.004)
1.003 (0.005)
1.000 (0.002)
1.001 (0.004)
1.002 (0.005)
1.002 (0.006)
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Table 23 Efficiency for various missing data methods (Aim 2)
Missing Data Method
Outcome
Death

Mechanism
MAR

MNAR Left

MNAR Middle

MNAR Right

ICU Length of Stay

MAR

MNAR Left

MNAR Middle

MNAR Right

Total Charges

MAR

MNAR Left

MNAR Middle

MNAR Right

Gamma
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40
10
20
30
40

Complete
Case Analysis
1.314 (0.069)
1.000 (0.001)
1.004 (0.003)
1.857 (0.173)
1.001 (0.002)
1.008 (0.005)
3.003 (0.531)
1.001 (0.002)
1.010 (0.007)
6.811 (2.671)
1.001 (0.003)
1.010 (0.009)
1.212 (0.043)
1.000 (0.000)
0.999 (0.001)
1.504 (0.086)
1.000 (0.000)
0.999 (0.002)
1.924 (0.151)
1.000 (0.000)
0.999 (0.002)
2.547 (0.231)
1.000 (0.000)
0.999 (0.002)
1.241 (0.059)
1.000 (0.000)
1.000 (0.002)
1.591 (0.102)
1.000 (0.000)
1.000 (0.003)
2.111 (0.179)
1.000 (0.000)
1.001 (0.003)
2.943 (0.293)
1.000 (0.001)
1.001 (0.003)
1.263 (0.056)
1.000 (0.000)
1.000 (0.003)
1.661 (0.141)
1.000 (0.001)
1.001 (0.004)
2.300 (0.335)
1.000 (0.001)
1.002 (0.005)
3.480 (0.935)
1.000 (0.001)
1.003 (0.005)

Median
Imputation
1.272 (0.047)
1.002 (0.002)
1.002 (0.005)
1.638 (0.095)
1.003 (0.003)
1.004 (0.008)
2.110 (0.175)
1.005 (0.003)
1.007 (0.011)
2.534 (0.315)
1.007 (0.004)
1.009 (0.013)
1.244 (0.038)
0.999 (0.000)
1.001 (0.003)
1.592 (0.075)
0.999 (0.001)
1.002 (0.005)
2.122 (0.152)
0.999 (0.001)
1.003 (0.006)
2.957 (0.319)
0.999 (0.001)
1.005 (0.007)
1.242 (0.046)
1.000 (0.001)
1.000 (0.003)
1.589 (0.086)
1.000 (0.001)
1.000 (0.005)
2.108 (0.147)
1.000 (0.002)
1.000 (0.006)
2.927 (0.231)
1.000 (0.002)
1.000 (0.008)
1.225 (0.043)
1.000 (0.002)
1.000 (0.005)
1.535 (0.085)
1.000 (0.002)
1.001 (0.007)
1.969 (0.150)
1.001 (0.003)
1.000 (0.009)
2.619 (0.252)
1.001 (0.003)
1.001 (0.011)

Zero
Imputation
1.251 (0.045)
0.971 (0.008)
1.000 (0.000)
1.589 (0.088)
0.947 (0.012)
1.000 (0.001)
2.029 (0.156)
0.929 (0.014)
1.000 (0.001)
2.491 (0.254)
0.916 (0.017)
1.000 (0.001)
1.244 (0.041)
0.995 (0.006)
1.000 (0.000)
1.590 (0.081)
0.992 (0.007)
1.000 (0.000)
2.116 (0.158)
0.990 (0.009)
1.000 (0.001)
2.950 (0.338)
0.988 (0.010)
1.000 (0.001)
1.242 (0.044)
0.994 (0.007)
1.000 (0.000)
1.589 (0.081)
0.990 (0.010)
1.000 (0.000)
2.107 (0.141)
0.987 (0.011)
1.000 (0.000)
2.916 (0.221)
0.985 (0.012)
1.000 (0.001)
1.227 (0.042)
0.994 (0.010)
1.000 (0.000)
1.535 (0.085)
0.987 (0.014)
1.000 (0.000)
1.975 (0.147)
0.982 (0.015)
1.000 (0.001)
2.640 (0.254)
0.978 (0.017)
1.000 (0.001)

Multiple
Imputation
0.989 (0.006)
1.000 (0.002)
1.000 (0.001)
0.978 (0.008)
0.999 (0.005)
1.000 (0.002)
0.969 (0.010)
0.996 (0.007)
1.001 (0.003)
0.960 (0.012)
0.991 (0.009)
1.001 (0.003)
0.998 (0.003)
0.999 (0.000)
1.000 (0.001)
0.996 (0.004)
0.999 (0.001)
1.000 (0.001)
0.995 (0.006)
0.999 (0.001)
1.000 (0.002)
0.993 (0.006)
0.999 (0.001)
1.000 (0.002)
0.997 (0.003)
1.000 (0.000)
1.000 (0.001)
0.995 (0.005)
1.000 (0.001)
1.000 (0.001)
0.993 (0.006)
1.000 (0.001)
1.000 (0.002)
0.991 (0.007)
1.000 (0.001)
1.001 (0.002)
0.997 (0.006)
1.000 (0.001)
1.000 (0.001)
0.993 (0.009)
1.000 (0.001)
1.001 (0.002)
0.989 (0.010)
1.000 (0.002)
1.002 (0.002)
0.986 (0.012)
1.000 (0.002)
1.002 (0.003)
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Appendix C. Correlation table

SOFA Card

SOFA Coag

SOFA Hep

SOFA Renal

SOFA Resp

Age Group

Male

Race

Died

Total Charges

ICU LOS

Charlson Score

3

4

5

6

7

8

9

10

11

12

13

14

―

2
0.233
< .0001

―

3
0.698
< .0001
-0.014
0.534

Italicized indicates the p-value: prob > |r| under H0: ρs=0
Bold indicates p < 0.05

SOFA CNS

2

―

SOFA

1

1

―

4
0.484
< .0001
-0.045
0.046
0.204
< .0001

―

5
0.467
< .0001
-0.050
0.029
0.218
< .0001
0.364
< .0001

―

6
0.560
< .0001
-0.003
0.881
0.267
< .0001
0.158
< .0001
0.201
< .0001

―

7
0.605
< .0001
-0.060
0.008
0.349
< .0001
0.169
< .0001
0.131
< .0001
0.177
< .0001

―

8
0.014
0.534
-0.024
0.294
0.045
0.046
-0.017
0.445
-0.019
0.410
0.065
0.004
-0.012
0.588

―

9
0.048
0.034
-0.018
0.419
0.001
0.965
0.042
0.065
0.068
0.003
0.073
0.001
0.059
0.009
-0.025
0.268

―

10
-0.038
0.093
-0.023
0.322
0.053
0.019
0.025
0.268
0.012
0.613
-0.186
< .0001
0.021
0.345
0.053
0.020
0.069
0.002

―

11
0.311
< .0001
0.150
< .0001
0.232
< .0001
0.155
< .0001
0.189
< .0001
0.158
< .0001
0.137
< .0001
0.168
< .0001
-0.056
0.014
0.057
0.013

―

12
0.088
0.0001
-0.089
< .0001
-0.003
0.892
0.166
< .0001
0.124
< .0001
-0.014
0.525
0.126
< .0001
-0.087
0.0001
0.046
0.044
-0.030
0.194
-0.171
< .0001

Table 24 Intercorrelations for variables used in this study, measured by Spearman’s rank correlation coefficient, 𝝆𝒔

―

13
0.035
0.120
-0.037
0.103
-0.046
0.043
0.083
0.001
0.075
0.001
-0.023
0.321
0.077
0.001
-0.018
0.418
0.017
0.449
-0.044
0.053
-0.169
< .0001
0.813
< .0001

―

14
0.229
< .0001
-0.053
0.019
0.067
0.003
0.154
< .0001
0.171
< .0001
0.313
< .0001
0.074
0.001
0.253
< .0001
-0.033
0.149
-0.104
< .0001
0.134
< .0001
0.155
< .0001
0.152
< .0001
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Appendix D. Example SAS Code

Missing data generation macro – MAR missing data mechanism
This macro selects records based on the MAR missing data mechanism, whereby 75% of the γ%
of observations are selected at random among patients who died during their admission and 25%
of the γ% of observations are selected at random among patients whose Charlson comorbidity
score is ≥ 2 and who survived the admission. A Charlson comorbidity score of 2 is the median
value among patients who survived the admission.

%macro mar(in=,out=,percent=);
data _NULL_; *** output the # obs to variable nrows;
if 0 then set &in nobs=n;
call symputx('nrows',n);
stop;
run;
%let n_SetMissing = %sysevalf(&nrows *
(&percent/100),ceil);
*round up to the nearest integer (e.g. 3.1 becomes 4);
%let n_SetMissing1 = %sysevalf(&n_SetMissing *
0.75,ceil);
*75% from Died=1;
%let n_SetMissing2 = %sysevalf(&n_SetMissing –
&n_SetMissing1,ceil);
*25% from Died=0 and CharlsScore > 2;
data _temp1;
set &in;
where died=1;
prob_SOFA_miss = rand("normal",0,1);
run;
data _temp2;
set &in;
where died=0;
if CharlsScore > 2 then prob_SOFA_miss =
rand("normal",0,1);
else prob_SOFA_miss = -9;
run;
proc sort data=_temp1;
by descending prob_SOFA_miss;
run;
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data _temp1;
set _temp1;
if _n_ <= &n_SetMissing1 then Selected=1;
else Selected=0;
drop prob_SOFA_miss;
run;
proc sort data=_temp2;
by descending prob_SOFA_miss;
run;
data _temp2;
set _temp2;
if _n_ <= &n_SetMissing2 then Selected=1;
else Selected=0;
drop prob_SOFA_miss;
run;
data &out;
set _temp1 _temp2;
run;
proc delete data=_temp1; run;
proc delete data=_temp2; run;
%mend;
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Missing data generation macro – MNAR missing data mechanism
This macro selects records based on the MNAR missing data mechanism with 3 variants: MNAR
Left, MNAR Middle, and MNAR Right. These 3 variants correspond to a missing data
mechanism whereby SOFA scores in the left, middle, and right sides of the empirical SOFA
distribution respectively are selected for deletion.

/*

Quantiles
Scores
Q1: 0-5
Q2: 6-8
Q3: 9-11
Q4: 12-24

n
469
536
428
497

LEFT
Rate
52
48
00
00

MID
Rate
00
50
50
00

RIGHT
Rate
00
00
48
52

Type= can be LEFT, MID, or RIGHT
*/
%macro mnar(in=,out=,type=,percent=);
data _NULL_; *** output the # obs to variable nrows;
if 0 then set &in nobs=n;
call symputx('nrows',n);
stop;
run;
%let n_SetMissing = %sysevalf(&nrows *
(&percent/100),ceil);
%if &type=LEFT %then %do;
%let Q1rate = 0.52;
%let Q2rate = 0.48;
%let n_Q1 = %sysevalf(&Q1rate * (&percent/100) *
&nrows, ceil);
%let n_Q2 = %sysevalf(&Q2rate * (&percent/100) *
&nrows, ceil);
proc surveyselect data=&in(where=(0<=SOFA<=5))
out=mnar1 method=SRS outall
sampsize=&n_Q1
noprint;
run;
proc surveyselect data=&in(where=(6<=SOFA<=8))
out=mnar2 method=SRS outall
sampsize=&n_Q2
noprint;
run;
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data mnar3;
set &in;
where SOFA>=9;
selected=0;
run;
%end;
%if &type=MID %then %do;
%let Q2rate = 0.50;
%let Q3rate = 0.50;
%let n_Q2 = %sysevalf(&Q2rate * (&percent/100) *
&nrows, ceil);
%let n_Q3 = %sysevalf(&Q3rate * (&percent/100) *
&nrows, ceil);
proc surveyselect data=&in(where=(6<=SOFA<=8))
out=mnar1 method=SRS outall
sampsize=&n_Q2
noprint;
run;
proc surveyselect data=&in(where=(9<=SOFA<=11))
out=mnar2 method=SRS outall
sampsize=&n_Q3
noprint;
run;
data mnar3;
set &in;
where (SOFA <= 5) or (SOFA >= 12);
selected=0;
run;
%end;
%if &type=RIGHT %then %do;
%let Q3rate = 0.48;
%let Q4rate = 0.52;
%let n_Q3 = %sysevalf(&Q3rate * (&percent/100) *
&nrows, ceil);
%let n_Q4 = %sysevalf(&Q4rate * (&percent/100) *
&nrows, ceil);
proc surveyselect data=&in(where=(9<=SOFA<=11))
out=mnar1 method=SRS outall
sampsize=&n_Q3
noprint;
run;
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proc surveyselect data=&in(where=(12<=SOFA<=24))
out=mnar2 method=SRS outall
sampsize=&n_Q4
noprint;
run;
data mnar3;
set &in;
where SOFA <= 8;
selected=0;
run;
%end;
data &out;
set mnar1 mnar2 mnar3;
run;
proc delete data=mnar1; run;
proc delete data=mnar2; run;
proc delete data=mnar3; run;
%mend;
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Multiple Imputation – Composite (Aim 1)

proc mi data=&SimTable nimpute=25 out=temp_Method4;
by sim_run;
class Age_Group Male Race2 payor_group2;
* Died should not be a class variable, per prior
literature;
var SOFA
Age_Group Male Race2 payor_group2
Died ICU_LOS TotalCharges
/* Outcomes */
SOFA_CNS SOFA_Coag SOFA_Hep SOFA_Ren SOFA_Resp
CharlsScore;
fcs reg(SOFA);
transform log(TotalCharges) log(ICU_LOS);
ods output ModelInfo=MI_Seeds1
VarianceInfo=MI_Variance1
ParameterEstimates=MI_Parms1;
run;
proc sql;
create index sim_mi on temp_Method4 (sim_run,
_imputation_ );
quit;
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Multiple Imputation – Component (Aim 2)

proc mi data=&SimTable nimpute=25 out=temp_Method4;
by sim_run;
class Age_Group Male Race2 payor_group2;
var Age_Group Male Race2 payor_group2
Died ICU_LOS TotalCharges
/* Outcomes */
SOFA_CNS SOFA_Card SOFA_Coag SOFA_Hep SOFA_Ren
SOFA_Resp CharlsScore;
fcs reg(SOFA_CNS SOFA_Card SOFA_Coag SOFA_Hep SOFA_Ren
SOFA_Resp);
transform log(TotalCharges) log(ICU_LOS);
ods output ModelInfo=MI_Seeds1
VarianceInfo=MI_Variance1
ParameterEstimates=MI_Parms1;
run;
data temp_Method4;
*Set MIN component score to zero ;
set temp_Method4;
if SOFA_CNS < 0 then SOFA_CNS = 0;
if SOFA_Card < 0 then SOFA_Card = 0;
if SOFA_Coag < 0 then SOFA_Coag = 0;
if SOFA_Hep < 0 then SOFA_Hep = 0;
if SOFA_Ren < 0 then SOFA_Ren = 0;
if SOFA_Resp < 0 then SOFA_Resp = 0;
SOFA = SOFA_CNS + SOFA_Card + SOFA_Coag + SOFA_Hep +
SOFA_Ren + SOFA_Resp;
run;

162

REFERENCES

1.

Halpern NA, Pastores SM, Greenstein RJ. (2004). Critical care medicine in the United
States 1985-2000: an analysis of bed numbers, use, and costs. Crit Care Med,
32(6):1254-1259. PubMed PMID: 15187502.

2.

Halpern NA, Pastores SM. (2010). Critical care medicine in the United States 2000-2005:
an analysis of bed numbers, occupancy rates, payer mix, and costs. Crit Care Med,
38(1):65-71. doi: 10.1097/CCM.0b013e3181b090d0. PubMed PMID: 19730257.

3.

Carson SS, Cox CE, Holmes GM, Howard A, Carey TS. (2006). The changing
epidemiology of mechanical ventilation: a population-based study. J Intensive Care Med,
21(3):173-182. doi: 10.1177/0885066605282784. PubMed PMID: 16672639.

4.

Jones C, Griffiths RD, Humphris G, Skirrow PM. (2001). Memory, delusions, and the
development of acute posttraumatic stress disorder-related symptoms after intensive care.
Crit Care Med, 29(3):573-580. PubMed PMID: 11373423.

5.

Marra A, Pandharipande PP, Patel MB. (2017). Intensive Care Unit Delirium and
Intensive Care Unit-Related Posttraumatic Stress Disorder. Surgical Clinics of North
America, 97(6):1215-1235. doi: 10.1016/j.suc.2017.07.008. PubMed PMID: 29132506.

6.

Bienvenu OJ, Gerstenblith TA. (2017). Posttraumatic Stress Disorder Phenomena After
Critical Illness. Critical Care Clinics, 33(3):649-658. doi: 10.1016/j.ccc.2017.03.006.
PubMed PMID: 28601139.

7.

Treggiari MM, Romand J-A, Yanez ND, Deem SA, Goldberg J, Hudson L, Heidegger CP, Weiss NS. (2009). Randomized trial of light versus deep sedation on mental health
after critical illness*. Critical Care Medicine, 37(9):2527-2534. doi:
10.1097/CCM.0b013e3181a5689f. PubMed PMID: 00003246-200909000-00005.

8.

Marra A, Ely EW, Pandharipande PP, Patel MB. (2017). The ABCDEF Bundle in
Critical Care. Critical Care Clinics, 33(2):225-243. doi: 10.1016/j.ccc.2016.12.005.
PubMed PMID: 28284292.

9.

McGiffin JN, Galatzer-Levy IR, Bonanno GA. (2016). Is the intensive care unit
traumatic? What we know and don't know about the intensive care unit and posttraumatic
stress responses. Rehabilitation Psychology, 61(2):120-131. doi: 10.1037/rep0000073.
PubMed PMID: 27196855.

163

10.

Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ. (2015). The stepped wedge
cluster randomised trial: rationale, design, analysis, and reporting. BMJ : British Medical
Journal, 350. doi: 10.1136/bmj.h391.

11.

Strand K, Flaatten H. (2008). Severity scoring in the ICU: a review. Acta
Anaesthesiologica Scandinavica, 52(4):467-478. doi: 10.1111/j.13996576.2008.01586.x.

12.

Schafer JL. (1997). Analysis of incomplete multivariate data. Boca Raton, FL: Chapman
& Hall. 444 p.

13.

von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. (2007).
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
statement: guidelines for reporting observational studies. Ann Intern Med, 147(8):573577. PubMed PMID: 17938396.

14.

Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, Sorensen HT,
von Elm E, Langan SM. (2015). The REporting of studies Conducted using
Observational Routinely-collected health Data (RECORD) statement. PLoS Med,
12(10):e1001885. doi: 10.1371/journal.pmed.1001885. PubMed PMID: 26440803.

15.

International Committee of Medical Journal Editors. (2016). Recommendations for the
Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.
Available from: http://www.icmje.org/.

16.

Motheral B, Brooks J, Clark MA, Crown WH, Davey P, Hutchins D, Martin BC, Stang P.
(2003). A checklist for retrospective database studies--report of the ISPOR Task Force on
Retrospective Databases. Value Health, 6(2):90-97. doi: 10.1046/j.15244733.2003.00242.x. PubMed PMID: 12641858.

17.

Berger ML, Sox H, Willke RJ, Brixner DL, Eichler HG, Goettsch W, Madigan D,
Makady A, Schneeweiss S, Tarricone R, Wang SV, Watkins J, Mullins CD. (2017). Good
Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness:
Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World
Evidence in Health Care Decision Making. Value in Health, 20(8):1003-1008. doi:
10.1016/j.jval.2017.08.3019.

18.

Wang SV, Schneeweiss S, Berger ML, Brown J, de Vries F, Douglas I, Gagne JJ, Gini R,
Klungel O, Mullins CD, Nguyen MD, Rassen JA, Smeeth L, Sturkenboom M. (2017).

164

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare
Database Studies V1.0. Value in Health, 20(8):1009-1022. doi:
10.1016/j.jval.2017.08.3018.
19.

PCORI. (2017). Methodology Standards. Available from:
https://www.pcori.org/sites/default/files/PCORI-Methodology-Standards.pdf.

20.

Rezvan PH, Lee KJ, Simpson JA. (2015). The rise of multiple imputation: a review of the
reporting and implementation of the method in medical research. BMC Med Res
Methodol, 15:1-14. doi: 10.1186/s12874-015-0022-1. PubMed PMID: 25880850.

21.

Truven Health Analytics. (2016). Truven Health MarketScan® Research Databases:
Commercial Claims and Encounters User Guide. Ann Arbor, MI.

22.

Birt JA, Tan Y, Mozaffarian N. (2017). Sjogren's syndrome: managed care data from a
large United States population highlight real-world health care burden and lack of
treatment options. Clin Exp Rheumatol, 35(1):98-107. PubMed PMID: 27749234.

23.

Evans R, Loeb A, Kaye KS, Cher ML, Martin ET. (2017). Infection-Related Hospital
Admissions After Prostate Biopsy in United States Men. Open Forum Infect Dis, 4(1):13. doi: 10.1093/ofid/ofw265. PubMed PMID: 28480258.

24.

Lip GY, Hunter TD, Quiroz ME, Ziegler PD, Turakhia MP. (2017). Atrial Fibrillation
Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent
Stroke. Circ Cardiovasc Qual Outcomes, 10(1):1-8. doi:
10.1161/circoutcomes.116.002864. PubMed PMID: 28096204.

25.

Nichols CI, Vose JG. (2017). Incidence of Bleeding-Related Complications During
Primary Implantation and Replacement of Cardiac Implantable Electronic Devices. J Am
Heart Assoc, 6(1):1-9. doi: 10.1161/jaha.116.004263. PubMed PMID: 28111362.

26.

Qin X, Tangka FK, Guy GP, Jr., Howard DH. (2017). Mammography rates after the 2009
revision to the United States Preventive Services Task Force breast cancer screening
recommendation. Cancer Causes Control, 28(1):41-48. doi: 10.1007/s10552-016-08351. PubMed PMID: 28025762.

27.

Saeed MJ, Olsen MA, Powderly WG, Presti RM. (2017). Diabetes Mellitus is Associated
With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C
Patients. J Clin Gastroenterol, 51(1):70-76. doi: 10.1097/mcg.0000000000000566.
PubMed PMID: 27306942.

165

28.

Sajisevi M, Schulz K, Cyr DD, Wojdyla D, Rosenfeld RM, Tucci D, Witsell DL. (2017).
Nonadherence to Guideline Recommendations for Tympanostomy Tube Insertion in
Children Based on Mega-database Claims Analysis. Otolaryngol Head Neck Surg,
156(1):87-95. doi: 10.1177/0194599816669499. PubMed PMID: 27625028.

29.

Solid CA, Peter SA, Natwick T, Guo H, Collins AJ, Arduino JM. (2017). Impact of Renal
Disease on Patients with Hepatitis C: A Retrospective Analysis of Disease Burden,
Clinical Outcomes, and Health Care Utilization and Cost. Nephron, 136(2):54-61. doi:
10.1159/000454684. PubMed PMID: 28214902.

30.

Stephens JR, Steiner MJ, DeJong N, Rodean J, Hall M, Richardson T, Berry JG. (2017).
Healthcare Utilization and Spending for Constipation in Children With Versus Without
Complex Chronic Conditions. J Pediatr Gastroenterol Nutr, 64(1):31-36. doi:
10.1097/mpg.0000000000001210. PubMed PMID: 27070656.

31.

Tao G, Patel C, Hoover KW. (2017). Updated Estimates of Ectopic Pregnancy among
Commercially and Medicaid-Insured Women in the United States, 2002-2013. South Med
J, 110(1):18-24. doi: 10.14423/smj.0000000000000594. PubMed PMID: 28052169.

32.

Wallace L, Kadakia A. (2017). Buprenorphine transdermal system utilization. Postgrad
Med, 129(1):81-86. doi: 10.1080/00325481.2017.1267537. PubMed PMID: 27901359.

33.

Wu JJ, Guerin A, Sundaram M, Dea K, Cloutier M, Mulani P. (2017). Cardiovascular
event risk assessment in psoriasis patients treated with tumor necrosis factor-alpha
inhibitors versus methotrexate. J Am Acad Dermatol, 76(1):81-90. doi:
10.1016/j.jaad.2016.07.042. PubMed PMID: 27894789.

34.

Zhang D, Johnson K, Newransky C, Acosta CJ. (2017). Herpes Zoster Vaccine Coverage
in Older Adults in the U.S., 2007-2013. Am J Prev Med, 52(1):e17-e23. doi:
10.1016/j.amepre.2016.08.029. PubMed PMID: 28340974.

35.

Brittan M, Richardson T, Kenyon C, Sills MR, Fieldston E, Hall M, Fox D, Shah S,
Berry J. (2017). Association between Postdischarge Oral Corticosteroid Prescription Fills
and Readmission in Children with Asthma. J Pediatr, 180:163-169.e161. doi:
10.1016/j.jpeds.2016.09.034. PubMed PMID: 27769549.

36.

Herzog MM, Marshall SW, Lund JL, Pate V, Spang JT. (2017). Cost of Outpatient
Arthroscopic Anterior Cruciate Ligament Reconstruction Among Commercially Insured

166

Patients in the United States, 2005-2013. Orthop J Sports Med, 5(1):1-8. doi:
10.1177/2325967116684776. PubMed PMID: 28210655.
37.

Millman AJ, Reynolds S, Duffy J, Chen J, Gargiullo P, Fry AM. (2017). Hospitalizations
within 14 days of vaccination among pediatric recipients of the live attenuated influenza
vaccine, United States 2010-2012. Vaccine, 35(4):529-535. doi:
10.1016/j.vaccine.2016.12.033. PubMed PMID: 28041779.

38.

Ullal AJ, Kaiser DW, Fan J, Schmitt SK, Than CT, Winkelmayer WC, Heidenreich PA,
Piccini JP, Perez MV, Wang PJ, Turakhia MP. (2017). Safety and Clinical Outcomes of
Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease. J
Cardiovasc Electrophysiol, 28(1):39-48. doi: 10.1111/jce.13118. PubMed PMID:
27782345.

39.

Wu H, Mendoza MC, Huang YA, Hayes T, Smith DK, Hoover KW. (2017). Uptake of
HIV Preexposure Prophylaxis Among Commercially Insured Persons-United States,
2010-2014. Clin Infect Dis, 64(2):144-149. doi: 10.1093/cid/ciw701. PubMed PMID:
27986691.

40.

Rosenbaum PR, Rubin DB. (1983). The central role of the propensity score in
observational studies for causal effects. Biometrika, 70(1):41-55. doi:
10.1093/biomet/70.1.41.

41.

Rubin DB. (1997). Estimating causal effects from large data sets using propensity scores.
Ann Intern Med, 127(8 Pt 2):757-763. PubMed PMID: 9382394.

42.

Hillestad R, Bigelow J, Bower A, Girosi F, Meili R, Scoville R, Taylor R. (2005). Can
electronic medical record systems transform health care? Potential health benefits,
savings, and costs. Health Affairs, 24(5):1103-1117.

43.

Liao KP, Cai T, Gainer V, Goryachev S, Zeng‐treitler Q, Raychaudhuri S, Szolovits P,
Churchill S, Murphy S, Kohane I. (2010). Electronic medical records for discovery
research in rheumatoid arthritis. Arthritis Care & Research, 62(8):1120-1127.

44.

Dean BB, Lam J, Natoli JL, Butler Q, Aguilar D, Nordyke RJ. (2009). Use of electronic
medical records for health outcomes research: A literature review. Medical Care
Research and Review, 66(6):611-638.

45.

eMERGE. (2014). About eMERGE. [Accessed 10/31/2017]. Available from:
https://emerge.mc.vanderbilt.edu/about-emerge/.

167

46.

Kho AN, Pacheco JA, Peissig PL, Rasmussen L, Newton KM, Weston N, Crane PK,
Pathak J, Chute CG, Bielinski SJ. (2011). Electronic medical records for genetic research:
results of the eMERGE consortium. Science Translational Medicine, 3(79):79re7179re71.

47.

Kirby JC, Speltz P, Rasmussen LV, Basford M, Gottesman O, Peissig PL, Pacheco JA,
Tromp G, Pathak J, Carrell DS, Ellis SB, Lingren T, Thompson WK, Savova G, Haines J,
Roden DM, Harris PA, Denny JC. (2016). PheKB: a catalog and workflow for creating
electronic phenotype algorithms for transportability. J Am Med Inform Assoc,
23(6):1046-1052. doi: 10.1093/jamia/ocv202. PubMed PMID: 27026615.

48.

Shortliffe EH. (1999). The evolution of electronic medical records. Academic Medicine,
74(4):414-419.

49.

Grippi MA. (2015). Respiratory Failure: An Overview. In: Grippi MA, Elias JA,
Fishman JA, Kotloff RM, Pack AI, Senior RM, Siegel MD, editors. Fishman's Pulmonary
Diseases and Disorders, 5e. New York, NY: McGraw-Hill Education. p.

50.

Matthay MA, Slutsky AS. (2016). Acute Respiratory Failure. In: Goldman-Cecil
Medicine [Internet]. Philadelphia, PA: Elsevier-Saunders. 25th. [655-664].

51.

Halle MJ, Levant S, DeFrances CJ. (2013). Trends in Inpatient Hospital Deaths:
National Hospital Discharge Survey, 2000–2010. Hyattsville, MD: National Center for
Health Statistics.

52.

Kochanek K, Murphy S, Xu J, Tejada-Vera B. (2016). Deaths: Final data for 2014.
National vital statistics reports. Hyattsville, MD: National Center for Health Statistics,
June 30, 2016. Report No.: Contract No.: 4.

53.

Hayman WR, Leuthner SR, Laventhal NT, Brousseau DC, Lagatta JM. (2015). Cost
comparison of mechanically ventilated patients across the age span. Journal of
Perinatology, 35(12):1020-1026. doi: 10.1038/jp.2015.131. PubMed PMID: 26468935.

54.

Khatutsky G, Ormond C, Wiener J, Greene A, Johnson R, Jessup E, Vreeland E,
Sengupta M, Caffrey C, Harris-Kojetin L. (2016). Residential care communities and their
residents in 2010: A national portrait. In: Department of Health and Human Services,
editor. Hyattsville, MD: National Center for Health Statistics.

168

55.

Farias JA, Fernandez A, Monteverde E, Flores JC, Baltodano A, Menchaca A, Poterala
R, Panico F, Johnson M, von Dessauer B, Donoso A, Zavala I, Zavala C, Troster E, Pena
Y, Flamenco C, Almeida H, Nilda V, Esteban A. (2012). Mechanical ventilation in
pediatric intensive care units during the season for acute lower respiratory infection: a
multicenter study. Pediatric Critical Care Medicine, 13(2):158-164. doi:
10.1097/PCC.0b013e3182257b82. PubMed PMID: 21725275.

56.

Aitken LM, Bucknall T, Kent B, Mitchell M, Burmeister E, Keogh SJ. (2015). Protocoldirected sedation versus non-protocol-directed sedation to reduce duration of mechanical
ventilation in mechanically ventilated intensive care patients. Cochrane Database Syst
Rev, 1:Cd009771. doi: 10.1002/14651858.CD009771.pub2. PubMed PMID: 25562750.

57.

Esteban A, Anzueto A, Frutos F, Alia I, Brochard L, Stewart TE, Benito S, Epstein SK,
Apezteguia C, Nightingale P, Arroliga AC, Tobin MJ. (2002). Characteristics and
outcomes in adult patients receiving mechanical ventilation: a 28-day international study.
Jama, 287(3):345-355. PubMed PMID: 11790214.

58.

Metnitz PG, Metnitz B, Moreno RP, Bauer P, Del Sorbo L, Hoermann C, de Carvalho
SA, Ranieri VM. (2009). Epidemiology of mechanical ventilation: analysis of the SAPS
3 database. Intensive Care Med, 35(5):816-825. doi: 10.1007/s00134-009-1449-9.
PubMed PMID: 19288079.

59.

Charlson ME, Pompei P, Ales KL, MacKenzie CR. (1987). A new method of classifying
prognostic comorbidity in longitudinal studies: development and validation. J Chronic
Dis, 40(5):373-383. PubMed PMID: 3558716.

60.

Deyo RA, Cherkin DC, Ciol MA. (1992). Adapting a clinical comorbidity index for use
with ICD-9-CM administrative databases. J Clin Epidemiol, 45(6):613-619. PubMed
PMID: 1607900.

61.

Elixhauser A, Steiner C, Harris DR, Coffey RM. (1998). Comorbidity measures for use
with administrative data. Med Care, 36(1):8-27. PubMed PMID: 9431328.

62.

Ladha KS, Zhao K, Quraishi SA, Kurth T, Eikermann M, Kaafarani HM, Klein EN,
Seethala R, Lee J. (2015). The Deyo-Charlson and Elixhauser-van Walraven
Comorbidity Indices as predictors of mortality in critically ill patients. BMJ Open,
5(9):e008990. doi: 10.1136/bmjopen-2015-008990. PubMed PMID: 26351192.

63.

Stavem K, Hoel H, Skjaker SA, Haagensen R. (2017). Charlson comorbidity index
derived from chart review or administrative data: agreement and prediction of mortality

169

in intensive care patients. Clinical Epidemiology, 9:311-320. doi: 10.2147/clep.s133624.
PubMed PMID: 28652813.
64.

Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK,
Suter PM, Thijs LG. (1996). The SOFA (Sepsis-related Organ Failure Assessment) score
to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related
Problems of the European Society of Intensive Care Medicine. Intensive Care Med,
22(7):707-710. PubMed PMID: 8844239.

65.

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M,
Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM,
Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus
DC. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock
(Sepsis-3). Jama, 315(8):801-810. doi: 10.1001/jama.2016.0287. PubMed PMID:
26903338.

66.

Office of the Assistant Secretary for Preparedness & Response. (2017). SOFA Score:
What it is and how to use it in triage. In: U.S. Department of Health & Human Services,
editor.

67.

Knox DB, Lanspa MJ, Pratt CM, Kuttler KG, Jones JP, Brown SM. (2014). Glasgow
Coma Scale score dominates the association between admission Sequential Organ Failure
Assessment score and 30-day mortality in a mixed intensive care unit population. J Crit
Care, 29(5):780-785. doi: 10.1016/j.jcrc.2014.05.009. PubMed PMID: 25012961.

68.

Stoller JK, Hill NS. (2016). Respiratory Monitoring in Critical Care. In: Goldman-Cecil
Medicine [Internet]. Philadelphia, PA: Elsevier-Saunders. 25th. [652-655].

69.

Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E,
Camporota L, Slutsky AS. (2012). Acute respiratory distress syndrome: the Berlin
Definition. Jama, 307(23):2526-2533. doi: 10.1001/jama.2012.5669. PubMed PMID:
22797452.

70.

Abrams CS. (2016). Thrombocytopenia. In: Goldman-Cecil Medicine [Internet].
Philadelphia, PA: Elsevier-Saunders. 25th. [1159-1167].

71.

Berk PD, Korenblat KM. (2016). Approach to the Patient with Jaundice or Abnormal
Liver Tests. In: Goldman-Cecil Medicine [Internet]. Philadelphia, PA: ElsevierSaunders. 25th. [983-993].

170

72.

Wan Z, Wu Y, Yi J, You S, Liu H, Sun Z, Zhu B, Zang H, Li C, Liu F, Li D, Mao Y, Xin
S. (2015). Combining serum cystatin C with total bilirubin improves short-term mortality
prediction in patients with HBV-related acute-on-chronic liver failure. PLoS One,
10(1):e0116968. doi: 10.1371/journal.pone.0116968. PubMed PMID: 25629773.

73.

Ong KL, Allison MA, Cheung BM, Wu BJ, Barter PJ, Rye KA. (2014). The relationship
between total bilirubin levels and total mortality in older adults: the United States
National Health and Nutrition Examination Survey (NHANES) 1999-2004. PLoS One,
9(4):e94479. doi: 10.1371/journal.pone.0094479. PubMed PMID: 24728477.

74.

Zheng MH, Shi KQ, Lin XF, Xiao DD, Chen LL, Liu WY, Fan YC, Chen YP. (2013). A
model to predict 3-month mortality risk of acute-on-chronic hepatitis B liver failure using
artificial neural network. J Viral Hepat, 20(4):248-255. doi: 10.1111/j.13652893.2012.01647.x. PubMed PMID: 23490369.

75.

Su HH, Kao CM, Lin YC, Lin YC, Kao CC, Chen HH, Hsu CC, Chen KC, Peng CC, Wu
MS. (2017). Relationship between serum total bilirubin levels and mortality in uremia
patients undergoing long-term hemodialysis: A nationwide cohort study. Atherosclerosis,
265:155-161. doi: 10.1016/j.atherosclerosis.2017.09.001. PubMed PMID: 28892712.

76.

Rivers EP. (2016). Approach to the Patient with Shock. In: Goldman-Cecil Medicine
[Internet]. Philadelphia, PA: Elsevier-Saunders. 25th. [672-681].

77.

Teasdale G, Jennett B. (1974). Assessment of coma and impaired consciousness. A
practical scale. Lancet, 2(7872):81-84. PubMed PMID: 4136544.

78.

Teasdale G, Maas A, Lecky F, Manley G, Stocchetti N, Murray G. The Glasgow Coma
Scale at 40 years: standing the test of time. The Lancet Neurology, 13(8):844-854. doi:
10.1016/S1474-4422(14)70120-6.

79.

Centers for Medicare & Medicaid Services, National Center for Health Statistics. (2017).
ICD-10-CM Official Guidelines for Coding and Reporting, FY 2018. Available from:
https://www.cdc.gov/nchs/data/icd/10cmguidelines2011_FINAL.pdf.

80.

Molitoris BA. (2016). Acute Kidney Injury. In: Goldman-Cecil Medicine [Internet].
Philadelphia, PA: Elsevier-Saunders. 25th. [778-783].

81.

Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I, Jaber BL.
(2013). World incidence of AKI: a meta-analysis. Clinical Journal of the American
Society of Nephrology, 8(9):1482-1493.

171

82.

Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D, Kellum
JA. (2006). RIFLE criteria for acute kidney injury are associated with hospital mortality
in critically ill patients: a cohort analysis. Crit Care, 10(3):R73. doi: 10.1186/cc4915.
PubMed PMID: 16696865.

83.

Barrantes F, Tian J, Vazquez R, Amoateng-Adjepong Y, Manthous CA. (2008). Acute
kidney injury criteria predict outcomes of critically ill patients. Crit Care Med,
36(5):1397-1403. doi: 10.1097/CCM.0b013e318168fbe0. PubMed PMID: 18434915.

84.

Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL,
Colardyn F, Blecher S. (1998). Use of the SOFA score to assess the incidence of organ
dysfunction/failure in intensive care units: results of a multicenter, prospective study.
Working group on "sepsis-related problems" of the European Society of Intensive Care
Medicine. Crit Care Med, 26(11):1793-1800. PubMed PMID: 9824069.

85.

Matics TJ, Sanchez-Pinto LN. (2017). Adaptation and Validation of a Pediatric
Sequential Organ Failure Assessment Score and Evaluation of the Sepsis-3 Definitions in
Critically Ill Children. JAMA Pediatr:e172352. doi: 10.1001/jamapediatrics.2017.2352.
PubMed PMID: 28783810.

86.

Forte DN, Ranzani OT, Stape N, Taniguchi LU, Toledo-Maciel A, Park M. (2007).
APACHE II and SOFA scores for intensive care and hospital outcome prediction in
oncologic patients. Critical Care, 11(Suppl 3):P93-P93. doi: 10.1186/cc5880. PubMed
PMID: PMC3301220.

87.

Elsayed FG, Sholkamy AA, Elshazli M, Elshafie M, Naguib M. (2015). Comparison of
different scoring systems in predicting short-term mortality after liver transplantation.
Transplantation Proceedings, 47(4):1207-1210. doi:
10.1016/j.transproceed.2014.11.067. PubMed PMID: 26036555.

88.

Hwang SY, Lee JH, Lee YH, Hong CK, Sung AJ, Choi YC. (2012). Comparison of the
Sequential Organ Failure Assessment, Acute Physiology and Chronic Health Evaluation
II scoring system, and Trauma and Injury Severity Score method for predicting the
outcomes of intensive care unit trauma patients. Am J Emerg Med, 30(5):749-753. doi:
10.1016/j.ajem.2011.05.022. PubMed PMID: 21802884.

89.

Demandt AMP, Geerse DA, Janssen BJP, Winkens B, Schouten HC, van Mook W.
(2017). The prognostic value of a trend in modified SOFA score for patients with
hematological malignancies in the intensive care unit. European Journal of Haematology,
99(4):315-322. doi: 10.1111/ejh.12919. PubMed PMID: 28656589.

172

90.

Mazzola P, Bellelli G, Perego S, Zambon A, Mazzone A, Bruni AA, Annoni G. (2013).
The sequential organ failure assessment score predicts 30-day mortality in a geriatric
acute care setting. J Gerontol A Biol Sci Med Sci, 68(10):1291-1295. doi:
10.1093/gerona/glt020. PubMed PMID: 23580741.

91.

Kantanen AM, Kalviainen R, Parviainen I, Ala-Peijari M, Backlund T, Koskenkari J,
Laitio R, Reinikainen M. (2017). Predictors of hospital and one-year mortality in
intensive care patients with refractory status epilepticus: a population-based study. Crit
Care, 21(1):71. doi: 10.1186/s13054-017-1661-x. PubMed PMID: 28330483.

92.

Oeyen S, Vermeulen K, Benoit D, Annemans L, Decruyenaere J. (2017). Development of
a prediction model for long-term quality of life in critically ill patients. J Crit Care,
43:133-138. doi: 10.1016/j.jcrc.2017.09.006. PubMed PMID: 28892669.

93.

Neto AS, Barbas CSV, Simonis FD, Artigas-Raventos A, Canet J, Determann RM,
Anstey J, Hedenstierna G, Hemmes SNT, Hermans G, Hiesmayr M, Hollmann MW,
Jaber S, Martin-Loeches I, Mills GH, Pearse RM, Putensen C, Schmid W, Severgnini P,
Smith R, Treschan TA, Tschernko EM, Melo MFV, Wrigge H, de Abreu MG, Pelosi P,
Schultz MJ. (2016). Epidemiological characteristics, practice of ventilation, and clinical
outcome in patients at risk of acute respiratory distress syndrome in intensive care units
from 16 countries (PRoVENT): an international, multicentre, prospective study. Lancet
Respir Med, 4(11):882-893. doi: 10.1016/s2213-2600(16)30305-8. PubMed PMID:
27717861.

94.

Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. (2001). Serial evaluation of the
SOFA score to predict outcome in critically ill patients. Jama, 286(14):1754-1758.
PubMed PMID: 11594901.

95.

Rubin DB. (1976). Inference and missing data. Biometrika, 63(3):581-592.

96.

Little RJA, Rubin DB. (2002). Statistical analysis with missing data. 2nd ed. Hoboken,
New Jersey: John Wiley & Sons.

97.

Allison PD. (2002). Missing Data. Thousand Oaks, CA: Sage Publications. 91 p.

98.

Rubin DB. (1987). Multiple imputation for nonresponse in surveys. New York, NY: John
Wiley & Sons. 258 p.

173

99.

Cornish RP, Tilling K, Boyd A, Davies A, Macleod J. (2015). Using linked educational
attainment data to reduce bias due to missing outcome data in estimates of the association
between the duration of breastfeeding and IQ at 15 years. International Journal of
Epidemiology, 44(3):937-945. doi: 10.1093/ije/dyv035.

100.

Ono M, Miller HP. (1969). Income nonresponses in the current population survey: US
Bureau of the Census.

101.

Graham JW. (2009). Missing data analysis: making it work in the real world. Annu Rev
Psychol, 60:549-576. doi: 10.1146/annurev.psych.58.110405.085530. PubMed PMID:
18652544.

102.

Bell ML, Fairclough DL, Fiero MH, Butow PN. (2016). Handling missing items in the
Hospital Anxiety and Depression Scale (HADS): a simulation study. BMC Res Notes,
9(1):479. doi: 10.1186/s13104-016-2284-z. PubMed PMID: 27770833.

103.

Little RJA. (1988). A Test of Missing Completely at Random for Multivariate Data with
Missing Values. Journal of the American Statistical Association, 83(404):1198-1202.
doi: 10.1080/01621459.1988.10478722.

104.

Allison PD. (2009). Missing Data. In: Milsap RE, Maydeu-Olivares A, editors. The
SAGE Handbook of Quantitative Methods in Psychology. London: SAGE Publications
Ltd. p.

105.

Park T, Davis CS. (1993). A test of the missing data mechanism for repeated categorical
data. Biometrics, 49(2):631-638. PubMed PMID: 8369395.

106.

Park T, Lee SY. (1997). A test of missing completely at random for longitudinal data
with missing observations. Stat Med, 16(16):1859-1871. PubMed PMID: 9280038.

107.

Heitjan DF, Basu S. (1996). Distinguishing missing at random and missing completely at
random. American Statistician, The, 50(3):207.

108.

Yeatts SD, Martin RH. (2015). What is missing from my missing data plan? Stroke,
46(6):e130-132. doi: 10.1161/strokeaha.115.007984. PubMed PMID: 25953373.

109.

Knol MJ, Janssen KJ, Donders AR, Egberts AC, Heerdink ER, Grobbee DE, Moons KG,
Geerlings MI. (2010). Unpredictable bias when using the missing indicator method or
complete case analysis for missing confounder values: an empirical example. J Clin

174

Epidemiol, 63(7):728-736. doi: 10.1016/j.jclinepi.2009.08.028. PubMed PMID:
20346625.
110.

Cohen J, Cohen P. (1983). Applied Multiple Regression/Correlation Analysis for the
Behavioral Sciences. 2nd ed. Hillsdale, NJ: Erlbaum.

111.

Jones MP. (1996). Indicator and Stratification Methods for Missing Explanatory
Variables in Multiple Linear Regression. Journal of the American Statistical Association,
91(433):222-230. doi: 10.2307/2291399.

112.

Lagu T, Lindenauer PK, Rothberg MB, Nathanson BH, Pekow PS, Steingrub JS, Higgins
TL. (2011). Development and validation of a model that uses enhanced administrative
data to predict mortality in patients with sepsis. Crit Care Med, 39(11):2425-2430. doi:
10.1097/CCM.0b013e31822572e3. PubMed PMID: 22005222.

113.

Rubin DB. (1996). Multiple Imputation after 18+ years. Journal of the American
Statistical Association, 91(434):473-489.

114.

Eekhout I, de Vet HC, Twisk JW, Brand JP, de Boer MR, Heymans MW. (2014).
Missing data in a multi-item instrument were best handled by multiple imputation at the
item score level. J Clin Epidemiol, 67(3):335-342. doi: 10.1016/j.jclinepi.2013.09.009.
PubMed PMID: 24291505.

115.

Allison PD. (2002). Missing data: Quantitative applications in the social sciences:
British Psychological Society. 193 p.

116.

Little RJA. (1988). Missing-Data Adjustments in Large Surveys. Journal of Business &
Economic Statistics, 6(3):287-296. doi: 10.1080/07350015.1988.10509663.

117.

Rubin DB. (1986). Statistical Matching Using File Concatenation With Adjusted Weights
and Multiple Imputations. Journal of Business & Economic Statistics, 4(1):87-94. doi:
10.1080/07350015.1986.10509497.

118.

U.S. Census Bureau. (2017). Center for Statistical Research & Methodology (CSRM):
Missing Data, Edit, and Imputation. [Accessed 10/1/2017]. Available from:
https://www.census.gov/srd/csrm/MissingData.html.

175

119.

Andridge RR, Little RJA. (2010). A Review of Hot Deck Imputation for Survey Nonresponse. International statistical review, 78(1):40-64. doi: 10.1111/j.17515823.2010.00103.x. PubMed PMID: PMC3130338.

120.

Bounthavong M, Watanabe JH, Sullivan KM. (2015). Approach to addressing missing
data for electronic medical records and pharmacy claims data research.
Pharmacotherapy:The Journal of Human Pharmacology & Drug Therapy, 35(4):380387. doi: https://dx.doi.org/10.1002/phar.1569. PubMed PMID: 25884526.

121.

van Buuren S. (2007). Multiple imputation of discrete and continuous data by fully
conditional specification. Stat Methods Med Res, 16(3):219-242. doi:
10.1177/0962280206074463. PubMed PMID: 17621469.

122.

Heitjan DF, Little RJ. (1991). Multiple imputation for the fatal accident reporting system.
Applied Statistics:13-29.

123.

Janssen KJ, Donders AR, Harrell FE, Jr., Vergouwe Y, Chen Q, Grobbee DE, Moons
KG. (2010). Missing covariate data in medical research: to impute is better than to
ignore. J Clin Epidemiol, 63(7):721-727. doi: 10.1016/j.jclinepi.2009.12.008. PubMed
PMID: 20338724.

124.

Welch CA, Petersen I, Bartlett JW, White IR, Marston L, Morris RW, Nazareth I,
Walters K, Carpenter J. (2014). Evaluation of two-fold fully conditional specification
multiple imputation for longitudinal electronic health record data. Statistics in Medicine,
33(21):3725-3737. doi: https://dx.doi.org/10.1002/sim.6184. PubMed PMID: 24782349.

125.

Lee KJ, Carlin JB. (2010). Multiple imputation for missing data: fully conditional
specification versus multivariate normal imputation. American Journal of Epidemiology,
171(5):624-632. doi: 10.1093/aje/kwp425. PubMed PMID: 20106935.

126.

Fitzmaurice GM, Kenward MG, Molenberghs G, Verbeke G, Tsiatis AA. (2015). Missing
data: Introduction and statistical preliminaries. In: Molenberghs G, Fitzmaurice GM,
Kenward MG, Tsiatus AA, Verbeke G, editors. Handbook of missing data methodology.
New York, NY: CRC Press. p. 3-22.

127.

Dempster AP, Laird NM, Rubin DB. (1977). Maximum likelihood from incomplete data
via the EM algorithm. Journal of the Royal Statistical Society Series B
(Methodological):1-38.

176

128.

Binquet C, VERRET C, CHENE G, SALMI L, LETENNEUR L, PALMER G, HAJJAR
M, SALAMON R. (1998). Principaux logiciels statistiques utilisables en épidémiologie.
Revue d'épidémiologie et de santé publique, 46(4):329-336.

129.

Yergens DW, Dutton DJ, Patten SB. (2014). An overview of the statistical methods
reported by studies using the Canadian community health survey. BMC Medical
Research Methodology, 14:1-7. doi: 10.1186/1471-2288-14-15. PubMed PMID:
PMC3922729.

130.

Dembe AE, Partridge JS, Geist LC. (2011). Statistical software applications used in
health services research: analysis of published studies in the U.S. BMC Health Services
Research, 11:1-6. doi: 10.1186/1472-6963-11-252. PubMed PMID: PMC3205033.

131.

Research Triangle Institute. (2017). About SUDAAN. [Accessed 9/13/2017]. Available
from: http://sudaansupport.rti.org/page.cfm/About_SUDAAN.

132.

PCORI Data Quality and Missing Data Workgroup. (2015). Data Quality and Missing
Data in Patient-Centered Outcomes Research Using EMR/Claims Data Meeting
Summary. [Accessed 8/31/2017]. Available from:
www.pcori.org/sites/default/files/PCORI-Data-Quality-and-Missing-Data-WorkgroupSummary-121015.pdf.

133.

Medical University of South Carolina. (n.d.). The Enterprise Data Warehouse.
[Accessed 10/20/2017]. Available from:
http://academicdepartments.musc.edu/edw/whytheEDW.

134.

Medical University of South Carolina. (n.d.). Accessing the EDW: Research. [Accessed
10/20/2017]. Available from:
http://academicdepartments.musc.edu/edw/accessingtheEDW/Research/.

135.

Medical University of South Carolina. (2017). MUSC Data Warehouse Status Run at: Fri
Oct 20 12:21:05 2017. [Accessed 10/20/2017]. Available from:
http://timon.musc.edu/lbg3/curstatus.html.

136.

Medical University of South Carolina. (n.d.). Biomedical Informatics Center: Research
Data Overview. [Accessed 10/20/2017]. Available from:
http://academicdepartments.musc.edu/bmic/ResearchDataOverview.html.

177

137.

Burton A, Altman DG, Royston P, Holder RL. (2006). The design of simulation studies
in medical statistics. Stat Med, 25(24):4279-4292. doi: 10.1002/sim.2673. PubMed
PMID: 16947139.

138.

Schulz KF, Grimes DA. (2002). Sample size slippages in randomised trials: exclusions
and the lost and wayward. Lancet, 359(9308):781-785. doi: 10.1016/s01406736(02)07882-0. PubMed PMID: 11888606.

139.

Bennett DA. (2001). How can I deal with missing data in my study? Australian and New
Zealand Journal of Public Health, 25(5):464-469. PubMed PMID: 11688629.

140.

Molenberghs G, Beunckens C, Sotto C, Kenward MG. (2008). Every missingness not at
random model has a missingness at random counterpart with equal fit. Journal of the
Royal Statistical Society: Series B (Statistical Methodology), 70(2):371-388.

141.

Hosmer DW, Lemeshow S, Sturdivant RX. (2013). Applied logistic regression. 3rd ed.
Hoboken, NJ: John Wiley & Sons, Inc. 500 p.

142.

Brand JP, van Buuren S, Groothuis-Oudshoorn K, Gelsema ES. (2003). A toolkit in SAS
for the evaluation of multiple imputation methods. Statistica Neerlandica, 57(1):36-45.

143.

Ambler G, Omar RZ, Royston P. (2007). A comparison of imputation techniques for
handling missing predictor values in a risk model with a binary outcome. Statistical
Methods in Medical Research, 16(3):277-298.

144.

Bondarenko I, Raghunathan T. (2016). Graphical and numerical diagnostic tools to assess
suitability of multiple imputations and imputation models. Statistics in Medicine,
35(17):3007-3020. doi: 10.1002/sim.6926.

145.

Plumpton CO, Morris T, Hughes DA, White IR. (2016). Multiple imputation of multiple
multi-item scales when a full imputation model is infeasible. BMC Res Notes, 9:45. doi:
10.1186/s13104-016-1853-5. PubMed PMID: 26809812.

146.

Allison PD. (2012). Paper 312-2012: Handling missing data by maximum likelihood. SAS
Global Forum 2012 [Internet]. Available from: www.statisticalhorizons.com/wpcontent/uploads/MissingDataByML.pdf.

147.

Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G,
Kahn JM, Shankar-Hari M, Singer M, Deutschman CS, Escobar GJ, Angus DC. (2016).

178

Assessment of Clinical Criteria for Sepsis: For the Third International Consensus
Definitions for Sepsis and Septic Shock (Sepsis-3). Jama, 315(8):762-774. doi:
10.1001/jama.2016.0288. PubMed PMID: 26903335.
148.

Bodner TE. (2008). What Improves with Increased Missing Data Imputations? Structural
Equation Modeling: A Multidisciplinary Journal, 15(4):651-675. doi:
10.1080/10705510802339072.

149.

Herritt B, Chaudhuri D, Thavorn K, Kubelik D, Kyeremanteng K. (2017). Early vs. late
tracheostomy in intensive care settings: Impact on ICU and hospital costs. J Crit Care,
44:285-288. doi: 10.1016/j.jcrc.2017.11.037. PubMed PMID: 29223743.

150.

Yoo BK, Kim M, Sasaki T, Hoch JS, Marcin JP. (2018). Selected Use of Telemedicine in
Intensive Care Units Based on Severity of Illness Improves Cost-Effectiveness. Telemed
J E Health, 24(1):21-36. doi: 10.1089/tmj.2017.0069. PubMed PMID: 28661790.

151.

Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE. (2012). Regression Methods in
Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models. 2nd ed. Gail M,
Krickeberg K, Samet JM, Tsiatis A, Wong W, editors. New York, NY: Springer.

152.

Manning WG, Basu A, Mullahy J. (2005). Generalized modeling approaches to risk
adjustment of skewed outcomes data. J Health Econ, 24(3):465-488. doi:
10.1016/j.jhealeco.2004.09.011. PubMed PMID: 15811539.

153.

Lilly CM, Zuckerman IH, Badawi O, Riker RR. (2011). Benchmark data from more than
240,000 adults that reflect the current practice of critical care in the United States. Chest,
140(5):1232-1242. doi: 10.1378/chest.11-0718. PubMed PMID: 21868469.

154.

SAS Institute Inc. (2016). SAS® 9.4 Functions and CALL Routines: Reference. Fifth ed.
Cary, NC: SAS Institute Inc. 1236 p.

155.

Matsumoto M, Nishimura T. (1998). Mersenne twister: a 623-dimensionally
equidistributed uniform pseudo-random number generator. ACM Transactions on
Modeling and Computer Simulation (TOMACS), 8(1):3-30.

156.

Shi L. (2008). Health services research methods. Clifton Park, NY: Delmar Cengage
Learning. 481 p.

179

157.

van Buuren S. (2010). Item imputation without specifying scale structure. Methodology,
6(1):31-36. doi: 10.1027/1614-2241/a000004.

158.

Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. (2012). Prognostic indices
for older adults: a systematic review. Jama, 307(2):182-192. doi:
10.1001/jama.2011.1966. PubMed PMID: 22235089.

159.

Johnson AEW, Pollard TJ, Shen L, Lehman L-wH, Feng M, Ghassemi M, Moody B,
Szolovits P, Anthony Celi L, Mark RG. (2016). MIMIC-III, a freely accessible critical
care database. Scientific Data, 3:160035. doi: 10.1038/sdata.2016.35.

